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Preface 
Photodynamic therapy (PDT) is an experimental modality for the treatment of benign and 
malignant lesions. Conventional forms of PDT involve the administration of an exogenous 
light-sensitive compound (photosensitizer) and subsequent exposure to visible light to induce 
tissue necrosis. 
PDT-research has been conducted in de Dr. Daniel den Hoed Cancer Centre (DDHK) 
in Rotterdam since 1979. The areas of research are: physical aspects, biological aspects and 
development of clinical applications. The physical group is mainly interested in the 
development of instruments for proper light delivery and light dosimetry during the treatment 
by PDT of, e.g., superficial bladder carcinoma and bronchogenic carcinoma. In the biological 
group the fluorescence and photodynamic properties of various exogenous photosensitizers are 
investigated. The exchange of knowledge between both groups is the strength of the PDT 
group in the DDHK. 
In 1989 a new method of tissue photosensitization was introduced by Kelmedy el al. 
Instead of administering of a photosensitizer, local photosensitization was induced by the 
application of 5-aminolevulinic acid (ALA), the precursor of the sensitizer protoporphyrin IX 
(PpIX). After application, the ALA is transformed into PpIX in the cells through the haem 
synthesis. In 1993 a project funded by the Dutch Cancer Society started in the DDHK called 
'Pholodynamic Iherapy and lissue fluorescence using pOJphyrill, elldogellously gellerated by 
applicalioll of 5-mlllllo-laeJ'lIlilllc acid: improJ'emelll of ALA-biom'ailabilily~ This project 
was a collabaration between three research groups. The research group in the DDHK was 
focused on clinical studies on the treatment of superficial skin tumours by ALA-PDT and on 
pre-clinical studies on the fluorescence kinetics and PDT responses in different animal models 
after topically and systemically adlninistered ALA. The other two research groups (Division of 
Medicinal Chemistry and the Division of Pharmaceutical Teclmology of the center for bio-
pharmaceutical sciences of the university of Lei den) were focused on improvement of the bio-
availability of ALA by increasing the ALA-penetration using lipophilic ALA-derivatives. The 
work done in Leiden was promising and three papers were published (Kloek el ai, 1996; Kloek 
el ai, 1998; Roemele el ai, not yet published). Unfortunately, due to the sudden death of H. 
Bodde, one of the principal investigaters, and the lack of further funding, research on ALA-
PDT in Leiden is minimal at tills moment. In the DDHK a follow-up project with clinical and 
preclinical research using ALA-PDT was started in 1998. TillS thesis presents the results of the 
preclinical research performed in the DDHK during the project mentioned above. 
Enschede, 1999 
Nynke van der Veen 
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Chapter 1 
Introduction 
In chapter 1 an outline is given of haem biosynthesis with a short review of the effect of 
abnoffilalities in the production of porphyrins, induced by deficiencies of enzymes or by 
exogenous ALA administration. The general principles of PDT are explained, followed by the 
basics of systemically and topically administered ALA. The clinical and preclinical studies are 
discussed separately and the results of some studies are mentioned as an illustration for the 
obtained effects and problems arising with PDT using ALA. In this chapter no ill vitro studies 
concerning ALA have been included. At the end of the chapter an outline of the thesis is given 
according to the route of ALA administration. The items that will be discussed in this chapter 
with the corresponding pages are shown below. 
Haem biosynthesis 
Porphyrin biosynthesis: 
in porphyria 
in tumours 
after ALA 
Photochemical reaction 
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PDT 
Routes of ALA administration 
Outline of the thesis 
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haem biosJ'lltllesis 
Haem synthesis can take place in all mammalian cells but the activity is quantitatively most 
prominent in bone marrow and liver. A simplified scheme of the haem biosynthetic pathway 
is shown in Figure 1. The haem biosynthetic pathway comprises eight steps, which are 
distributed between the mitochondria and the cytosol of the cell. Of all the enzymes in the 
pathway, ALA synthase (ALAS) has the lowest activity, followed by porphobilinogen 
deaminase (pBGD), whereas the other enzymes have much higher activities. The rate-limiting 
step is the conversion of glycine and succinyl CoA to ALA, which is under negative feedback 
control by haem. In the normal cells the enzymatic activities are strictly regulated to prevent 
damage due to an accumulation of toxic substrates. 
Haem Biosynthetic Pathway 
Glycine + Suecinyl-CoA 
-------------------------------
8-Aminolevulinie Aeid ~ 
Porphob i lino ge-~ ------------------~ -------- -
::,7:~:~~:~::+:= 
('
0 
proporph yri I~~~~l~-;;; -" -------l---------
protoporphyrin~~~I~-;~----------l---------
P;:::~yrin:~~::::::::::::::::I:::::::= 
I Haem 
Figure 1. Simplified biosyntheNc pat!nvay!or haem. 
Enzymes 
8-Aminolevulinic Acid synthase 
8-Aminole\~1Iinic Acid dehydratase 
Porphobilinogen deaminase 
Uroporphyrinogen synthase 
Uroporphyrinogen decarhoxylase 
Coproporphynnogcn oxidase 
Protoporphyrinogen oxidase 
Ferrochelatasc 
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POJphyrill biosynthesis ill porphyda 
The effect of metabolic abnonnalities in the haem biosynthetic pathway is seen in patients 
suffering from porphyrias. Human porphyrias are due to a partial deficiency of one of the 
eight enzymes. The predominant clinical manifestations of the porphyria can be divided into 
two general areas: neurologic abnormalities (an overproduction of porphyrin precursors) and 
cutaneous photosensitivity (an overproduction of porphyrins). The neurological 
manifestations (2 out of 8 porphyrias) are marked by recurrent, acute attacks which may be 
precipitated by exposure to certain drugs (antibiotics, homlOnes, sedatives), decreased food 
intake, infections and by an excess of alcohol intake. During an acute attack the primary 
clinical manifestations in patients are abdominal pain and psychiatric disturbances and 
peripheral neuropathy probably caused by the high ALA levels. In 6 out of 8 porphyrias, 
cutaneous photosensitivity is observed and depending on the deficient enzyme, excess ALA, 
PBG, copro, uro is observed in urine and protoporphyrin in faeces. Depending on the type of 
porphyria the clinical manifestation varies from an itching and bunling sensation to 
progressive mutilation and disfiguration of sun exposed areas. The photosensitive porphyrias 
are mainly non-acute. Severely afflicted patients must live under subdued light levels to 
prevent skin reactions. 
Porphyrill biosYllthesis ill tUlllours 
The first observation of a selective accumulation of porphyrins in malignant tissue was by 
Policard (1924) who noted typical red fluorescence in tumours of humans and animals when 
haemolysis was present. Benign and malignant liver tumours were also found to induce the 
skin photosensitivity as seen in porphyrias. Accordingly, porphyrin and precursor contents 
were estimated in various malignant tumours including adenocarcinoma (RaseUi et al., 1963) 
endocrine gland tumours (Zawirska ef al., 1979) and metastases of liver and kidney tumours 
(Zawirska ef al., 1979). By the end of the 1970's there was an increasing amount of evidence 
that the haem biosynthesis pathway could be disturbed in neoplastic disease. In general it was 
observed that the activity of PBG deaminase was increased and the activities of ALA 
dehydratase and ferrochelatase were reduced in various malignant and regenerating tissues 
(Schoenfeld ef al., 1987 and 1988). 
Porphyrin biosynthesis after ALA admillistration 
In search for a good model to investigate porphyrias, the first experimental porphyrin 
sensitization was performed by Meyer-Betz in 1913. He injected himself with 
hematoporphyrin which resulted in photosensensitization of the skin lasting for more than two 
months. In 1956 Berlin ef al. induced skin photosensitivity by oral ALA administration to 
animals and humans. The skin of the volunteers was exposed to light when it was cloudy, 
sunny and sunny in combination with snow. The skin reaction ranged from erythema and 
tingling sensation on the face, and painful burning followed by desquamation. The skin 
photosensitivity after ALA administration was limited to several days. 
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In the 1980's ALA induced photosensitization was investigated as a tool for inducing 
tumour cell death by photodynamic therapy. Kinetic studies using fluorescence were 
perfonned to examine which tissues were sensitive for PpIX accumulation. It was found that 
nonnal tissues may also show high PpIX levels after systemic ALA administration. Especially 
epithelial surfaces like epidennis, oral mucosa, respiratory tract mucosa, vaginal mucosa, 
rectal mucosa, endometrium and urothelium or glands/organs in continuity with such surfaces 
like liver, sebaceous glands, salivary glands and seminal vesicles may accumulate PpIX. 
Tissues of mesodermal origin like muscle, cOIlllective tissue, cartilage and blood cells did not 
show significantly enhanced PpIX after administration of ALA (Kennedy and Pottier, 1992). 
In 1990 Kennedy et al. introduced topical application of ALA to the skin. Local 
photosensitization was induced and the PpIX accumulation was found to be sufficient to 
produce damage to superficial actinic keratoses (AK) and squamous cell carcinoma (SCC) 
upon illumination. This type of photosensitization drew much attention and a large number of 
papers have been published on treating superficial non-melanoma skin lesions using topical 
ALA-PDT. 
Photochemical reactioll 
Protoporphyrin IX can be excited by light of an appropriate wavelength corresponding with 
the absorption spectmm of the sensitizer. The wavelengths applied with ALA-PDT are 
commonly 514,5 nm and between 632 and 635 mn. By absorbing photons PpIX can be 
excited to its excited singlet state and this excited singlet state can then decay back to the 
singlet ground state and emit light (fluorescence) without altering the PpIX molecule. After 
excitation to the excited singlet state the sensitizer can also undergo intersystem crossover to· 
its excited triplet state. Then, in the presence of oxygen the triplet excited state photosensitizer 
exchanges its energy with oxygen through collisions, which will lead to excited (singlet) 
oxygen (Type II reaction). The triplet photosensitizer can also react with biological substrates 
and fonn radicals, which can react with oxygen and fonn oxidized products (Type I reaction). 
The triplet photosensitizer thus falls back to the singlet ground state (Dougherty et al., 1984). 
Fluorescence 
With ALA-PDT, fluorescence is a useful tool to detennine the quantity, location and the 
kinetics of PpIX. HPLC measurements, cryomicroscopy and non-invasive measurements are 
used to detemline the fluorescence. Each method has it own (dis-)advantages which makes a 
combination of methods necessary. In this thesis non-invasive fluorescence in combination 
with cryomicroscopy measurements were perfomled. Three main problems arising with non-
invasive fluorescence detection are briefty discussed. One problem may be the relatively high 
autofluorescence signal of several tissues like the skin. Autofluorescence is the fluorescence 
of the tissue without the sensitizer. It is due to collagen, NADH and keratin and has an 
excitation optimum around 400 run. Depending on the site of the tumour the autofluorescence 
may strongly contribute to the fluorescence signal which consists of PpIX fluorescence and 
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autofluorescence. A method to overcome tIus problem is with dual wavelength excitation. The 
fluorescence of the target tissue is excited with two wavelengths, one of which is absorbed by 
both the sensitizer and the autofluorescence and a second wavelength at which only the 
autofluorescence is excited. By subtracting both signals the sensitizer signal can be estimated. 
A second problem using fluorescence detection may be the type of tissue surrounding the 
tumour. As mentioned before, proliferating and metabolically active cells can also produce 
considerable PpIX levels after ALA administration. The lesion may be difficult to detect when 
it is located in the liver or on the skin. The third problem is that the specificity of PpIX 
fluorescence after ALA administration is not high. Necrotic tissue or inflammation reactions 
may also fluoresce after ALA administration. 
Photodynamic therapy 
Singlet oxygen is the most important agent for inducing tissue damage with PDT. Singlet 
oxygen is a very short lived product (Foster ef al., 1991) and will therefore act locally (Moan, 
1990). The site of damage to the cell depends on the site of PpIX production and the 
localisation of the PpIX molecule within and outside the cell. PpIX is a lipophilic 
photosensitizer and will mainly cause damage to membranes (e.g. lysosomes, mitochondria, 
cytoplasm) after exposure to light (Moan ef al., 1989; Hilf ef al., 1992). Other PDT induced 
reactions, including apoptosis and the release of vascular mediators, have been described. 
Besides by this direct effect, an indirect effect may be necessary to achieve complete tumour 
destruction. Henderson ef al. (1995) observed in tissues removed immediately after the 
illumination no complete tumour destmction. Depletion of nutrients by vascular shut down, 
for a certain amount of time, seems necessary to induce complete tumour destruction. 
During PDT the concentration of oxygen in the tissue is reduced by oxygen 
consumption in the oxidative reactions taking place. The oxygen concentration during 
illumination is dependent on the rate of oxygen consumption and the rate of reoxygenation of 
the cell. Three factors influence the oxygen concentration in the cell during treatment. 
a Vascularisation of the tissue. 
The vascular development can barely keep up with rapidly proliferating tumours. Solid 
tumour masses have abnonnal blood vessel networks unlike vessels in nonnal tissues. The 
large intercapillary distances in tumours lead to hypoxic areas (Chapman, 1984) that arc less 
sensitive to PDT (Henderson and Fingar, 1987). During illumination the hypoxic area may 
expand when the rate of oxygen depletion is higher than the rate of reoxygenation. This effect 
is more likely to occur in tumour tissues than in Honnal tissues. 
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b Therapeutic conditions. 
The concentration ofPpIX in the cell, the wavelength and the fluence rate of the light applied 
influence the rate of oxygen consumption during illumination. \Vith a higher PpIX 
concentration the oxygen consumption is larger. The \vavelength used in systemic ALA-PDT 
is ofleu 514,5 or between 632 and 635 nm. At the lower wavelength the absorption of light is 
higher which results in a faster oxygen consumption compared to an illumination with 635 
nm. Illuminating with a high fluence rate also results in a higher oxygen consumption. 
c Vascular constriction. 
During illumination vascular constriction may occur. Constriction of alierioles is observed 
immediately after the start of the illumination, and the venules follow in time during the 
illumination. \Vhen the illumination is stopped the constriction is largely reversible. The 
explanation for this effect is not yet clear but the consequence is a strongly reduced oxygen 
concentration in the cell due to a limited reoxygenation. The constriction is believed to occur 
only after systemically administered ALA. Several studies indicate however that also after 
topical ALA vascular shutdown occurs. The fluence rate used influences the severity of the 
vascular constriction. A low fluence rate results in less constriction (this thesis, chapter 6). 
ROlltes of ALA administratioll 
ALA can be administered systemically (intravenously and intraperitonially in animals and 
orally in humans) and topically. Because both routes have their own target tissues and 
problems they will be discussed separately. For systemic ALA administration more preclinical 
studies than clinical studies have been published, for topical ALA administration this was 
reverse. Therefore, preclinical studies on systemic administration will be discussed first 
whereas for topical ALA-administration clinical studies will be discussed before the 
preclinical studies. 
Systemic ALA administration 
Preclinical studies 
In animal studies ALA dissolved in PBS was administered intravenously (Lv.) or 
intraperitonially (Lp.). The dntg doses varied between 100 and 1200 mglkg but at the high 
dmg dose animals showed toxic reactions and some died. Several studies have been published 
using orally administered ALA (Van den Booger! ef al., 1998; Loh ef al., 1993; Van 
Hillegersberg ef al., 1992). Loh ef al. (1993) examined the difference in PpIX accumulation 
between orally and Lv. administered ALA (bolus). They observed that Lv. and orally 
administered ALA gave similar PpIX fluorescence kinetics in tissues, although a higher oral 
dose was required to achieve the same amount of porphyrins as by Lv. injection. Van 
Hillegersberg ef al. (1992) dissolved ALA in the drinking water of rats for 2-11 days which 
resulted in detectable PpIX levels in a colon tumour transplanted in the liver. 
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In the initial animal studies PplX levels in different nomlal tissues and tumours after 
ALA administration were detennined. In general it was found that in most nonnal tissues 
deriving from ecto- and endodenn and in tumours PpIX levels peaked at approximately 1-8 
hours after ALA administration and were almost completely eliminated within 24 hours. The 
interval to maximal fluorescence was dependent on the dmg dose used. ·With a high ALA 
dose PpIX levels peaked later than with a low ALA dose (Bedwell el al., \992). Higher PpIX 
levels could also be obtained by fractionated ALA administration instead of a bolus (Regula el 
al., 1995). In general it was found that the fluorescence kinetics of PpIX probably depends 
upon the type ofnomlal tissue and tumour, ALA dose and fractionated ALA administration. 
After detennining the interval of maximum tissue fluorescence, PDT studies were 
executed. Although detectable PpIX levels occurred, systemic ALA-PDT often produced 
insufficient and uureproducible damage. 
Present studies are focussed on improving the PDT~efficacy. Besides increasing the 
bioavailability of ALA, optimization of the oxygen concentration during illumination is being 
investigated. Messmann et al. (1995) observed an increase in depth of necrosis ofnonnal rat 
colon after a single intelTuption of about one minute. Hua et al. (1995) and Cumow el al. 
(1999) obtained a considerably increased delay in tumour growth when the applied light was 
fractionated (30 slight, 30 s no light). De Bruijn el al. (1999) observed in a solid tumour 
model an increased tumour growth delay after twofold illumination. 
Clillical sludies 
There is a limited number of pUblications about systemic ALA-PDT in patients. Grant et al. 
(1993) reported the first clinical results for oral ALA. Patients with oral cancer received ALA 
dissolved in orange juice in doses of 30 and 60 mg/kg ALA. Besides mild, transient nausea 
orland transient abnonnalities of liver function no other side effects or neurotoxic symptoms 
were observed. PplX induced fluorescence peaked 4~6 hours after administration of ALA, 
depending on the dose, and had disappeared after 24 hours. Several studies were published of 
limited numbers of patients with rectal adenomas following surgery (Warloe el al., \995), 
gastrointestinal tumours and polyps (Regula el aI., 1995; Mlkvy el al., 1995), cancer and 
dysplasia in Barrett's oesophagus (Barr el al., 1996). In all cases only partial necrosis of non-
superficial or even superficial tumours could be obtained. 
Because of toxicity, the PDT efficacy can not be increased using higher oral ALA 
doses. A fannulation for intravenous ALA administration to patients may resolve this 
problem. Treatment schemes obtained from animal studies seems not successful in patients. 
Fan el al (1996) treated patients with precancer and cancer of the oral cavity with 
unsatisfactory results also after fractionated light doses and twofold illuminations. It should be 
noted that the low ALA doses used in this study are likely to account for the lack of damage 
after PDT. 
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Figure 2. Fluorescence illlage of hlllllan basal cell carcinollla following a 4 hOllr ALA-
application period. The fluorescence was excited with 514.5 11111 Iigh' and detected through all 
OG 570 high passjiller. 
Topical ALA admiuistratioll 
Clinical studies 
The ALA-PDT protocol used by Kennedy el 01. (1990) still fomlS the basis for much clinical 
research to date. The treatment consists of local application of a 20% ALA solution to the 
target area for 3 to 8 hours followed by illumination. After the application red PpIX 
fluorescence can be observed in the tumour which is clearly demarcated from the surrounding 
normal skin (illustration in Figure 2). The photosensitized tumour with a margin of 
surrounding skin is illuminated with light of a suitable wavelength and dose which results in 
superficial tumour necrosis. In the past 8 years many investigators studied the efficacy of 
ALA-PDT for the treatment of superficial actinic keratoses (AK), basal cell carcinoma (BCC), 
squamous cell carcinoma (SeC) and Bowen's disease. Long term histological complete 
responses were 92% for AK, 87% for Bee, 81 % for see and 85% for Bowen's disease 
(Caimduff el al., 1994; Lui el al., 1995; Meijnders el 01., 1996; Stables el 01., 1997; Svanberg 
el al., 1994; Wolf el 01., 1993). Nodular BCC and SCC were also treated with ALA-PDT but 
the results were disappointing in all studies (between 0 and 50% complete clinical response 
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rate). Fink-Puches ef al. (1998) reported a projected disease free rate of36 months atier ALA-
PDT of 50% for superficial Bee and only 8% for superficial see. The light source, tiuence 
rate and light fluence applied varied markedly between the different studies. Although the 
results of treating nOIHnelanorna skin lesions with ALA-PDT are promising, large variations 
within and between patients have been observed. These variations in combination with the 
large variations in the treatment conditions like wavelength, fluence rate and light fluencc, 
make the results of comparative studies difficult to interpreted. In several studies the 
fluorescence of the tumour after topically applied ALA was monitored. In nonnal skin the 
fluorescence was limited to the cpidemlal layer and the skin appendages. Also, it was found 
that the grade of lesions correlated inversely with the level of PpIX fluorescence after topical 
ALA-application (Jeffes ef al., 1997; Szeimies ef aI., 1996). PpIX fluorescence could only be 
detected superficially and in nodular lesions no fluorescence was detected in the deeper layers 
as demonstrated by Martin ef al. (1995). 
The stratum comenm (SC), the protective layer of the skin (Goff ef al., 1992) plays a 
cmcial role in the penetration of ALA through the skin. The thickness and the composition of 
the se above skin lesions like AK, sec and Bee is different from nomlal skin which 
generally results in an increased penetration of ALA through the abnomlal skin. In the SC 
layer there is hardly any metabolic activity and the SC acts like a passive diffusion medium. 
The penetration of the dmgs in general is correlated with the thickness and composition of the 
SC (Maibach, 1971). The thickness and composition of the se vary strongly between 
different parts of the body. Non-melanoma skin lesions occur most frequently on the head, 
neck and hands, parts ofthe body habitually exposed to sunlight. In humans, the skin and AK 
on the face and scalp show a higher fluorescence intensity than on the extremities or the tnmk. 
(Jeffes ef al., 1997; Szeimies ef al" 1996). Subsequently, atier light irradiation a significantly 
better response of AKs on the face and scalp (9l% complete response) was observed than on 
the tnmk and extremities (45% complete response) (Jeffes ef al" 1997). 
Options to improve the therapeutic ejJectil'elleSS of ALA-PDT. 
Although topical ALA-PDT is promising for snperficiallesions, the effectiveness needs to be 
improved to compete with conventional treatments. Also, the effectiveness of ALA-PDT for 
nodular lesions must be improved. Several options, mainly focused on improving the ALA 
penetration through the skin, will be discussed briefly. 
- Penetration enhancer. Dimethylsulfoxide (DMSO) is a skin penetration enhancer which is 
otien used in demlatophannacology for topically applied dmgs. DMSO increased the 
flnorescence atier ALA-application of nodular lesions (Peng ef al., 1995). However, the PDT 
effect of treating nodular lesions was not clearly improved (\Varloe et al., 1995; Peng et al., 
1995). 
- Penetration enhancer in combination with an iron chelator. Ethylene-diamine-tetra-acetic 
acid disodium salt (EDT A) is a chelator and reduces the iron concentration in the tissue and 
therefore reduces the conversion of PpIX to haem. A combination of ALA with 
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EDT AlDMSO applied simultaneously or DMSO applied as a prefactor resulted in an 
increased fluorescence in nodular BeC, although the fluorescence distribution was still 
inhomogeneous in some cases, Especially the efficacy of PDT for nodular lesions smaller than 
2 nl1l1 improved after the combination therapy (Orenstein el al., 1995; Warloe el al., 1995). 
In this group lesions treated with ALA alone showed a complete response rate of 67% 
whereas lesions treated with a combination of ALAfDMSO/EDT A showed a complete 
response rate of 91 %. The complete response rate of superficial BeCs was not improved 
(Warloe el al. , 1995). 
- Prolonged ALA-application. In clinical studies ALA is mostly applied for 3 to 8 hours. 
Szeimies el al. (1993) reported that an application interval of 4 h was too shoti to detect 
substantial fluorescence in Bee. Only after 12 h of application, fluorescence was detectable 
in tumour cells in the deep demlis. Also, application intervals of 16 to 19 hours has been used 
in clinical studies (Meijnders el al., 1996). After this long interval the fluorescence of the 
surrounding skin was similar to the fluorescence of the tumour. No comparative studies 
between a short and a long ALA application interval have been perfonlled to detenlline the 
differences on the ALA-PDT induced damage. 
- Repeated ALA-PDT. Rcpeated topical ALA-PDT has been used for lesions that failed to 
respond to previolls treatments. The number of treatments varies. Calzavara-Pinton (1995) 
treated lesions every other day until complete clinical disappearance. Repeated treatments, 
which mostly consisted of 2 additional ALA-PDT treatments, did not clearly improve the 
complete response rate for superficial lesions and for small nodular lesions compared to a 
single treatment. Only for nodular BeC larger than 2 mm did the complete response rate 
increase from 43% after a single treatment to 76% after repeated treatments (Svanberg et at., 
1994; Warloe el al., 1995; Fijan el al., 1995). Using long application intervals (up to 24 h) 
and repeated treatments (up to 8 times) cutaneons T-cell lymphoma could be histologically 
cleared (Shanler el al., 1994). 
- Iontophoresis. Iontophoresis is a successful tecllllique to deliver water soluble drugs into the 
skin. It involves the active delivery of small charged molecules into the skin by the 
application of an electrical CUlTen!. Rhodes el al (1997) applied this method to nomml human 
skin and depending on the current applied they observed a high increase in fluorescence of the 
skin compared to skin only with ALA and llsing only passive diffusion. 
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Olher c1il/ical applicatiol/s for lopical ALA-based PDT 
Promising topical ALA application methods are instillation of ALA in the bladder to detect 
and treat carcinoma in situ (Eder el al., 1995; Kriegmair el al., 1994; Stenzl el al., 1996) and 
inhalation of ALA aerosols to detect and treat early cancer in the bronchi (Baumgartner el al" 
1996). Nonneoplastic skin diseases in which the use of topical ALA-PDT is under 
investigation are, psoriasis (Nelson el al., 1995), condyloma acuminata (Frank el al., 1996) 
and hirsutism (Grossman el al., 1995). 
Preclinical studies 
Most studies have been performed on tumours transplanted subcutaneously in rats and (nude) 
mice. Similar experimental conditions were applied as in the clinical studies. With in-vivo 
and ex-vivo fluorescence studies it was observed that the fluorescence in normal skin was 
localized in the epidemJis, hair follicles and sebaceous glands (Henderson el al., 1995; Peng el 
al., 1992). The fluorescence of the skin overlying the tumour was the highest followed by 
nomlal skin and the least fluorescence was observed in the tumour (Henderson et al., 1995; 
Peng el al., 1992). The tumour growth delay after topical ALA-PDT was only minor 
(Caimduff el al., 1995; Henderson el al., 1995; Peng el al., 1992). Henderson el al. (1995) 
examined the perfusion of the skin after illumination and observed less blood flow compared 
to the blood flow before the illumination. This indicates that also after topical ALA vascular 
constriction may occur. These results were supported by our experiments as shown in chapter 
6. Malik el al. (1995) reported that in a subcutaneously transplanted colon tumour the 
fluorescence could not significantly be increased after applying ALA in combination with 
DMSOIEDTA. 
Concludillg remarks 
In this chapter the different ALA administration routes have been discussed briefly. With PDT 
using systemically administered ALA the maximum depth of necrosis in tissues is 
insufficient. in both preclinical and clinical studies. Topical ALA-PDT for the treatment of 
superficial non-melanoma skin tumours in humans seems successful. The PDT -efficacy in 
nodular skin tumours is insufficient. 
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Olltlille oft"e t"esis 
In this thesis the effectiveness of PDT following systemic and topical ALA administration 
was investigated in different animal models. \Vith both administration routes the fluorescence 
kinetics were first detennined and based on the kinetics, intervals to a therapeutic illumination 
were chosen. Based on the observed damage effects new treatment protocols were assessed to 
improve the effectiveness of PDT. 
Studies llsing systemically administered ALA 
Chapter 2 
The rat skin fold observation chamber contains a thin layer of subcutaneous tissue (approx. 0.6 
mm thick) with paired small arterioles and venules, into which a syngeneic tumour (mammary 
tumour) can be transplanted. In this model the fluorescence kinetics after two different doses 
of systemically administered ALA were monitored. At the time of maximum difference of 
fluorescence between the tumour and the surrounding tissue, the chambers were illuminated 
and the differences in effects between a high and a low ALA dose were examined. During the 
illumination vascular constriction of both the arterioles and venules of the subcutaneous tissue 
was found. The PDT-effect on the blood flow in arterioles, venules and capillaries of 
subcutaneous tissue and tumour tissue after the illumination was monitored until 7 days post 
PDT. Based on the observed damage effects treating at maximum selectivity, an illumination 
earlier after ALA administration and multiple illuminations (early p.i. and at maximum 
selectivity) were applied after the highest ALA dose to successfully increase the effectiveness 
of PDT. 
Chapter 3 
The solid tumour model is an isologous rhabdomyosarcoma which grows subcutaneously on 
the thigh of rats. \Vhen the tumour reached a diameter of 4-5 nun ALA was administered 
systemically and an illumination was given through the skin. After illumination the tumour 
growth was measured using callipers and the macroscopical damage effects of the illuminated 
skin were detennined. The solid tumour model was used to rapidly evaluate the ALA-PDT 
effects of different treatment schemes after systemically administered ALA. The effect of 
interval p.i. to illumination (PpIX concentration), reduced fluence rate (less constriction and 
less oxygen consumption), ShOli tenn light fractionation schemes (reoxygenation) and long 
teml light fractionation scheme (reoxygenation, new PpIX) on the tumour growth delay were 
detennined. 
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Study concerning the difference hI fluorescence between systemically and topically 
administered ALA 
Chapter 4 
The hairless mouse model develops small skin lesions like AK and SCC on the back as a 
result of daily UVB illumination. These tumours show a strong resemblance with sunlight 
induced skin lesions like AK and SCC observed in humans. In this chapter the differences in 
fluorescence kinetics between intraperitonially and topically administered ALA were 
detemlined. At the time of maximum fluorescence tissues were harvested and the localisation 
of fluorescence was detemlined using fluorescence cryo-microscopy 
Stlldies IIsing topically applied ALA 
Chapter 5,6 
In chapter 5 and 6 the cffectiveness of topically applicd ALA-PDT was examined in the 
hairless mouse model. Based on the fluorescence kinetics presented in chapter 4, two intervals 
for illumination were chosen: immediately after a 4 hr ALA-application (clinical protocol) 
and at maximum tumour fluorescence, 6 hours after the end of the 4 hr ALA-application 
(t~lO). The photobleaching during aud the fluorescence spectra during PDT were detemlined 
to obtain infonnation about the bleaching rate (Chapter 5). In the same chapter re-appearancc 
of fluorescence is shown following PDT. Also, the fluorescence spectra were measured to 
detennine whether the new fluorescence after PDT showed the characteristic PpIX spectrum. 
In Chapter 6 the results arc presented of illumination immediately after the application 
interval or at maximum fluorescence intensity. The development and recovery of damage to 
the illuminated area was detennined macroscopically up to a maximum of 3 weeks after PDT. 
Vascular cffects during the illumination was examined with two methods: fluence-rate 
measurcments under the skin during the illumination and fluorescein dye exclusion 
measurements immediately after the illumination. Subsequently, the effect of the fluence-rate 
and long light fractionation (illuminations at t~4 and t~10) on the effectiveness of PDT was 
detennined. 
Chapter 7 
In this chapter the PpIX-fluorescence kinetics in nonnal and tape-stripped human skin was 
determined during and after ALA application. To examine differences in fluorescence 
between various locations, the fluorescence was detennined in areas on the flexor of the 
foreann and the lower part of the back. In addition, the effect of a prolonged application 
interval of 16 hours was compared with an application interval of 4 hours. The fluorescence 
was cxcitcd with 3 different wavelength bands, violet (400 ± 30), green (500 ± 20) and red 
(625 ± 20) light. 
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Chapter 2 
In vivo fluorescence kinetics and photodynamic therapy 
using ALA-induced porphyrin: increased damage after 
multiple inadiations. 
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Abstract 
The kinetics of fluorescence in tumour (TT) and subcutaneous tissue (ST) and the vascular 
effects of photodynamic therapy (PDT) were studied using protoporphyrin IX (PpIX), 
endogenously generated after i.v. administration of 100 and 200 mglkg 5-aminolevulinic acid 
(ALA). The experimental model was a rat skinfold observation chamber containing a thin 
layer of ST in which a small syngeneic mammary tumour grows in a sheetlike fashion. 
Maximum TT and ST fluorescence following 200 mglkg ALA was twice the value after 100 
mglkg ALA, but the initial increase with time was the same for the two doses in both TT and 
ST. The fluorescence increase ofST was slower and the maximum fluorescence was less and 
appeared later compared to TT. Photodynamic therapy was applied usil1g green argon laser 
light (514.5 11m, 100 J/cm'). Three groups received a single light treatment at different 
intervals after administration of 100 or 200 mglkg ALA. In these groups no cOlTclation was 
found between the fluorescence intensities and the vascular damage following PDT. A fourth 
group was treated twice and before the second light treatment some fluorescence had re~ 
appeared after photobleachil1g due to the first treatment. Only with the twofold light treatment 
was lasting TT necrosis achieved) and for the first time with any photosensitizer in this model 
this was accomplished without complete ST necrosis. 
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Introduction 
Photodynamic therapy (PDT) is an experimental cancer treatment modality using 
photosensitizers that can produce tissue destruction upon absorbing light of an appropriate 
wavelength and dose. The photosensitizer Photofrin, a derivative of hematoporphyrin, is 
currently under clinical investigation. Photofrin consist of a mixture of porphyrins, 
hydrophillic and hydrophobic, which have different fluorescent and photodynamic properties 
(Kessel, 1982; Dougherty, 1987). The hydrophillic components fluoresce but are less 
photodynamically active, whereas the hydrophobic and photodynamically active components 
generally lack fluorescence. Therefore, the amount of tissue fluorescence after photosensitizer 
administration is not directly related to the possible PDT effect. Besides this complexity, the 
major side effect of Photofrin administration is prolonged photosensitivity of the skin 
(Dougherty e/ al., 1990). These drawbacks have stimulated a search for better 
photosensitizers for hnnour localization and PDT. 
An alternative to administering exogenous photosensitizer is to stimulate cells to 
generate their own photosensitizer. This can be achieved by 5-aminole\~llinic acid (ALA) 
which can be converted in situ into protoporphyrin IX (PpIX). ALA is present in all mam-
malian cells and is the first committed intem1cdiate in the haem biosynthesis pathway. 
Exogenous ALA bypasses the feedback control, which is regulated by haem, and can 
therefore induce an intracellular accumulation of PpIX. PpIX is an effective photosensitizer 
which is associated with the skin phototoxicity seen in patients with porphyria (Jarrett el al., 
1956; Shanley e/ al., 1972). Animal experiments have shown that after intravenous (i.v.) ALA 
administration only certain types of tissues manifest PpIX fluorescence (Bedwell et al., 1992; 
Loh e/ al., 1992). This tissue-specific photosensitation provides a basis for using ALA-
induced PpIX for tumour localisation and photodynamic therapy. In contrast to Photofrin, the 
fluorescence intensity after ALA administration is an indication of the PpIX concentration in 
tissues (Loh e/ al., 1993). Therefore, fluorescence kinetics can probably be used for 
determining the optimum interval between ALA administration and light treatment. Another 
advantage of ALA induced PpIX is the various possibilities for administration of ALA, 
besides i.v .. Promising results have been obtained in treating basal cell carcinomas using 
topically applied ALA (Kennedy and Pottier, 1992). With topical application an enhanced 
selective effect with PDT can be expected because of the restriction of the induced sensitizer 
to the lesion and the immediately surrounding nomlal skin. Loh e/ al. (1993) reported about 
selective fluorescence of inoperable rectal adenocarcinomas after oral administration in two 
patients. Grant e/ al. (1993) treated patients suffering from oral cavity squamous cell 
carcinomas with PDT after oral ALA administration. They found no side effects and a rapid 
clearance of the sensitizer within 24 hours. 
17 
In this paper we describe the fluorescence kinetics of PpIX, in rat mammary hnllour 
and subcutaneous tissue, after two Lv. doses of ALA. Based on the fluorescence dynamics 
different treatment time-points post injection (poi.) were chosen and a comparison was made 
between the photodynamic effects with the two drug doses and different intervals between 
ALA administration and light treatment. Finally, the vascular effects during and after treat-
ment and the role of these effects on the outcome of tumour tissue necrosis are discussed. 
Materials and Methods 
Allimal model 
All studies were perfonned on 12 weeks old female \V AGlRij rats weighing 1l0-120 g and 
supplicd by ITRIITNO, Rijswijk, The Netherlands. The model used was a skin fold 
observation chamber previously described by Reinhold e/ al. (1979). The transparcnt chamber 
(l cm diameter of visible tissue) contains a thin layer of subcutaneous tissue (approx. 0.6 mm 
thick), with paircd small arterioles (approx. 0.03 mm) and venules (approx. 0. I mm), in which 
a transplantable tumour can grow in a sheet-like fashion. Briefly, the chamber was attached to 
a piece of mica (4.5 x 2.5 cm) which was subcutaneously implanted in the skinfold. A piece 
of plastic was placed over the skinfold to protect the chamber. After two weeks preparation 
time a small piece of syngeneic mammary carcinoma (0.5 mm3) was transplanted into the 
tissue close to a large blood vessel. During all surgical procedures Hypnonn (fluanisollfenta-
ny! mixture, Janssen Phannaceutics, Belgium) was used as an anaesthetic and Garamycin 
(Essex Laboraties) was administered to prevent bacterial infection. To ensure adequate 
tumour growth the animal was kept in a temperature controlled cabinet at 32°C. The ambient 
light level was less than 30 mW/cm', with a 12112 h light/dark interval, to prevent unwanted 
photodynamic damage after sensitization of the animal. Approximately one week after 
transplantation, when the tumour had grown to about 3 mm diameter and adequate circulation 
in both tumour and subcutaneous tissue had established, experiments were started. 
Fluorescence killetics studles 
The fluorescence set up consisted of a CCD camera with a two stage image intensifier and a 
25 mm Leitz Photar macrolens. Fluorescence was excited with 514.5 nm Argon laser light 
using 0.1 m'\V/cm2 and fluorescence was detected through a high pass coloured glass filter 
(RG 665). For each recording the chamber was exposed to the excitation light for a period of 
60 seconds. About 10 recordings were made, so that the maximal light dose was 0.06 J/cm2 
which proved to be sufficiently low to avoid photodynamic damage. Animals were 
anaesthetized with Hypnorm and placed on a temperature controlled stage under the CCD 
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camera. An autofluorescence image was recorded before Lv. ALA administration. ALA was 
obtained as hydrochloride in 98% pure powder fom1 from Sigma Chemie (Bomcm, Belgium), 
It was dissolved in phosphate buffered saline and immediately administered i.v. via a tail 
vein. Two groups, each of six animals, received 100 or 200 mg/kg ALA and at various time 
inten'ais from 30 up to 360 min p.i. fluorescence images were recorded and stored in the 
computer. Fluorescence was quantified digitally by calculating the mean grey scale value 
within selected areas of the recorded fluorescence image. All fluorescence measurements, 
except those rccorded after a light treatment (Fig 3), were corrected for their respective 
autofluorescence signals in the same area before ALA administration. 
Phototherapy studies 
Four groups, each of six animals receiving 100 or 200 mg/kg ALA, were treated at different 
starting points p.i.. The treatment starting points were based on the results obtained from the 
fluorescence experiments (Table I). Animals were anaesthetized and placed on a temperature 
controlled stage of a microscope. The circulation of arterioles and venules of subcutaneous 
tissue (ST) and the capillaty beds of ST and tumour tissue (TT) was observcd and through an 
optical fibre and a lens system with diaphragm a unifonn beam of 514.5 11m light, with a 
power density of 100 mW/cm', was projected through the stagc onto the back of the entirc 
chamber. Green light was chosen for convenience, since this was also used for fluorescence 
excitation and is at least as effective for PDT as red light. The tissue layer of the chamber is 
so thin that green light penetration is sufficient, 8nd we S8W no difference in damagc between 
both sides of the chamber. The treatment dose was 100 J/cm1 which required a treatment time 
of 17 minutes. After 5 minutes (30 J/cm2) the irradiation was briefly intermpted to see 
whether immediate constriction of the vessels occurred. It should be notcd that IT only 
contains small capillaries and no large venules and arterioles like ST. Up to 7 days after 
treatment the status of the circulation was detennincd daily. The total damage to TT and ST 
was translated into a score on a 0 to S scale, i.e. nine levels. Damage scores during and at the 
end of the treatment were based on other effects than those obscrved at I up to 7 days after 
treatment. During treatment effects like ischaemia, constriction and stasis were obsenred. 
From I up to 7 days after treatmcnt vascular stasis was the predominant obsen'ation and was 
therefore also the dominant fhctor in the damage score (Table II). If the circulation ofTT had 
not completely recovered after 7 days, the content of the chamber was transplanted into the 
flank of the same animal to sce whether regrowth occurred. 
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Table 1. Summary of the phototherapy studies on four groups of animals receiving 
100 or 200 mg/kg ALA and treated at different times p.i. (max.= maximal, diff.= 
difference, TT = tumour tissue, ST = subcutaneous tissue). 
Group ALA dose Light dose PDT p.i. Fluorescence 
(mglkg) (J/cm') (min) at PDT 
A 100 100 120 max. diff. IT-ST 
B 200 100 150 max.diff. IT-ST 
C 200 100 60 113 ofmax.diff. TT-ST 
D 200 100/100 60/150 113 and max.diff. IT-ST 
Results 
Fluorescence kinetics studies 
The fluorescence data of IT and ST after Lv. administration of 100 mg/kg ALA are shown in 
Figure la and those of 200 mg/kg ALA in Figure lb. All values in these graphs were 
corrected for background fluorescence using the autofluorescence image, which had a grey 
scale level of25 for both IT and ST. With both drug doses, at all intervals recorded, no fluo-
rescence of the blood vessels could be detected. For TT an almost similar increase of 
fluorescence was observed during the first 90 min p.i. for both drug doses. After 90 min p.i. 
the fluorescence intensity in the 100 mglkg group levelled off reaching a peak at 150 min p.i. 
after which fluorescence intensity declined rapidly. With 200 mg/kg ALA an increase could 
be absenTed up till 240 min p.i. and maximal fluorescence intensity was almost twice the 
value compared to 100 mg/kg ALA. Fluorescence of ST after both doses increased more 
slowly compared to TT. With both doses nearly the same increase of fluorescence was 
observed during the first 150 min. After ISO min p.i. fluorescence maintained the same level 
during at least 120 min with 100 mg/kg. With 200 mglkg an increase could be observed up till 
330 min p.i. and the maximal intensity was twice compared to 100 rug/kg. With both doses 
the fluorescence intensity of IT and ST had returned to background level at 24 hours p.i.. 
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Flglll'e 1. Fluorescence kinetics, Istandard error a/mean (s.e.1J1.j, expressed as grey scale 
values, of tumour tissue alld subcutaneous tissue after adminis/ratioll of 100 (aJ and 200 
mg/kg (b) ALA. Both doses were studied with six animals each. Fluorescence measllremellfs 
were corrected for their respective autofluorescence. 
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Table II. Circulation damage scores used for quantification of vascular damage by PDT to tumor tissue and subcutaneous tissue 
in the skin fold observation chamber. Intermediate scores were assigned to damage levels between those defined in the table 
(capil = capillaries; rbcc = red blood cell column). 
Circulation 
Damage 
Score 
o 
2 
4 
6 
8 
Subcutaneous tissue Tumour tissue 
During and 
after PDT 
1-7 days 
after PDT 
During and 
after PDT 
no observable damage to capillaries or venules 
Arteriolar spasm 
:;:;25% capillary stasis 
Mildly reduced RBCC in 
venules and arteriolar 
spasm 
'" 25% capillary stasis 
'" 50% capillary stasis 
Mildly reduced blood 
flow in vessels 
",75% capillary stasis ",70% capillary stasis 
Strongly reduced RBCC in Strongly reduced blood 
venules and arteriolar 
spasm 
flow in vessels 
Ischaemia 
Dilatation and 
",50% capillary stasis 
Dilatation and 
",75% capillary stasis 
no observable circulation to capillaries or venules 
1-7 days 
after PDT 
~25%stasis capil. 
",50% capillary stasis 
",75% capillary stasis 
Phototherapy studies 
Vascular effects of ALA-PDT were examined in four groups of six rats each, differing in 
ALA dlUg dose and/or treatment starting-point p.i. (Table I). Treatment statting-points p.i. of 
group A (120 min p.i.) and B (ISO min p.i.) were taken at the maximum difference between 
TT and ST fluorescence. Observed vascular damage effects during and after treatment, 
expressed as damage scores using Table II, are shown in Figure 2a for group A and figure 2b 
for group B. Despite differences in fluorescence intensity between group A and B at the 
treatment starting point, hardly any differences in circulation damage during and after treat-
ment was observed. After 5 min of light treatment strong constriction of venules, 
disappearing arterioles in ST and ischaemia in IT were observed. After treatment, 
constriction was maximal and in IT some vasodilatation was observed. One day after 
treatment circulation started to recover and 6 days later hardly any damage had remained 
visible. 
Group C was treated at 60 min p.i. using 200 mg/kg ALA. The vascular damage 
effects during and after light treatment are shown in Figure 2c. There was hardly any 
constriction of venules during treatment. The arterioles constricted but remained visible and 
there was a mild ischaemia in TT. Maximum damage was reached 1 day after treatment after 
which the circulation started to recover. There was a selective TT damage but no complete 
circulation stop. 
Group D (200 mg/kg) received two light treatments, at 60 and ISO min. p.i .. Before 
and after the treatments fluorescence images were recorded to examine ifphotobleaching had 
occurred during the irradiation and if new fllloreseelice was fomled after the first light 
treatment. This would indicate the presence of new porphyrin that could be used to increase 
the effectiveness of PDT. The results of these fluorescence recordings are shown in Figure 3. 
The values in this graph were not corrected for background fluorescence. After the first light 
treatment photobleaching of fluorescence occurred to a level slightly below the autofluo-
rescence intensity. Just before the second light treatment new fluorescence was observed and 
after treatment it had returned to the same level as after the first treatment. The vascular 
damage scores of the two subsequent light treatments are shown in Figure 2d. During the first 
treatment the same constriction of arterioles (Fig 4b) occurred as in group C. Before the 
second treatment constriction in ST and the circulation in TT had recovered to some extent. 
During the second treatment the same vascular constriction of venuies and arterioles was seen 
as in group A and B (fig 4c). At the end of the second treatment complete stasis of the 
circulation in TT was observed. The damage to ST at day one was maximal (but not 
complete) and recovered to some extent but even after 7 days some areas remained damaged. 
Necrosis ofTT persisted during 7 days with the exception of one tumour which showed some 
circulation at its border after 4 days post treatment. In this group the contents of the chambers 
were re-transplantated after 7 days and only two showed regrowth. 
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Figure 2. Circulatioll damage scores (Is.e.m.) o/tumour tissue (IT) alld subcutaneous tissue 
(ST), durillg (lIIill ajler stal'l o/irradiatioll) alld ajler light treatlllelll (days). AI/illlais received 
100 or 200 IIIglkg ALA alld were treated with a light dose 0/100 J!clll' (IOO IIIl1'lclII'. 514.5 
I/III), at differellt tillle-poillts p.i. a (IOO IIIglkg, 1I~6), 120 lIIill p.i.; b (200 IIIgikg, 1I~6), 150 
lIIill p.i.; C (200 IIIglkg, 1I~6), 60 lIIill p.i.; d (200 IIIglkg, 1I~6), 60 (0 ~ be/ore PDT at 60 lIIill 
p.i.) alld 150 lIIill (O·~be/ore PDT at 150 lIIill p.i) 
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Figure 3. Photobleaching of fluorescence (:t s.e.IlI.) ill tumow' (TT) alld subcutaneous tissue 
(STj. recorded il/ 6 al/ill/als Irealed wilh 100 J/cll/ 1 oj 514.5 11/1/ light al 60 as well as 150 II/il/ 
p,i,., The autofluorescence has 1I0t been subtracted from the fluorescence measurements after 
ALA administraiion. 
Flglll'e 4. Status of the vasculature before fl, and during the jiJ:<;t light treatment at 60 mill b, 
alld the second light treatment at 150 mill p.i, c, During the early treatment cOllstrictioll of 
the arteriole (arrow) occurred, but it remailledvisible.This arteriole disappeared during the 
second treatment alld a strong cOllstrictioll of the larger venule was seen. The border of the 
tumour all the photograph looks dark because of fat cells and there was minor necrosis ill the 
centre oflhe tumour. 
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Discussion 
Fluorescence killetics studies 
In this study we have examined the fluorescence kinetics of IT and ST after 100 and 200 
mglkg of Lv. administered ALA. After both ALA doses the rate of fluorescence increase in 
TT was higher than in ST. It is known that various malignant tissues have a higher activity of 
porphobilinogen deaminase (PBGD) and a decrcased activity of felTochelatase (van 
Hillegersberg ef al., 1992). Therefore it is likely that the higher rate of fluorescence increase 
in IT may represent a higher capacity for conversion of ALA to porphyrin, PpIX to haem or a 
combination of both. 
Another explanation for a higher rate of increase in IT may be a higher ALA uptake. 
However, if ALA uptake detennined the rate of fluorescence increase a steeper rate of 
increase is expected after a higher ALA dose. This did not occur and although maximal 
fluorescence intensity was twice that after 200 mglkg administered ALA, the same maximal 
rate of increase of fluorescence in both tissues was observed as after 100 mglkg. As a result, 
the time to reach maximal fluorescence was longer for the higher ALA dose. This was also 
found in the nonnal skin of mice by Pottier ef al. (1986). It may indicate that the limiting 
factor in the rate of fluorescence increase is the biosynthesis of haem. 
An interesting observation is the difference between IT and ST in time interval of 
reaching maximal fluorescence. Maximal IT fluorescence was reached earlier than ST and as 
a result ST fluorescence was still increasing at a point \vere IT fluorescence already decrea-
sed. This is not expected if ALA uptake in IT is higher than ST and if ferrochclatase activity 
in IT is decreased. It is likely that i.v. administered ALA is rapidly cleared from the 
circulation. This results in a strong reduction of available ALA for IT in the course of time. It 
may be possible that maximal ALA accumulation in cells takes place directly after injection 
and that ALA, or an intenllediate of the haem synthesis, is retained there. As a result, ALA or 
intemlediates in the cell will be depleted faster in IT due to the increased PpIX synthesis. 
This could explain why IT fluorescence started to decrease before ST fluorescence. The 
difference in maximum fluorescence between IT and ST may then be explained by a 
difference in ALA-uptake. 
\Ve observed no difference in fluorescence kinetics following Lp. or Lv. administered 
ALA (unpublished data). Loh ef al. (1993) found that the fluorescence kinetic after oral ALA 
was similar to i. v. administered ALA although a higher ALA dose was necessary to achieve 
the same tissue concentrations of PpIX. Therefore, no difference in fluorescence kinetics after 
oral ALA administration compared to Lv. is expected to occur in our model. \Vhether 
fluorescence kinetics after topical ALA is similar to Lv. ALA will be investigated in this 
model in the future. 
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Phototherapy studies 
The vascular effects during and after treatment were examined in four groups of animals 
differing in ALA dose and interval between ALA administration and light treatment. 
Treatment time-points were chosen based on the observed fluorescence kinetics after 100 and 
200 mglkg ALA. The chambers of the first two groups (A and B) were treated at maximal 
difference between TT and ST. These experiments were set up to achieve maximal selective 
TT circulation damage. Therefore, the chambers were treated at maximal difference between 
TT and ST fluorescence and not at maximal fluorescence. 
Despite differences in fluorescence intensities between the two doses of ALA and 
between TT and ST, no differences in the level of circulation damage could be observed. 
Furthennore, the overall circulation damage effects were relatively minor, and there was no 
complete circulation stop in TT. The basis of the apparent discrepancy between the 
fluorescence intensities and the lack of photodynamic damage may be the strong vascular 
constriction during treatment observed after both ALA doses. These vascular effects during 
treatment are comparable with those observed with almost all sensitizers investigated in this 
model (Star ef al., 1986; van Leengoed ef al., 1993). An optimal oxygen supply during treat-
ment is necessary to obtain tissue damage with PDT (Henderson and Fingar, 1987; Moan et 
al., 1985). Therefore, a reduction of tissue oxygenation, as a result of vascular shutdown 
during treatment, limits the effectiveness of PDT. 
No constriction was observed during treatment at 60 min p.i. with group C (200 
mglkg). This lack of constriction during treatment could be caused by a low capacity of 
endothelial cells to generate PpIX. Although the fluorescence intensity was less, a larger and a 
more selective level of TT damage was obtained compared to a treatment at maximal 
difference in fluorescence belween TT and ST. This may have been made possible by the 
blood supply remaining intact during treatment. The increased selective effects on IT treated 
at 60 min p.i. could also be the result of translocation within the cell of porphyrin from the mi-
tochondrion to less sensitive sites (Malik and Lugaci, 1987; Kessel, 1986). Since PpIX is 
fonned in the mitochondrion and because the mitochondrion is very sensitive for PDT 
damage (Salet el al., 1986; Rilf el al., 1986) an increased effect may be expected when 
treating at an interval where the rate of fluorescence increase is maximal as done in group C. 
SUIlunarizing, in this model no correlation was found between the fluorescence 
intensity and the level of damage after a single light treatment. As discussed, two factors may 
determine the level of damage after treatment: the quality of blood supply during trealment 
and the localization of PpIX in the cell in the course of time. Based on the results obtained 
with our experiments the optimal interval for a single light treatment may be early p.i. where 
maximal rate of PpJX accumulation is observed and no vascular constriction during treatment 
seems to occur. The relative importance of the intracellular localization of PpIX and the 
vascular effects during treatment may be detennined by in vitro experiments. 
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With in vitro studies conditions of oxygen supply can be kept constant and the localization of 
PpIX in the cell in relation to damage after treatment can be examined. 
With two subsequent light treatments, at 60 and 150 min p.i., complete necrosis in IT 
during the observation period could be achieved while permanently damaging only a 
relatively small area of ST. With all dyes stndied in this model so far (Star el al., 1986: van 
Leengoed et al., 1993), a large area of pemlanent ST necrosis was necessary to yield per-
manent TT necrosis. This could indicate an increased fraction of direct tumour cell kill by 
ALA-PDT, compared for example with PDT llsing Photofrin, where this fraction is quite 
small (Henderson and Fingar, 1987). 
During the recovery period of75 min between the end of the first and the beginning 
of the second treatment the minor constriction caused by the first treatment recovered. After 
the first light treatment the flnorescence had bleached to a level slightly below the autoflu-
orescence. This could be caused by bleaching of naturally OCCUlTing fluorochromes, for 
example degradation products of chlorophyll present in animal food (Weagle el al., 1988). 
However, no photodynamic damage was obsen'cd in control animals treated with light alone. 
Before the second treatment new fluorescence in IT and ST was observed which was 
less, in absolute terms, than observed in untreated animals at similar time points. This might 
indicate that after the first treatment cells were damaged and had therefore lost haem 
generating capacity. Cells that still have that capacity can form new PpIX. Dan el al. (1993) 
reported about a decreased felTochelatase activity in cells after a single light treatment. This 
induced decrease can result in an increase in the rate of PpIX accumulation. These cells may 
be damaged severely by the second treatment which might explain the increased damage 
effects after two subsequent treatments. Another possible explanation for the severe damage 
effects with two subsequent treatments may be that cells that are damaged by the first 
treatment will release PpIX. This PplX may then cause damage to other cells during the 
second treatment. However this is not likely to occur because complete bleaching after the 
first treatment was observed. 
In conclusion, no direct conelation was found between fluorescence intensity and the 
amount of vascular damage to TT and ST in this model after i.v. administration of ALA. \Vith 
a single light treatment no complete circulation stop in TT was obtained. Only with a double 
treatment could persistent tumour necrosis be obtained without causing complete necrosis of 
the surrounding subcutaneous tissue. 
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Abstract 
We have studied different single and fractionated illumination schemes after systemic 
administration of 5-aminolevulinic acid (ALA) to improve the response of nodular (umors to 
ALA-mediated photodynamic therapy. Tumors transplanted on the thigh of female WAGlRij 
rats were transdellllally illuminated with red light (633 run) after systemic ALA administra-
tion (200 mglkg). The effectiveness of each treatment scheme was detennined from the tumor 
volume doubling time. A single illumination (100 J/cm' at 100 mW/cm', 2.5 h after ALA 
administration) yielded a doubling time of 6.6 ± 1.2 days. This was significantly different 
from the untreated control (doubling time, 1.7 ± 0.1 days). The only treatment scheme that 
yielded a significant improvement compared to all other schemes studied was illumination at 
both Ih and 2.5 h after ALA-administration (both 100 J/cm' at lOa mW/cm') and resulted in a 
tumor volume doubling time of 18.9 ± 2.9 days. A possible mechanism to explain this 
phenomenon is that the protoporphyrin IX fonned after administration of ALA is 
photo degraded by the first illumination. In the 75-min interval, new porphyrin is fOlllled 
enhancing the effect of the second illumination. 
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Introduction 
PDT using ALA induced PpIX as a photosensitizer is widely used as an experimental therapy, 
especially for cutaneous cancer. A complete initial response rate of> 90% has been reported 
for treatment of human superficial basal cell carcinoma with topically applied ALA-PDT 
(Kennedy el al., 1991.; Calzavara-Pinton el al., 1995; Meijnders el al., 1996). However, for 
nodular BCC, a much lower complete response of 50% is obtained (Calzavara-Pinton el al., 
1995; Peng el al., 1997). An explanation for this lower efficacy might be that topically 
applied ALA does not penetrate to the deep layers of the tumor (Peng el al., 1995; Martin el 
al., 1995). Oral or systemic administration of ALA may improve the biodistribution of PpiX 
(Peng el al., 1995 ; Tope el al., 1998). However, also after systemic ALA-PDT, only 
superficial necrosis was found in patients treated for dysplasia of the mouth (Fan el al., 1996) 
or the esophagus (Barr el al., 1996). These clinical reports show the need for improvement of 
topical and systemic ALA-PDT. A number of animal studies have demonstrated that the 
response to PDT after systemic ALA administration can be improved by modifying the 
illumination scheme, for example by reducing the fluence rate, to improve oxygenation 
(Pogue el al., 1997; Hua el al., 1995; Robinson el al., 1998). Another option is the use of light 
fractionation with either a short (Pogue el al., 1997; Hua el al., 1995; Messmann el al., 1995) 
or a long-term interval (Van der Veen el al., 1994). The short-term light fractionation scheme 
(with one or more intemlptions of seconds or min) may allow reoxygenation during the dark 
period. Theoretically, this will lead to more singlet oxygen formation (Pogue el al., 1997). 
\Ve define a long-tenn light fractionation scheme as an illumination scheme with two light 
fractions separated by an interval of I hour or longer. After the first light fraction, PpIX is 
partially Of completely photobleached, and in time, posttreatment new PpIX is fonned, which 
can be used for a second illumination (Van der Veen el al., 1994; Van der Veen el al., 1997). 
Van der Veen el al. (1994) reported complete necrosis of four out of six tumors in a rat 
skin fold observation chamber model using a long-tenn light fractionation scheme (with an 
interval of75 min) after a single ALA administration. No necrosis was observed after a single 
illumination. These studies show that improvement of ALA-PDT using different illumination 
schemes is possible. Our interest here was to improve systemic ALA PDT of nodular tumors. 
\Ve, therefore, studied the effectiveness of different illumination schemes published by our 
own group (Robinson el al., 1998; Van der Veen el al., 1994) and others ( Hua el al., 1995; 
Messmann el al., 1995) by measuring the tumor volume doubling time of a transplantable rat 
rhabdomyosarcoma after transdennal illumination. 
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Materials and Methods 
ALA hydrochloride (Finetech ) Haifa, Israel) was dissolved in a 0.9% Nael infusion solution 
(90 mg ml"). A freshly prepared ALA solution was administered i.v., to a dose of200 mg kg" 
body weight under ether anesthesia. After administration the animals were kept under 
subdued light conditions. 
Rat rhabdomyosarcoma (Rh), originally derived from an isologous undifferentiated 
rhabdomyosarcoma, was maintained by subcutaneously transplanting small pieces of tumor 
('" I nlln) on the thigh of female W AGlRij rats (12 - 13 weeks old). The tumor growth was 
monitored daily by measuring the three orthogonal diameters using calipers and the tumor 
volume was estimated by the formula for an ellipsoid, V=(rr/6) *Dl*D2*D3. Tumors were 
randomly assigned to control and treatment groups when their volume rcached 50 111m3. 
PDT was carried out under general anesthesia using intra muscular, 0.5 ml kg'! 
HypnonTI (Janssen Pharmaceutica, Tilburg, The Netherlands) and, 2.5 1111 kg- t diazepam. Prior 
to the light treatment the skin overlying the tumor was shaved. The animals were placed on a 
temperature controlled stage and covered with a black polythene mask. Tumors were 
transdennally illuminated with a 10 mm diameter plane parallel light beam (633 nm, 
(Meijnders e/ al., 1996)). Immediately after PDT, the animals were housed under subdued 
light conditions at 28°C for the first 24 h. This was done to minimize the decrease in body 
temperature caused by the anesthesia, Subsequently, the animals were kept at room tempera-
ture. 
Ten groups of animals were treated according to various treatment schemes. Groups 
A, Band C served as controls and were treated either with anesthesia only (11=6), light only 
(100 J cnl" at 100 mW cnl"; IF3) or ALA only (200 mglkg i.v.; IF3) respectively. Groups D 
to J, (n=6 for each group), were treated according to different illumination schemes as shown 
in Fig 1. Each illumination was carried out at either I or at 2.5 h after injection of ALA. 
These time points were based on a pharmacokinetic study performed on this animal model in 
which we found a maximal PpIX fluorescence of the tumor at 2.5 h postinjection. At I h post 
ALA administration, approximately one third of the maximal PpIX fluorescence was 
observed. 
In group D and E, the tumors were illuminated with a single light fluence of 100 
J cm·2 at a fluence rate of 100 m\V cm-2 delivered at either I and 2.5 h post-ALA~injection, 
respectively. In groups F~I the tumors were illuminated at 2.5 h post-injection of ALA. The 
tumors in group F received 100 J cm·2 at 25 m\V crn,2 so that the treatment time was 4 times 
longer than in groups 0 and E. The short-term light fractionation schemes were applied in 
group G and H. In group G, 100 J cm·2 at 100 m \V cnf2 was delivered with one intermption of 
150 seconds afler the first 5 J cn'-' (Messmann e/ al., 1995). In group H 100 J en'" at 100 m W 
cm-
2 
was delivered with multiple intermptions, being turned off and on every 30 s. (Hua et al., 
1995). Groups I and J were both treated with a double light fluence of 200 J en'" at 100 m W 
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cm-
2 given either in onc fraction (2.5 h p.i. of ALA) or according to a long-term Jight 
fractionation scheme of two equal fractions of 100 J cm-2 with an intemlption of 75 min 
(treatment at 1 and 2.5 h p.i. of ALA, (Van der Veen ef al., 1994). 
The light distribution within the tumors treated in this study was studied in a separate 
series of experiments using two isotropic probes (500 J.tm. bulb diameter, Rare Earth Medical, 
West Yarmouth MA, USA). The isotropic probes were connected to a dosimetry device that 
enables real-time fluence (rate) measurements to be recorded. One probe was placed 011 top of 
the skin at the center of the illuminated area. The second probe was implanted between the 
base of the hUllor and the underlying muscle at the center of the iHuminated area. Insertion of 
the isotropic probe through the skin was performed at a site that was distant from the hun our 
(> 1 cm) to reduce the effect of bleeding on the measurements. The fluence rate was measured 
continuously during illumination at 100 m\V cm-2 to a fluence of 100 J cm-2 in five tumors 2.5 
h after administration of ALA (scheme E). These data were used to estimate the mean optical 
attenuation coefficient of the combination of tumor and overlying skin. 
D 
E 
F 
G 
H 
J 
1 hour 2.5 hours 
Figure]. Schematic diagram of the treatment schemes studied. 
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Tumor re-growth and macroscopic changes to the surrounding normal tissue were monitored 
every I or 2 days following therapy until the size of the tumor had reached 5 times its 
treatment volume. The treatment volume of each tumor (approximately 50 mm3) was defined 
as 100% and the points in time (in days after treatment) at which the hunor rcached certain 
fixed volumes; 50%, 200%, 500% etc, were linearly interpolated. The effectiveness of each 
treatment scheme was detennined by comparison of the mean tumor volume doubling time of 
each group, defined as the number of days the tumor required to double its pre-treatment 
volume. The effect on the tumor growth posttreatment was detemlined for each group 
(detennined by the number of days the tumor required to grow from 200% to 500%). All 
results are presented as mean (± SEM). The relative effectiveness of each treatment scheme 
was statistically compared using the ANOYA followed by a Student-Newman-Keuls test, as 
necessary. For all tests a P < 0.05 was considered to be statistically significant. 
Results 
Normal tissue response to PDT. Three types of macroscopic normal tissue response were 
observed: edema of the thigh, discoloration of the skin overlying the tumor and crust 
fonnation. None of the total of 12 animals in the three control groups showed any type of 
normal tissue damage. 
The edema was investigated by measuring the thickness of the leg adjacent to the 
tumor daily. All animals treated with ALA-PDT showed a mild to severe edema of the leg 
which was found to be maximal on day I post-treatment and cleared by day 4. Normally the 
leg has a thickness of approximately 7 mm, but at day I posttreatment the leg could measure 
10.7 - 15.8 mm thick (Table I). The edema found for tumors treated at I h after administration 
of ALA was significantly less compared to the other treatment schemes. The edema found for 
tumors illuminated with 200 J cm·2 in one fraction (scheme J) was significantly greater 
compared to the rest of the treatment schemes. 
Almost all treatment schemes induced a bluish/black discoloration of the skin 
overlying the tumor after treatment which cleared within a few days. The involved area was 
as large as the illuminated tumor under the skin, that is smaller than the illuminated area. In 
some treatment schemes severe discolouration was accompanied by crust fonnation (Table J). 
To investigate whether the edema, discoloration and crust fonnation were influenced by the 
presence of an underlying tumor, a group of 4 animals without a tumor was illuminated 
according to the treatment scheme used in group 1. The edematous response was found to be 
the same for skin and muscle illuminated in the absence of tumor. The discoloration was 
found to be less marked being only pale blue for the group with no tumor compared to dark 
bluelblack for the group with a tumor. The crust seemed to be thinner and smaller in size and 
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appeared only in 50 % of the animals. 
To histologically determine the location of the edema and the cause of the discolor-
ation, a separate set of experiments were perfomled. Four extra animals were illuminated with 
200 J cm·2 given either in one fraction or according to a long-tenn light fractionation scheme 
(groups I and J, respectively). The illuminated area was excised at day I post treatment for 
histology. Sections of the leg, including skin and soft tissues were stained with haemotoxylin 
and eosine after fonnalin fixation. The epidennis and the demlal adnexa showed necrosis after 
both illumination schemes. Severe edema was found in the dermis and the muscle surrounding 
and underlying the tumor whereas the tumor showed little or no edema. Enlarged blood 
vessels that were located around and at the border of the tumor were heavily damaged and 
there was evidence of hemorrhage. 
Table I. Nonnai tissue damage caused by the different treatment schemes used. 
Group Normal tissue damage 
Edema (null) 
D 10.7 ± 0.3' 
E 14.2 ± 0.9 
F 13.8 ± 0.3 
G 12.4 ± 0.2 
H 13.3 ± 0.7 
15.8 ± 0.3' 
J 12.7±0.7 
a) Significantly less edema than to the other groups 
b)Significantly more edema than to the other groups 
Crusts (n) 
2 
4 
2 
2 
3 
6 
TUlllor l'olume measuremellts. The error associated with the tumor volume measurements 
was estimated by comparing the measurements of two independent observers for 14 tumors 
treated in this study in a range of tumor volumes. The relative error decreased from 5.3 ± 
0.9% for tumor volumes below 30 mm3, to 3.7 ± 1.3% for tumor volumes ranging from 30 to 
60 nun3, to 3.5 ± 0.7% for tumor volumes ranging from 60 to 120 mm3, to 2.3 ± 0.5% for 
tumor volumes ranging from 120 to 240 mm3• 
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TIlIJJOI' response 10 PDT, There was no significant difference in treatment volume for the 
hUllors in different groups and the mean treatment volume was measured to be 50.3 ± 1.4 
mm) (n~54). The tumor volume doubling times measured for the three control groups (A-C) 
were not significantly different. These data were combined and used as a pooled control 
group for comparison with the remaining treatment schemes. The rhabdomyosarcoma was 
found to have a mean tumor volume doubling time of 1.7 ± 0.1 days (n~ 12). 
All of the PDT schemes investigated demonstrated a significantly longer tumor 
volume doubling time compared to control hnnors, as shown in Figure 2. Tumors illuminated 
with a light fluenee of 100 J cnl" at 100 mW CU1', I and 2.5 h after ALA administration 
demonstrated a tumor volume doubling time of 5.0 ± 1.5 days and 6.6 ± 1.2 days respectively 
(group D and E). The use of a short-tenn light fractionation scheme with a dark interval of 
150 s, after the first 5 J cm·2 of the total 100 J cm-2 was delivered, showed a hllllor volume 
doubling time of 7.5 ± 1.5 days. This was comparable to the tumor volume doubling time 
found for the other short-telm light fractionation scheme (30 slight onloff, 7.5 ± 0.8 days). 
Although the mean tumor volume doubling time found for both sh0l1-tenll light fractionation 
schemes is longer compared to illumination with a single fraction (group E), the increase was 
not found to be statistically significant. Also illumination with a 4 times lower fluence rate 
(group F) resulted in an increased mean hllllor volume doubling time (8.8 ± l.9 days) 
compared to group E which was again not statistically significant. Even increasing the fluence 
to 200 J cm" (group I) did not increase the mean tumor volume doubling time (8.6 ± 0.8 days) 
significantly, compared to group E. Only the use of a long-term light fractionation scheme 
(100 J cnt" at both I and 2.5 h p.i. of ALA, group J) showed a significantly increased tumor 
volume doubling time compared to all the other illumination schemes: 18.9 ± 2.9 days. 
None of the investigated protocols resulted in a "cure" of the tumor and only in group 
J three out of six tumors were not palpable for 10 to 13 days before the tumor was again 
detectable. No statistically significant difference could be shown in the hlmor growth 
posttreatment defined as the time a tumor required to grow from 200 to 500%. The tumor 
volume increased by a factor ofl.5 in 2.58 ± 0.06 days. 
Tumor Iftickuess. As might be expected since the illumination was superficial, the tumor 
response to PDT seemed to be conelated to the thickness of the treated tumor. After observa-
tion of the growth curves of the individual tumors in the groups there seemed to be a 
threshold for the thickness. Tumors thinner than 4 nun responded significantly better to 
treatment with a total fluence dose of 100 J cm-2 compared to thick h1lll0rs. The mean tumor 
volume doubling time for thin tumors of groups D - H was 12.0 ± 2.2 days (n~5) compared to 
a mean tUlllor volume doubling time of 5.9 ± 2.2 days for thick tumors (n=25). For illumina-
tions with a total light fluence of 200 J cm-2 delivered either in one fraction or according to a 
long-ternl light fractionation scheme (groups I and J, respectively) this difference in volume 
doubling time between thin and thick tumors was not found. 
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Light distributiou. No significant variation in the measured fluence rate was obsentcd during 
irradiation in individual trcatments. The fluence rate measured by the probe placed on top of 
the skin overlying the tumor was 184.4 ± 14 mW en'" (IF5) in which the incident light 
tluence rate was 100 m\V cm'2. The fluence rate measured by the probe placed at depth 
between the tumor base and the underlying muscle was 42.3 ± 3.2 m\V cm,2 (n=5). Therefore 
the fluence rate at the base of the tumor was approximately 23% of the tluence rate measured 
at the top of the tumor. From these measurements, a mean effective attenuation coefficient, 
(eff, was calculated to be 3.5 ± 1.2 em'! ). 
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Figure 2, Relative tllmor l'o/ume ill time after ALA-PDT using different iIIuminatioll schemes: 
cOlllrol (110 symbol); scheme D, Ih, 100 Jlcm' al 100 mWlcm' ("; scheme E. 2,5 h, 100 
Jlcm' al 100 mWlcm' ("""'); scheme F, 2,5 h, 100 Jlcm' al 25 mWlcm' (Q); scheme G, 2,5 h , 
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150 s afier 5 Jlcm' (';; scheme H, 2,5, 100 Jlcm' at 100 mWlcm' IIsillg a shorl·lerm 
[ractiollatioll scheme: 30 sec 011130 sec off (0); scheme J, 2.5 h" 200 Jlcm' al 100 m Wlcm' 
(') alld scheme 1, both 1 alld 2.5 h, 100 alld 100 Jlcm' at 100 mWlcm' (~). Dala poillls, 
means; bars, ± SEll"-
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Discllssion 
In this study, we have demonstrated a dramatic increase in tumor volume doubling time 
following systemic ALA PDT using a long-tenn light fractionation scheme (two light 
fractions separated by a dark interval of 75 min). In previous studies, it was shown that new 
PpIX is fanned after complete photobleaching cansed by the illumination (Van der Veen ef 
al., 1995; Van der Veen ef al., 1997). This newly fOlTIled PpIX can be used during a second 
illumination. Van def Veen et al. (1995) showed in a skinfold chamber model that a long-Icnn 
light fractionation scheme resulted in four out of six tumors with complete necrosis at day 7 
posttreatment compared to no necrosis for a single illumination scheme. In this long-Ienn 
light fractionation scheme a double light fluence (200 J cnf') was delivcred (Veen ef al., 
1995) compared to the single illumination (lOa J cnf') which might explain the increased 
effect. However, when PpIX is completely photohleached, a longer illumination is not 
expected to be more effective; this is also demonstrated here. Treating the tumor with a 
double light fluence (200 J cm'i) did not significantly increase tumor volume doubling time 
compared to 100 J cm'] whereas treatment with the same total fluence according to a iong-
tenn light fractionation scheme did (Fig, 1). In fact, this scheme increased the tumor volume 
doubling time by a factor of 2,6, The substantially improved tumor response can only be 
explained by the use of the dark interval between two light fractions. As we have discussed 
the long intemlption may allow time for the fonnation of new PpIX which can be used for a 
second illumination and result in extra cell death. The origil1 of this ne\v PpIX fluorescence is 
as yet unknown. One possibility is that ALA is still present in the tissue and can be converted 
into PpIX by the surviving cells. 
The edema fonnation was not increased using a long-tenn light fractionation scheme 
compared to a single illumination of 100 J cm'2. The discoloration was more pronounced 
compared to a single illumination and all the animals fonned cmst. From the histology it can 
be concluded that the discoloration was caused by hemorrhage of the blood vessels around 
and at the border of the tumor. This means that the discoloration and the accompanied crust 
fom1ation caused by necrosis of epidenllal, dennal and tumor tissue was actually a combined 
nonnal and tumor tissue response. Thus the fact that we saw more crust after illumination 
with a long-tenn light fractionation scheme is not surprising. 
In contrast, ALA PDT using a low fluence rate or a short-tenn light fractionation 
scheme did not significantly improve the tumor volume doubling time. These illumination 
schemes were designed to increase the amount of singlet oxygen fonnation during the 
treatment by reducing the demand rate for oxygen (Pogue ef al., 1997). Several authors have 
shown that this can enhance the PDT response in a variety of animal models. Robinson et al. 
(I 998) reported a higher damage score ofnon11al hairless mouse skin after topical ALA-PDT 
with a low fluence rate. They observed that the difference in damage score between an 
illumination with a fluence rate of 150 and 50 III \V cm-2 was rather sIllall whereas the 
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difference between these fluence rates and 5 m\V cm·2 was considerable. Hua et al. (1995) 
showed a 1.5 times longer volume doubling time for tumors illuminated with a 4 times lower 
fluence rate after systemic ALA administration. The volume doubling time was found to be 
further enhanced for tumors treated with a 30 seconds light on/off short-tenll light fraction-
ation scheme. Messmann el al. (1995) obtained a greater area of necrosis of nornlal colon 
after illumination using several short-ternl light fractionation schemes. Off course , it is 
difficult to compare these studies because the animal model used, the ALA doses and the 
illumination methods are all different. The fact that we could not show an improved tumor 
response using any of these schemes indicates that little or no extra tumor damage was 
obtained by the use of a low fluence rate or dark periods of several seconds or min for this 
tumor model. These results imply that improving the tumor response to ALA PDT is not 
simply a matter of intemlpting the illumination for a few seconds or min and that tumor 
response may be different both for different sizes of tumor and for different tumor types. 
Fan et al. (1996) investigated the short and long-tenn light fractionation schemes in 
patients treated for mouth dysplasia with orally administered ALA. They were not able to 
show an improved tumor response using either of these treatment schemes compared to a 
single fraction illumination. It should be noted that the maximum ALA dose orally adminis-
tered in patients is 60 mg kg· l whereas experimental animals are given 200 mg kg· l intrave-
nously. 
In summary, no significant improved tumor response could be obtained using a low 
JllIence rate or a short-tenn light fractionation scheme (dark interval of seconds or min) for the 
illumination of a solid rhabdomyosarcoma transplanted on the thigh of a rat. This could only 
be achieved by using a long-terlll light fractionation scheme with an dark period of 75 min 
between two light treatments. 
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Abstract 
In this study the kinetics and localisation of protoporphyrin IX (PpIX) fluorescence in skin 
and skin tumours were examined after topically (20%, for 4 hours) or systemically (200 
mg/kg, i.p.) administered 5-aminolevulinic acid (ALA). As a model we used hairless mice 
with skin lesions (actinic keratoses and squamous cell carcinoma) which were induced by 
daily UV-B irradiation. The epidennis of the skin surrounding the tumours (T) was altered 
(AS); due to the UV -B irradiation the epidermis was thicker and less elastic. Therefore, non-
UVB irradiated mice were used to assess fluorescence of normal skin (NS). Light from a 
halogen lamp was used to excite at 500 ± 20 nm and fluorescence was detected through a 
filter which passes light of 670 ± 50 mll. Maximal fluorescence following i.p. ALA was 
observed after 2 h p.i. and was 3 times less thall after topically applied ALA. Furthermore, 
after i.p. ALA a lower T selectivity (TINS) could be obtained than after topically applied 
ALA. Maximal fluorescence following topically applied ALA was achieved 6 h after the end 
of the 4 h application time. At that interval fluorescence of Twas 2 times higher than directly 
after the application period. Furthermore, T selectivity (TINS) after topical ALA at the 
interval of maximal fluorescence was higher than at the inten'ai directly after application. 
With fluorescence cryo-microscopy localisation of fluorescence in the skin at the interval of 
maximal fluorescence was detennined after both administration routes. For both cases 
fluorescence was mainly located in T, epidemlis and hair follicles. Fluorescence in subcutis 
could only be observed at 2 h post i.p. ALA and at 6 h post topical ALA. No fluorescence 
could be observed in muscle. \Ve conclude that, in this model and with these ALA doses, a 
higher fluorescence intensity and selectivity (TINS) was achieved after topically applied ALA 
than after systemically administered ALA. These results make topically applied ALA more 
favourable for ALA-PDT of superficial skin tumours in this model. In general these results 
imply that by optimizing the time after ALA application thc efficacy and selectivity of topical 
ALA-PDT for skin tumours may be improved. 
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Introduction 
A new approach in photodynamic therapy (PDT) to photosensitize tumour tissue is the use of 
endogenously produced photosensitizers. This can be achieved by administration of 5-
aminolevu-linic acid (ALA), an agent which utilizes the haem biosynthetic pathway, by 
bypassing the feedback control of this pathway, to create diagnostic and therapeutic levels of 
the sensitizer protoporphyrin IX (PpIX). 
The activity of several enzymes involved in the haem biosynthetic pathway varies in 
different tissue types. For example, various malignant tissues have an increased 
porphobilinogen deaminase activity, which converts ALA into porphobilinogen. and a 
decreased ferrochelatase activity, which converts PpIX into haem (van Hillegersberg el aI, 
1992). This alteration in enzymatic activities may cause an increased fluorescence in tumour 
tissue compared to nonnal tissue after ALA administration (van der Veen et ai, 1994; Bedwell 
et ai, 1992). Several nonnal tissues, especially those originating from ecto- and endodenn 
may also become photosensitized after exposure to ALA. This in contrast to tissues from 
mesodemlal origin (Divaris ef ai, 1990; Loh ef ai, 1993). 
In both human and animal studies ALA has been administered via various routes. 
Topically applied ALA-PDT has proven to be a successful treatment modality for nOIl-
melanoma superficial malignant skin tumours (Kennedy and Pottier, 1990; Svanberg et ai, 
1994). Also, humau studies have been perfonned using oral1y applied ALA (Grant ef ai, 1993; 
Regula ef ai, 1995) and topical1y applied ALA (Kricgmair ef ai, 1994) for endoscopic PDT 
treatments as well as photodetection of cancer. Sufficient tissue levels of PpIX for diagnostic 
and treatment purposes can also be achieved by administering ALA intravenously (Lv.) or 
intraperitonial1y (i.p.) as observed in animal studies by Iinuma ef al (1995) and Peng ef al 
(1992). 
Administering ALA via various routes may reveal a dissimilarity. in the bio-
availability of ALA which Jllay result in different fluorescence dynamics and localisation of 
PpIX fluorescence. To examine these differences in Jllore detail the fluorescence kinetics after 
i.p. and topically administered ALA of small skin tumours were studied. Furthennore, 
localisation of PpIX after both topical and i.p" ALA was examined using fluorescence cryo-
microscopy. As a model we used hairless mice with small skin lesions (actinic keratoses and' 
squamous cell carcinomas) which were induced by UV -B irradiation, 
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Materials and Methods 
Anima/model 
The animals used were inbred female hairless albino mice, Skh hrl, 18 weeks old, obtained 
from the University of Utrecht. These mice were irradiated daily with UV-B light (1.5 KJ n1"') 
using a Westinghouse FS40TLl2 lamp according to a method described by de Gnlijl el at 
(1983). The lamps were mounted above the cages so that mainly the dorsal skin of the mice 
were exposed to the UV -B light. The animals developed multiple primary tumours in the 
exposed area after approximately 80 days. Small tumours (1-2 mm in diameter), which were 
mainly squamous cell carcinoma, actinic keratoses and seborrhoeic keratoses, were used in the 
experiments. Non-UVB irradiated animals were used to assess BonnaI skin fluorescence. This 
was necessary because as a reaction to the daily UV-B irradiation the skin was altered and 
became thicker and less elastic. 
ALA 
5-Aminolevulinic acid was obtained as hydrochloride in 98% pure powder fonn from Sigma 
Chemic (Bomem, Belgium), For the topical application ALA was dissolved ill Carboxy-
methylcellulose 3% to yield a 20% solution. The solvent was set at pH 5.5 by adding NaOH 
(2M), to avoid i1Titation of the skin. Before ALA application the animals received a low dose 
of diazepam (Centrafann b.v., Etten-leur, Holland) to avoid an.xiety and therefore movement 
orthe solvent. The freshly made solvent was placed on the entire dorsal skin and covered with 
a gauze. A piece of transparent film dressing (Molnlycke, \Varemme, Belgium) was placed 
over the gauze to achieve occlusion and to prevent evaporation and movement of the solvent. 
The solvent was applied to the skin for 4 hours after which it was carefully removed. 
For systemic administration ALA was dissolved in PBS after which the solution was 
set at pH 6 using NaOH (2M) to prevent necrosis at the injection site. The freshly made 
solution was injected intraperitonially (Lp.) in a dose of200 mg/kg. 
Experimental set-up fol' ill l'h'o experiments 
Fluorescence kinetics after topically and i.p. administered ALA were detennined in six UV-B 
and six non-UVB irradiated mice per administration route. Fluorescence after i.p. 
administered ALA was recorded every hour for 12 hours. The fluorescence after topical ALA 
was recorded every two hours for 24 hours. This long observation period after topical ALA 
made it necessary to compose each 24 hour series from two groups of mice each followed for 
12 hours. During the fluorescence recordings the animals were anaesthetized with a combina-
tion of ethrane/oxidionlN20 and positioned on a temperature controlled stage under an 
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intensified CCD~camera. In each UV-B irradiated mouse, after Lp. or topical ALA, three areas 
each of 1 cm in diameter were recorded; two areas with tumours and one area which was 
macroscopically free of tumour. In each non-UVB irradiated mouse two randomly chosen 
areas of 1 em in diameter on the dorsal skin were recorded. Small pieces of fluorescent plastic 
positioned in the recorded areas were used for focusing on the skin and for cOlTections of 
small variations in output of the excitation light. Light from a halogen lamp and bandpass 
filter were used to excite fluorescence at a wavelength of 500 ± 20 nm with dose rate of 0.2 
111 \V cnf2. Tlrrough a dichroic mirror light was projected on the skin and fluorescence was 
detected through a filter which passes light of 670 ± 50 nm. Fluorescence images were 
recorded using a CCD camera with a two stage image intensifier and a 50 mm Leitz Photar 
macrolens. No photodynamic damage, caused by the excitation light, could be observed (total 
maximum excitation light dose was 0.04 J cm·2). During the application period and between 
the fluorescence recordings the animals were kept in the dark. 
The recorded digitized images were analyzed yielding average grey scale values per 
time interval of selected areas of interest in tumours (T), UV-B irradiated skin (AS) and non-
UVB irradiated skin (NS). 
Fluorescellce cl,)'o-micl'oscopy studies 
For the fluorescence cryo-microscopy study the same administration routes and ALA doses 
were applied as used with the fluorescence kinetics studies. Fluorescence in T and in hair-
follicles (HF), epidermis (EP), subcutis (SC) and muscle (M) of AS and NS was examined at 
2 intervals after topical ALA; directly after 4 h application (t=4) and at maximal fluorescence 
(t~1 0; 6 h afier the end of the application period). With systemic ALA, fluorescence was only 
examined at interval of maximum fluorescence which was 2 h p.i. for T and AS and 6 h p.i. 
for NS. FUl1hennore, unsensitized animals were used to examine the autofluorescence of T, 
AS and NS. At each interval 2 animals were sacrificed after which in each animal 2 samples 
of 0,5 cm2 were excised and immediately frozen in liquid nitrogen. Of each sample 4 
transversal sections of 30 ~m thick were cut using a cryostat and placed on a slide. The slides 
were kept in the dark and preserved in the refrigerator. 
The fluorescence set-up consisted of a CCD-camera fitted to a Leitz DM fluorescence 
microscope. Excitation light of 543 ± 28 nm with an irradiance of 1 m\V cm·2 was used and 
fluorescence of a freshly made section was detected through a 615 lUll high pass filter. No 
photobleaching was obsenred after the recordings (total energy was less than 0,0 I J cm·2). 
\Vith phase contrast representative areas in 4 sections per sample ofT and HF, EP, SC and M 
ofUV-B and nOIl-UVB irradiated skin were identified and recorded. In the resulting digitized 
images average fluorescence grey scale values of these structures were detennined. 
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Results 
Fluorescellce kiJletics studies 
The fluorescence after topical ALA of T (n~50), AS (n~6) and NS (n~12) observed in 6 
animals per interval was assessed every 2 hours during 24 hours (fig. la). The results aftcr i.p. 
administered ALA of T (n~50), AS (n~6) and NS (n~12), measured every hour during 12 
hours in 6 animals per interval, are displayed in figure I b. All values in these graphs were 
corrected for background fluorescence using the autofluorescence image, which had an 
average grey scale value of29 for T, 27 for AS and 24 for NS. The grey scale values in fig. Ia 
and fig. 1 b arc proportional to the fluorescence with the same factor. 
After topically applied ALA the rate of fluorescence increase of T and AS was higher 
than NS, Furthennore, maximum fluorescence of T and AS was attained at the same interval, 
about 10 hours after the start of the application. At that interval the mean fluorescence 
intensity of tumours was 1,4 times higher than AS and 4 times higher than NS. After 10 hours 
a rapid decrease in fluorescence was observed but even at 24 hours a certain amount of fluor-
escence could be detected. Fluorescence of NS increased slower and the fluorescence stayed 
at the same level between 6 and 24 hours. 
After i.p. administered ALA differences in the rate of fluorescence increase between T 
and NS were observed as shown in figure lB. However, maximal fluorescence of both T and 
AS was 3 times less than after topically applied ALA. Maximal fluorescence intensity of NS 
afier i.p. was almost the same as after topically applied ALA. After i.p. ALA maximal 
fluorescence in T and AS was achieved around 2 hours whereas maximal fluorescence in NS 
was attained around 6 hours p.i. After interval of maximum fluorescence, a decrease in the 
same rate as the fluorescence increase could be observed. As a result the fluorescence of T 
was only higher than AS and NS till 4 hours p.i. and after that time interval the fluorescence 
ofNS exceeded T and AS fluorescence. Twelve hours p.i. fluorescence ofT, AS and NS had 
almost retumed to autofluorescence level. 
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Figure 1. III vivo fluorescence kinetics, ± standard error of the mean (s,e.m.), e.\pressed as 
grey scale values. a/Tumour ( •• Altered skill (q alld Normal skill (+J after topically (AJ 
and systemically (B) administered ALA. At each time interval the mean fluorescence (± s.e.m.) 
of 6 animals is plotted, each corrected for their respective autofluorescellce. 
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Fluorescence localisatioll studies 
Mean fluorescence was detennined in 4 sections per sample of tumour (T), epidermal layer 
(EP), hair follicles (HF), subcutis (SC) and muscle (M) ofUV-B and non-UVB irradiated skin 
without ALA and after topical and systemic ALA. Mean fluorescence per time interval was 
assessed in 16 sections per 4 samples obtained in 2 animals. 
The fluorescence in UV-B and non-UVB irradiated mice examined directly (t=4) and 
1O hours after start of topical ALA application is shown in figure 2a and 2b. In un sensitized 
UV-B and non-UVB irradiated animals only a low autofluorescence signal was observed in all 
stmctures. Directly afier ALA application fluorescence in UV-B irradiated skin (fig 2a) was 
mainly located in HF, EP and in T. Between these structures comparable fluorescence 
intensities were observed. No fluorescence could be detected in SC and :Nt Fluorescence at 10 
h was also located in T, EP and HF and was 2 times higher than at 4 h. No fluorescence could 
be observed in M but a low fluorescence level in SC was detected at 10 h. In nOIl-UVB 
irradiated skin (fig 2b) fluorescence could be detected at both 4 and 10 h in EP and HF and 
not in SC and M. The increase in fluorescence in EP and HF at 10 h was small and not 
significantly different from 4 h. Differences in fluorescence intensities at 4 h between HF and 
EP ofUV-B and non-UVB irradiated skin were not significantly different. However, at 10 h 
the fluorescence in EP and HF ofUV-B irradiated skin was approximately 2 times higher than 
in EP and HF oflloll-UVB irradiated skill. 
Fluorescence after i.p. administered ALA, shown in fig 2c, was detemlined at 2 h p.i. 
for UV-B and 6 h p.i. for nOll-UYB irradiated mice. In UV-B irradiated skin fluorescence was 
mainly located in T, HF and EP. A low level of fluorescence could be detected in SC whereas 
no fluorescence was observed in M. Fluorescence intensity ofHF, EP and 1\1 at 6 h p.i. in nOI1-
UVB itTadiated mice was similar to fluorescence ofUV-B irradiated mice at 2 h p.i., except 
in SC of nOll-UVB irradiated skin where no fluorescence could be detected. The fluorescence 
intensities of T, EP, HF in UV-B irradiated mice after i.p. ALA were comparable with 
intensities found in UV-B irradiated mice at interval directly after application (4 h). 
Figllre 2. Results a/fluorescence clJ'o-microscopy, expressed as grey scale values (± s.e.m.), 
ill tlll/lOlir (1), epider/llis (EP), Itair jollicles (HF), SllbClltis (SC) alld /lllIscle (M) are 
displayed ill fig Ja, 2b alld 2c. III fig. 2a tlte flllorescence bejore (t~O), directly after (t~4) alld 
6 It after (t~ I 0) topically applied ALA oj st/'llctures ill UV-B irradiated skill are displayed. 
Fig 2b shows the fluorescence 0/ structures ill flOn-UVB irradiated skill after topical ALA, 
determined at similar intervals as shown ill fig 2a. III fig 2c the fluorescence after i.p. 
administered ALA, be/ore alld at 2 h p.i. ill UV-B irradiated skill and at 6 h p.i. ill 110n-UVB 
irradiated skill are displayed. 
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Discussion 
In this study the differences in kinetics and localisation of PpIX fluorescence between 
topically and systemically administered ALA of small skin tumours, induced in mice by daily 
UV-B irradiatioll, were detennined. Human skin cancers, particularly basal cell and squamous 
cell carcinomas, are also closely associated with chronic, repeated exposure of the skin to 
solar UV radiation (Fears ef ai, 1976). De Graiji ef al (1983) reported that in this modcI the 
fraction of actinic keratoses decreases with increasing diameter whereas the fraction of 
squamous cell carcinoma increases with increasing diameter. This means roughly that 
tumours smaller than 2 mm mainly consists of actinic keratoses whereas tumours between 2 
and 4 111m in diameter mainly consist of squamous cell carcinoma. In this study only smail 
tumours of approximately 2 111m (actinic keratoses and squamous cell carcinoma) were 
included. Larger tumours revealed considerable variations in appearance and incidence of 
necrosis or bleeding on top of the tumours. 
In human skin a thickening of the epidennis is seen after exposure to sunlight. This 
reaction is only temporary and the thickness returns to nom1al values within weeks when the 
skin is no longer exposed to sunlight. Also in mouse skin this epidennal thickening due to 
UV-B irradiation was observed. Sterenborg ef (II (1986) found that this reaction is UV-B dose 
dependent. They also observed that the thickness of the stratum comeum was roughly 
proportional to the thickness of the whole epidennis. The UVwB doses used in this experiment 
were at the threshold for prodncillg edema. As a reaction to the high daily doses ofUV-B light 
an acute thickening of epidenllis occurred which is no longer UV-B dose dependent 
(Sterenborg et aI, 1986). This acute reaction maintains longer and is only partly reversible. 
This made it necessary to use non-UVB irradiated animals to examine the fluorescence of 
nom1al skin. 
Differences in fluorescence kinetics between UV-B and nOIl-UVB irradiated mice. 
The variation in thickness ofepidennis between nOI1-UVB and UV-B irradiated mice accounts 
to some extent for the differences in fluorescence kinetics between T, AS and NS observed 
afier both topically and systemically administered ALA. The thickness of the epidennis in the 
skill ofnon-UVB irradiated mice is 23 ~m (s.e.m. ± I) whereas in UV-B irradiated skin the 
epidennal thickness is 52 fUll (s.e.m. ± 5). The thickness in UV-B irradiated skin of tumour 
with the underlying epidemlis is 404 ftm (s.e.m. ± 70). We observed with fluorescence cryo-
microscopy a significant amount of PpIX fluorescence in the epidcnnal layer. Therefore a 
higher fluorescence increase and intensity in UV -8 irradiated skin than in non-UVB irradiated 
skin can be expected with our fluorescence set-up. 
The imp0l1ance of the thickness of the epidemlal layer for the fluorescence increase 
and intensity is confinned by our fluorescence cryo-microscopy study. \Vith this method, 
which excludes variations in epidenl1al thickness and elevated tumours, no significant 
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differences in fluorescence intensities between T and AS fluorescence were observed. 
However, with fluorescence cryo-microscopy a significant difference in fluorescence intensity 
(factor 2) at 6 hr post application between T (and AS) and NS was observed. Therefore, 
differences in kinetics between a slightly elevated T, a thickened AS and NS can only partly 
be accounted for variations in thickness oCthe epidel111allayer. 
A factor which also may explain the higher rate of fluorescence increase in T and AS 
compared to NS is an altered activity of enzymes involved in the haem biosynthetic pathway 
in T and AS. It is known that the activity of two enzymes, porphobilinogen deaminase and 
ferrochelatase. can be changed in malignant tissues (van HilJegersberg el aI, 1992). This may 
result in a steeper rate of fluorescence increase in T and AS compared to NS after both 
topically and systemically administered ALA. That a disparity in enzymatic activity is an 
important factor in a different rate of fluorescence increase was supported by a previous study 
with a different animal model (van der Veen el aI, 1994). In this model the same differences 
in rate of fluorescence increase between T and surrounding subcutaneous tissue were observed 
after Lv. administered ALA. FurthemlOre, in both T and subcutaneous tissue no enlargement 
in rate of fluorescence increase occurred after doubling of the administered ALA dose. This 
observation confinned that the higher rate of fluorescence increase in T and AS could 
represent a higher capacity for conversion of ALA to pOlphyrin or a lower capacity of 
conversion of PpIX to haem or a combination of both. It also excludes that differences in rate 
of fluorescence increase after systemic ALA were detcrmined by a disparity in ALA uptakc. 
vascularisation or quality of blood vessel wall between T and NS. Otherwise, an enhancement 
in rate of fluorescence increase was expected after a two-fold ALA dose. Variations in ALA 
uptake and vascularisation may however account for differences in maximal fluorescence 
intensities after systemically administered ALA. 
Differences ill fluorescence kinetics between topically muf i.p. administered ALA. 
Between Lp. and topically administered ALA clear differences in fluorescence kinetics of T, 
AS and-NS were observed. There was a large difference in interval of reaching maximal fluor-
escence. This difference may be the result of a dissimilarity in the bio-availability of ALA 
between both administration routes. 
\Vith systemically administered ALA maximal fluorescence in T and AS occurred 2 h 
post injection (p.i.) whereas maximal NS fluorescence was reached 6 h poi. This short interval 
of fluorescence increase in T and AS may be caused by a combination of a limited retention of 
ALA in the circulation and an increased PpIX synthesis. After systemic ALA administration a 
substantial fraction of ALA will be accumulated by the liver. ALA is also rapidly cleared 
from the circulation resulting in a strong reduction of ALA in the course of time. Therefore, it 
is likely that maximal ALA accumulation takes place directly p.i. and that ALA, or an 
intennediate of the haem synthesis, is retained in the cells. As a result, ALA or intennediates 
will be depleted faster in T and AS than in NS owing to the increased PplX synthesis in T and 
AS. This may explain the disparity in time required to reach maximal fluorescence between T 
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and NS, a phenomenon also observed by Peng ef al (1992) and van der Veen ef al (1994). 
This difference between tissues in interval to rcaching maximal fluorescence may be 
an important element in detcnnining the time interval p.i. for a PDT treatment. For example if 
treatment in this model would be perfonned at 6 h p.L, an interval where fluorescence in NS is 
3 times higher than in T, 110 T damage but severe NS damage can be expected. That relatively 
small variations in time interval p.i. for PDT treatments may result in large variations in 
damage effect on T and Hennal tissues has been illustrated by several studies. Peng et af 
(1992) observed maximal fluorescence in mammary T at 1 h p.i. whereas maximal skin 
fluorescence was observed 3 h p.i. They obselved a delay of T growth treating at I h p.i. 
(maximal fluorescence) but no delay of growth treating at 5 h p.i.. Also, Orth ef al (1994) 
examined the fluorescence after systemically administered ALA in mouse skin and in a sub CUM 
taneously transplanted colonic tumour. At 3 h p.i. they found a higher fluorescence intensity 
in skin than in T and no T damage after a single treatment at 3 h p.i. could be obtained. 
Furthel1110re, van der Veen et al (1995) found no direct correlation between fluorescence 
intensity and the amount of vascular damage to tumour and nonnal tissue after systemic ALA 
administration. These results emphasize the importance of further studies on the relationship 
between fluorescence kinetics and optimum interval of PDT treatment of tumours and host 
tissues before systemic ALA-PDT can be a successful and reliable treatment modality for 
human studies. Furthenllore, it also seems necessary to investigate whether the bio-
availability of ALA can be improved by for example using liposomes (Fukuda ef ai, 1989) as 
a carrier system. A successful option for increasing the retention of ALA in the circulation is 
by administering fractionated ALA doses. Regula ef al (1995) were able to produce plateau 
levels of ALA in patients by 6 fractionated ALA doses given orally at hourly intervals. 
In contrast to systemically administered ALA, maximal fluorescence in T and AS after 
topical ALA was reached 6 hours after the end of the application period. Malik ef al (1995) 
observed an increase in fluorescence intensity of nonnal mouse skin till 2-4 hours after the 
end of 2 hours topically applied ALA. It may be possible that during the 4 hour application, 
on the skin of hairless mice, a large depot of ALA is fonned in the homy layer or in other 
parts of the skirl. This ALA can be metabolized over a long period of time which may explain 
this long interval of fluorescence increase in T and AS. Fluorescence in NS increased only till 
4 hours post application after which the fluorescence stayed at the same level. As a result 
maximal fluorescence intensity in Twas 4 times higher than in NS. This is in contrast with 
systemically administered ALA where fluorescence ofT at 2 h p.i. was only 1.8 times higher 
than NS fluorescence. The increased sclectivity of T and AS over NS after topically applied 
ALA may be the consequence of an altered skin barrier of T and AS. The abno1111al layer of 
keratin that is produced by some skin tumours like squamous cell carcinoma is rapidly pen-
etrated by ALA. Also skin that shows evidence of chronic sun bum damage and actinic 
keratoses usually shows an increased penetration of ALA. This was illustrated by Goff et al 
(1992) who induced a dismpted stratum corneum by tape stripping the skin of guinea pigs and 
found an increased damage effect after topical ALA-PDT compared to ALA-PDT on skin 
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with an intact stratum comeum. Because of the altered skin barrier of T and AS an increased 
ALA depot in the skin may be fonned during the application period which may result in an 
increase in fluorescence over a long period of time. In NS less ALA can penetrate the skin 
during the application period because of an intact skin banier. This may then result in an 
increased selectivity ofT and AS compared to NS till interval of maximal fluorescence. 
At 10 h after the start of application fluorescence intensity in T and AS was at least 
1.5 times higher than directly after the application period. Furthennore, the fluorescence ratio 
ofT compared to NS between 4 and 10 h had increased from 3.3 to 4.3. This increase in fluor-
escence intensity and selectivity implies that treatment directly after the 4-6 h ALA-
application, as commonly applied in human studies (Caimduff ef ai, 1994; Wolf ef ai, 1993; 
Svanberg ef ai, 1994), may not be optimal. Instead, 4-6 h of ALA-application and postponing 
illumination for another 4-6 h may result in improved tumour response and improved 
therapeutic ratio. 
Another option for increasing the fluorescence intensities after topical ALA is 
prolonging the ALA-application period. Szeimies ef al (1994) observed an increase in 
fluorescence intensity in human basal cell carcinoma by applying ALA for 12 h instead of a 4 
h application period. However, with this prolonged application interval they also observed an 
increase in fluorescence in surrounding nonnal tissue. Also in our clinic we have used a 
prolonged ALA application (16-19 h) for treating skin malignancies with ALA-PDT. With 
this prolonged application more damage effect after ALA-PDT is observed but in contrast 
with a 4 hour application period hardly any difference in fluorescence between T and 
surrounding skin can be observed. Nevertheless, the therapeutic ratio and cosmetic effect are 
not adversely effected. It may be possible that due to a prolonged ALA application and 
therefore prolonged occlusion the difference in ALA penetration between T and surrounding 
skin diminishes. Considering the results obtained with the experiments in hairless mice it may 
be more favourable to apply ALA for a limited time and illuminate the applied area at a later 
interval. 
In further studies the influence of the interval of ALA application on selectivity and 
fluorescence intensities will be investigated. Also studies will be performed to examine the 
correlation between fluorescence intensities and therapeutic effects by treating at different 
intervals after topically applied ALA. 
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Fluorescence localisatioll study. 
The results obtained with the fluorescence cryo-microscopy study showed no important 
variations in localisation of PpIX fluorescence in the skin between topically and systemically 
administered ALA. Fluorescence after both administration routes in NS and AS was mainly 
localised in the epidennallayer and in the hair follicles. No fluorescence could be detected in 
the muscle layer. In AS a small increase in fluorescence could be observed in the submucosa 
at 2 h post i.p. and at 6 h post topical ALA application. For topical ALA this could imply that 
in the course of time ALA slowly penetrates through the epidennal layer into the dem1al 
layer. 
\Vith the fluorescence kinetics study we even observed some fluorescence at 20 h after 
ALA application. This fluorescence was spotty and inhomogeneous and was mainly obsen'ed 
in the tumours that were macroscopically rough on the top. In a pilot fluorescence cryo-
microscopy study it became clear that this fluorescence was located in necrosis of tumours 
and some areas of the stratum corneum of the tumour. This may be caused by porphyrins 
excreted fi·om cells and diffused to the necrotic parts in the tumour. Fluorescence in stratum 
corneum was also observed in humans after a 12 h application period by Szeimies et al 
(1994). They suggested that this fluorescence could also been synthesized by bacteria. 
Summal)' 
In the hairless mouse model we observed differences in fluorescence kinetics between 
topically and systemically administered ALA. The most apparent differences between both 
administration routes were the maximal fluorescence intensity and the inten/al to reaching 
maximal fluorescence in T and AS. Because of the disparity in bio-availability maximal 
fluorescence after systemic ALA in T was reached early (2 hpj.) but was 3 times lower than 
maximal fluorescence after topical ALA which occurTed at 10 h after start of ALA 
application. Furthermore, a higher selectivity of T compared to NS could be observed after 
topically applied ALA. These differences make topically applied ALA probably more 
favourable for a successful ALA-PDT in this model than systemic ALA. 
In general it can be concluded that by optimizing the time of ALA application or 
interval after ALA application the efficacy and selectivity of topical ALA-PDT for skin 
tumours may be improved. 
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Abstract 
Photodynamic therapy (PDT) using protoporphyrin IX (PpIX) induced by topically applied 5-
aminolaevulinic acid (ALA) seems a promising alternative for the treatment of superficial 
non~melanol11a skin cancer and actinic keratosis. In this study the kinetics were dctcnnined of 
new PplX fluorescence arising afler a PDT treatment that had photobleached the original 
fluorescence. The purpose was to examine the feasibility of multiple irradiations, following a 
single topical ALA-application, to increase the PDT efficacy. In addition the photobleaching 
during PDT and the fluorescence spectra during and aftcr PDT were studied. As a model we 
used hairless mice without and with UVB induced skin lesions. ALA was applied to the skin 
for 4 hours. An illumination was delivered either immediately after application or 6 hours 
after the end of the application (at interval of maximum fluorescence). During PDT, the 
fluorescence ofnoffiml skin decreased at a faster rate than the fluorescence of the skin lesions. 
In the fluorescence study after PDT, the areas treated immediately post application showed a 
similar fluorescence increase in time as non-treated areas on the same mice. A remarkable 
result was that the fluorescence of areas treated at maximum fluorescence increased whereas 
the fluorescence of non-treated areas did not increase in time. \Vith both treatment intervals 
the new fluorescence showed a characteristic PpIX spectmm. These results demonstrate that a 
second illumination, when new PpIX-fluorescence has been fonned, may increase the PDT 
efficacy aner topical ALA-application. This finding has been demonstrated previously for 
systemic ALA administration. 
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In tl'oduction 
Photodynamic therapy (PDT) is an experimental cancer treatment modality using a 
photosensitizer, which localizes in tumour tissue and can produce tissue destmction upon 
absorbing light of an appropriate wavelength and dose. 5-Atninolae",linic acid (ALA) is a 
prodmg that can be converted in situ into the effective photosensitizer protoporphyrin IX 
(PpIX), the penultimate step in the haem biosynthetic pathway. A simplified scheme of this 
biosynthetic pathway for haem is shown in figure 1. Under Bannai conditions the synthesis of 
haem is controlled by a feedback mechanism in which the presence of free haem inhibits the 
synthesis of ALA. An excess of exogenous ALA bypasses this feedback control mechanism to 
create diagnostic and therapeutic levels of intracellular PpIX. Besides PpIX other 
photosensitive products like Uroporphyrin (Up) I and III and Coproporphyrin (Cp) I and III 
are synthesised in situ. Up and Cp are very water soluble and are rapidly removed from the 
body. Therefore, they arc nonnally not observed in vivo. 
Protoporphyrin IX is a photo labile sensitizer absorbing light thronghout the near-
ultraviolet and visible region. Light absorption brings the PpIX molecule to an excited state 
from which it may decay back to the groundstate via an intenncdiate excited state, thereby 
raising available oxygen from its triplet ground state to the excited singlet state. Singlet 
oxygen is highly reactive and may cause cellular damage and eventually tissue destmctiol1. 
Especially the mitochondrion is very sensitive to PDT damage (Hilf ef al., 1986). This was 
demonstrated by linuma ef al. (1994) and Malik el al. (I 987) who observed early irreversible 
photodynamic damage of the mitochondrion, the site ofPpIX synthesis. 
Photo-destmction of PpIX by PDT results in bleaching of fluorescence and the 
fonnation of photoproducts. Because photodestmction is dependent on the oxygen 
concentration the process of photobleaching may be used as an indicator for the effectiveness 
of ALA-PDT (Robinson ef al., 1996). The same may account for the process of photo product 
fonnation (Konig ef al., 1993; Ahram ef al., 1994) but the role of photoproducts in the 
effectiveness of ALA-PDT is stillunc1ear (Gudgin Dickson ef al., 1995). 
PDT with topically applied ALA has proven to be effective for a variety of superficial 
skin malignancies. In clinical studies (Kennedy ef al.; 1990, Wolf ef al.; 1993, and Calzavara-
Pinton et a/., 1995) superficial basal cell carcinoma, actinic keratoses, Bowen's disease and 
squamous cell carcinoma could be treated successfully (initial complete respolls rate of 
approximately 85%). However, its efficacy for nodular lesions is still insufficient. Multiple 
irradiations may be a modality for increasing the PDT efficacy. This was illustrated in a 
previous study by van der Veen ef al. (1994). In that study two light treatments with an 
interval of 75 minutes were delivered after one systemically administered ALA dose. After a 
single treatment, which bleached the fluorescence, no necrosis oftumour tissue was observed. 
New fluorescence was observed in the course of time after the first treatment and total tumour 
necrosis could be accomplished after two treatments. This work should be distinguished from 
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that of Messmaml el al. (1995) and Hua el al. (1995) who studied illumination with brief 
interuptions to reoxygenate the tissues rather than by using new fluorescence. In the present 
study the feasibility for multiple irradiations with topically applied ALA was determined by 
examining the fluorescence kinetics after a single illumination. In addition the bleaching of 
fluorescence in skin lesions and normal skin during treatment was followed without 
intemlpting the illumination. During and after treatment fluorescence spectra were monitored 
to examine the formation of photoproducts. As a model we used hairless mice without and 
with small skin lesions (actinic keratoses and squamous cell carcinomas), which were induced 
by UYB irradiation. 
Feedback 
control 
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Figure 1. Simplified biosynthetic pathway for haem. The principal biosynthetic route for 
ALA-induced protopOlphyrill IX is indicated by open arrows. The haem feedback control is 
indicated with a dashed lille. All fluorescent compollents are encircled; the most potellt 
sel1sitizer (Pp/X) is double encircled. 
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Materials and methods 
Animal model 
Inbred female albino mice, Skh hrl, of 18 weeks old were obtained from the University of 
Utrecht. The dorsal skin of the mice had been exposed to a daily UVB dose of 1.5 kJ m-' using 
a Westinghouse FS40TLl2 lamp according to a method previously described by de Gmijl e/ 
al. (1983). After approximately 80 days multiple primary tumours developed in the exposed 
area. In the experiments small lesions (1·2 mm diameter) were included, which were mainly 
squamous cell carcinoma, actinic keratoses and seborrhoeic keratoses. Non-UVB irradiated 
animals were used to assess the fluorescence of nomml skin. This was necessary because as a 
reaction to the daily UVB dose the exposed dorsal skin showed an acute thickening of the 
epidennis which was only partly reversible (altered skin). In this article the UVB-irradiated 
animals will be referred to as UYB animals and the non-UYB irradiated animals will be 
referred to as n-UVB animals. 
Preparation alUl administratioll oJALA 
5-Aminolevulinic acid hydrochloride (98%) was purchased from Finetech Ltd. (Haifa, Israel). 
ALA was dissolved in Carboxymethylcellulose 3% after which the solvent was set at pH 5.5 
by adding NaOH (2M) to prevent irritation of the skin. Before application the animals 
received a low dose of Hypnonn (fluanisollfentanyl mixture, Janssen Phannaceutics, 
Belgium) and diazepam (Centrafann b.v., Etten-Leur, The Netherlands) to avoid anxiety 
caused by the dressing. A thin gauze was soaked in a solution containing 20% ALA and 
placed on the entire dorsal skin. A piece of transparent film dressing (M6Inlycke, Waremmc. 
Belgium) was placed over the gauze to achieve occlusion and to prevcnt evaporation and 
movement of the solvent. The solvent was applied to the skin for four hours after which it was 
carefully removed. 
Experimellt{/l {/PP{/l'{/fIIS 
Fluorescence imaglllg meaSll1'emeuts (Flllf) 
Fluorescence images during PDT were recorded using a CCD~camera with a two stage image 
intensifier and a 50 mm Leitz Photar macrolens. Fluorescence was detected through a 
bandpass filter of 670 ± 50 11m. Excitation light from an Argon laser with an incident power 
density of 100 mW en,' and a wavelength of 514 nm was gnided by a 400 ~m fiber. The fiber 
was attached to the CCD-eamera by a specially developed holder. With a mierolens fitted to 
the end of the fiber a homogeneous light field of 7 mm diameter was projected on the mouse 
skin at an angle of 25 degrees with the nonnal. Variations of the beam profile (± 10%) were 
examined at 9 points in the light field using an isotropic light probe (Van Staveren et al., 
1995). The treatment dose was 100 J cm,2 which required a treatment time of 16 minutes and 
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40 seconds. To prevent overload of the CCD-camera by the fluorescence light grey filters 
were placed in front of the Leitz Photar lens. \Vith this set-up it was possible to record the 
fluorescence during treatment without intemlpting the illumination beam. The recorded 
digitized images were analyzed yielding average grey scale values of selected areas of 
interest. 
The experimental set-up for the fluorescence recordings after PDT was partly similar 
to the set-up used during PDT. Fluorescence images were also recorded using the CCD-
camera with a two stage image intensifier and a 50 Bun Leitz Photar macro lens. Light from a 
halogen lamp and a laser line filter were used to excite fluorescence at a wavelength of 514 
11m. Through a dichroic mirror light with a maximal irradiance of 0.2 m\V CI11,2 was projected 
perpendicularly on the skirl. Fluorescence was detected through a bandpass filter of 670 ± 50 
nm. The recorded digitized images were analyzed yielding average grey scale values of 
selected areas of interest. 
FluoresceJlce spectroscopy measurements (FSll1) 
ALA-induced fluorescence emission spectra of UVB and n-UVB animals were detennined 
with an Instaspec IV system (Oriel, Stratford, CT USA). Fluorescence during PDT was 
excited with 514 11m light from an Argon laser with an incident power density of 100 
m\V cm-2_ Fluorescence after PDT was excited with 514 nm from an Argon laser with an 
incident power density of 75 ~l\V cm-2• The fluorescence emission spectrum was recorded 
above 570 mll using a long pass filter to examine both PpIX emission bands (640 and 710 
nm). The animals were placed against a specially developed holder to ascertain a constant 
distance between skin and flbertip during the recordings_ 
Experimelltal desigll of FIM ami FSM 
The numbers of animals included in the FIM and FSM study are shown in Table 1. In the FSM 
study only a small number of animals were used because the possibility for recording spectra 
arose at the end of the study. Therefore, the results should be seen as a support and an 
enhanced understanding of the results obtained with the fluorescing imaging study. The 
animals were divided in three groups, each group containing UVB and n-UVB animals. The 
first group (A) served as a control and received a PDT treatment after application of the 
solvent which contained no ALA. The second group (B) received a PDT treatment at (=4 
(directly after the ALA application) and the third group (C) received a PDT treatment at t~1O 
(6 hours after the end of the application period). These intervals for a PDT treatment were 
based on the fluorescence kinetics study described by van der Veeu et al. (1996) which was 
carried out under similar cOl1ditions. Briefly, the interval for PDT in group B was chosen for 
comparison with clinical treatments and the PDT interval for group C was chosen because 
maximal fluorescence of UVB skin was observed at that interval. In each animal two areas of 
1 cm in diameter were chosen and ALA was applied to both. One area received a PDT-
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illumination and the other served as a control. 
For the FIM during PDT the animals were anaesthetized with a combination of 
EthranelOxygenlN,o and placed under the eeD-camera on a temperature controlled stage. To 
avoid photobleaching and PDT -damage the untreated skin was covered with black plastic. 
During the treatment of almost 17 minutes, 35 fluorescence recordings were made on· line to 
examine the photobleaching, 
For the FIM after PDT the animals were briefly anaesthetized with a combination of 
EthranelOxygenlN,o and (re-)positioned under the eeD camera. Before ALA application 
(autofluorescence) and at several intervals after PDT the fluorescence of the treated and the 
control area was recorded, The fluorescence after treatment of group A and B was recorded 
every 15 or 30 minutes for 5 hours, The fluorescence after treatment of group C was recorded 
every 15 minutes for 120 minutes. Between the fluorescence recordings the animals were 
housed under subdued light conditions with water and food ad libitum. 
In UVB and n·UVB animals of each group spectra of both areas were recorded to 
examine the fluorescence after PDT. The spectra were measured before ALA·application and 
before PDT, directly after PDT and I and 2 hours after PDT. During the recordings the 
animals were briefly anaesthetized with a combination of EthraneiOxygenIN20 and (re-
)positioned under the holder. In an additional experiment the spectra during PDT in UVB and 
n·UVB animals were recorded every 10 seconds to examine the possible fonnation of 
photoproducts duri1lg the treatment. In each animal one area was treated at t=4 and a second 
area was treated 17 minutes later. 
Table I. Number of animals (UVBln-UVB) of3 groups treated at t~O (A, before application), 
t~4 (B) and t~IO (e). The animals were used for fluorescence imaging measurements (FIM) 
during and after PDT and for fluorescence spectroscopy measurements (FSM) during and 
after PDT. 
Group FIM FSM 
During PDT Post PDT During PDT Post PDT 
A 212 212 212 
B 616 616 212 212 
e 616 616 212 
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Results 
FIM dllrillg PDT 
As an indication for differences in bleaching rate between tissues and for different PpIX 
concentrations we examined the light dose at which the fluorescence was reduced to 50% 
(FBD50). This was detemlined in UVB and n-UVB skin treated at t~4 (group B) or t~IO 
(group C). The result for each animal was corrected for the autofluorescence, which was 
partly photobleached, and for the non-bleached fluorescence. Between UVB and n-UVB skin 
a clear difference in the FBD50 was observed in both groups. In group B the dose for UVB 
skin was 9.S J cnf' (s.e.m. ± 1.1) and for n-UVB skin 4.S J cnf' (s.e.m. ± O.S). In group C 
almost the same values (9.7 ± 1.4 and 5.9 J ± 0.9 cm" respectively) were obtained. 
Treatment with 100 J cm-2 at a dose rate of 100 m \V cnf2 lasted almost 17 minutes. 
The fast photobleaching, as illustrated by a FBD50 of approximately 10 J cnf', suggest that it 
may be possible to shorten the treatment time without loss of biological effect. As an 
indication for the effective treatment time the dose at which SO% (FBDSO) and 90% (FBD90) 
ofthe fluorescence had bleached was detennined. In both UVB and n-UYB in group Band C 
no difference in FBDSO and FBD90 was observed. Therefore, the results of the two groups 
were taken together. In the UYB treated skin the FBDSO was already observed aner 30 J cnf' 
(s.e.m. ± I) and the FBD90 after 49 J cnf' (s.e.m. ± 2). In n-UVB skin this dose was achieved 
faster, after 20 (s.e.m. ± 2) and 40 J cnf' (s.e.m. ± 2) respectively. 
FIMposlPDT 
The fluorescence kinetics after PDT of group A, Band C were recorded. Also, the 
fluorescence kinetics of non-treated areas, which served as controls, in the same animals were 
recorded. The results are presented in Figure 2 as fluorescence increase in time and not as 
fluorescence intensity. Therefore, the fluorescence values directly post PDT of non-treated or 
treated areas were subtracted from all fmiher recorded images for each area. Differences in 
fluorescence intensities before ALA, before treatment and immediately after treatment of the 
3 groups are shown in Table II. The fluorescence increase in figure 2 and the fluorescence 
intensities shown in table II are not corrected for the autofluorescence. 
The first group (A) received a PDT treatment without ALA to examine the 
autofluorescence. Because the autofluorescence oftul11our could not be distinguished from the 
surrounding altered skin the average grey scale value of the entire recorded area was measured 
as a function of time. The fluorescence levels of both areas before treatment were similar and 
after treatment the fluorescence levels of the treated areas were approximately 2 times less 
than the intensities before treatment (see Table II). After PDT no increase of the 
autofluorescence of both treated and non-treated areas in DVB and n-UVB skin could be 
observed. This is not shown in figure 2 to limit the number of graphs. 
The second group (B) received a treatment at t=4 which was immediately after ALA 
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application. At t=4 the ALA-induced fluorescence of tumour was approximately 7 times, 
altered skin 6 times and nonna1 skin 3 times higher than their respective autofluorescence. 
The fluorescence intensities of treated areas of these tissues directly after PDT decreased 
almost to the fluorescence intensities observed before ALA-application (see Table II). The 
fluorescence of treated and non-treated areas increased after PDT which is shown in figure 2a 
and 2b for tumour and nonnal skin. During the observation time of 300 minutes the increase 
of fluorescence in tumour was higher than in altered skin which was higher than in non11a1 
skin. In tumour and altered skin a similar increase until 150 minutes was observed in both the 
treated area and non-treated area. After 150 minutes the increase in fluorescence of the treated 
area seemed to be slightly higher (not significant) than the non-treated area. In nom131 skin 
(Figure 2b) a slight increase in time could be observed which was similar in both areas. This 
total increase at the end of the observation time was less (2.5 times) than observed in tumour. 
The third group (C) received a treatment at t~IO which was 6 hours after the end of the 
ALA-application pedod. The fluorescence intensities at this interval in tumour, altered skin 
and Bonnal skin were approximately 1.4 times higher than at t=4. After PDT the fluorescence 
in the treated areas of normal skin had decreased to the intensities observed prior to ALA 
application. In both tumour and altered skin the fluorescence after PDT was higher than the 
intensities observed prior to ALA application (see Table II). In figure 2c and 2d the 
fluorescence increase of tumour and altered skin is shown. For practical reasons the 
fluorescence after PDT in group C was monitored for 120 minutes. The results obtained in 
this group were quite fascinating. In all tissues there was a significant difference in 
fluorescence iI/crease between treated and non-treated areas. In the non-treated areas the 
fluorescence did not increase whereas in treated areas the fluorescence increased during the 
observation time. The fluorescence increase in tumour was higher than altered skin which was 
higher than nomlal skin. The increase in group C of the treated areas was similar to the 
increase observed in group B. To illustrate this fluorescence increase 4 images recorded 
before treatment (I), immediately after treatment (II), I (IlJ) and 2 (IV) hours after treatment 
are displayed in Figure 3. Note that the irradiance of the fluorescence excitation light before 
treatment (I) was a factor of 3 smaller than after treatment (II, IlJ, IV). In this figure a decrease 
in fluorescence intensity in both tumour and altered skin after PDT was monitored. In the 
images recorded 1 and 2 hours after treatment an increase, which was higher in tumour than in 
altered skin, can be seen. 
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Figure 2. Fluorescence increase (J: s.e.lII.) ill treated areas (solid lines alld closed symbols) 
after PDT alld control areas (dashed lilies alld open symbols) as a fimctioll of time. Animals 
with skill lesions (T, 2a) alld Il-UVB animals with normal skill (NS, 2b) oj group B received a 
treatment at {=4, Animals of group C (T; 2c alld NS; 2d) received a treatment at t= 1 O. The 
arbitrary uuits are the sallie ill 2a, 2b, 2c and 2d. Note the difference ill the scale of the 
horizOlllal axis between 2a, band 2e, d, respectively. 
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Table II. Mean fluorescence intensities expressed in arbitrmy units of 3 groups (± s.e.m.) 
Treated at t~O (A, before application), t~4 (B) or t~1O (C). In all groups the fluorescence of 
tumour (T), altered skin (AS) and nomlal skin (NS) was detennined before ALA-application 
(Autoflu.), prior to PDT (pre-PDT) and immediately aner PDT (post PDT). 
Autoflu. Pre-PDT Post-PDT 
Group A T,AS 42 ±4 45 ± 9 26±3 
NS 45 ± 2 44 ±5 28 ± I 
Group B T 45 ± 6 322 ± 46 65 ± 10 
AS 45 ±6 261 ± 28 59 ± 8 
NS 50 ± 9 170 ± 13 48 ± 7 
Group C T 49 ± 7 473 ± 49 82 ± 4 
AS 49±7 380 ± 37 75 ± 4 
NS 47± 10 219 ± 22 45 ±4 
FSM 
The spectra aner PDT of3 groups consisting each ofUVB and n-UVB animals treated at t~O 
(no ALA, group A), t~4 (B) and t~10 (C) were recorded. In each animal spectra of the PDT 
area and the control area were detennined before ALA-application and PDT, directly after 
PDT and subsequently I and 2 hours aner PDT. All recordings were corrected for background 
spectra and for small variations in excitation light intensity. 
An autofluorescence spectmm was recorded in both areas of all the animals (6 UVB 
and 6 non-UVB irradiated mice). In 19 out of 24 measurements no clear emission bands 
between 600 and 720 nm could be distinguished. However, in 5 measurements (3 UVB and 2 
n-UVB) a weak emission band around 679 nm could be detected. This band did not always 
occur in both areas of one mouse and no correlation between the location of the area and the 
occurrences of this band could be made. Also, within these observations large variations in 
fluorescence intensities were observed. In group A the spectmm was examined of the 
bleached autofluorescence of UVB and n-UVB animals. In both groups the areas after PDT 
showed a lower intensity of the entire spectra (in 2 animals also of the 679 run band) recorded 
between 600 and 720 Iml whereas the spectra of the control areas did not alter. In both areas 
no increase of fluorescence in time after PDT could be observed. In group B the spectra 
before and aner PDT at t~4 were determined. A typical example of the spectrum of a treated 
and a control area of an DYB mouse is shown in figure 4a and 4b. Except for differences in 
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height no differences in spectra between UVB and n-UVB animals before and after PDT were 
observed. In both gronps typical PpIX spectra with emission bands around 640 lun and 709 
nIll were detected before PDT. After treatment both emission bands had almost disappeared in 
the treated areas and the spectra were similar to the autofluorescence spectra. After 1 and 2 
hours post PDT a small fluorescence increase of the first emission band (640 Illll) was 
observed indicating a PpIX increase. The fluoresccnce intensity of the control area increased 
in time as illustrated in Figurc 4b. In group C the spectra before and after PDT at t= 1 0 were 
detennined. In Figure 4c and 4d the spectmm of the treated and the control area of an UVB 
mouse is shown. Before PDT a similar spectmm but with higher emission bands was observed 
as at t~4 (group B). Immediately after PDT the spectnun of the treated areas was almost 
similar to the autofluorescence spectra. At 1 and 2 hours after PDT an increase of the 640 11m 
band was observed whereas the fluorescence intensity of the control area decreased as shown 
in Figure 4d. In n-UVB and UVB animals the spectra during PDT were recorded every 10 
seconds to examine the fonnalion of photoproducts. A fast decrease with the same rate of the 
640 and the 709 run band was obsenTed. The fluorescence intensity at 680 nm decreased at a 
lower rate but during PDT no additional bands could be observed (data not shown). After 
PDT there were no clear emission bands. 
Figure 3. Fluorescence increase at 4 intervals of UVB skin treated at t=10 (group C): I; 
before PDT; IL post PDT, III; 1 h post PDT alld IV 2 h post PDT. Note that the irradimlce of 
the fluorescence excitation light before treatment (1) was a factor of 3 smaller than after 
treatment (IL IIL IV). T can be recognized in J, IlL IV as a bright fluorescent spot in the 
centre of each image. 
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Figure 4. III vivo fluorescence emission spectra of skin lesions prior 10 ALA (au); pre PDT; 
post PDT; J h post PDT alld 2 /I post PDT. III each box t/le time of measuremellts of t/le 
spectra is indicated ill rank order from high to low fluorescence intensity. The data of the 
control areas, which receil'ed no irradiaNoll are illdicated by quotation marks. Figure 4a 
represents the area of olle mOllse treated at 1=4 (group B) and Fig. 4b shows the related 
spectra of the controt area (ALA bUllIO PDT). Figure 4c represents spectra a/the area of olle 
mouse treated at (=10 whereas Fig. 4d represents spectra of the COJllrol area. 
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Discussion 
Allimal model 
In this study hairless mice were used with small lesions on the dorsal skin which were induced 
by daily UVB irradiation. De Gmijl ef al. (1983) observed that the nature of the lesions 
differed depending on their size. They found that the fraction of actinic keratoses decreases 
with increasing diameter whereas the fraction of squamous cell carcinoma increases with 
increasing diameter. This means roughly that lesions smaller than 2 111m mainly consist of 
actinic keratoses whereas lesions between 2 and 4 mm mainly consist of squamous cell 
carcinoma, In this study only small lesions of 1 to 2 111m were included to avoid considerable 
spread in the results. Larger lesions revealed considerable variations in appearance and 
incidence of necrosis or bleeding on top of these lesions. 
The UVB treated hairless mice were chosen for their resemblance with skin lesions 
like actinic keratoses and squamous cell carcinomas obsen'ed in humans. These skin lesions 
are also closely associated with repeated exposure to DV irradiation (Fears et al., 1976). In 
both humans and mice a thickening of the epidennis is seen after exposure to UV light. In 
humans this reaction is only temporary and the thickness retums to nonnal values within 
weeks when the skin is no longer exposed to sunlight. The daily UVB dose given to mice was 
so high that an acute thickening of the epidennis occurred which remained longer and was 
only pal1ly reversible (altered skin). This made it necessary to use n~UVB mice to examine 
skin with nomlal epidennal thickness. Therefore, in this paper we emphasise the comparison 
between n~UVB skin and skin lesions of DYB skin and not between skin lesions and the 
surrounding DVB skin. 
Experimental apparatus 
In this paper two methods (FIM and FSM) were used for fluorescence measurements. These 
two methods have their own advantages and disadvantages but by combining the methods a 
good indication about the distribution and nature of ALA-induced fluorescence could be 
obtained. With FIM the fluorescence distributiou could be visualised and after recording of 
the images the mean fluorescence intensity of several areas of different size could be 
measured. Additional infonnation about the nature of the fluorescence and especially changes 
in spectra could be obtained with FSM. 
A comparison between these two methods was made with regard to fluorescence 
kinetics. With FSM the area under the curve of the fluorescence measured between 620 and 
720 nm (the band of detection used with FIM) was detemlined at several intervals and 
compared with the fluorescence intensities recorded with FIM. \Vith both the photobleaching 
and the study conceming new fluorescence the same fluorescence kinetics were observed. 
For PDT~treatment and for the fluorescence kinetics after treatment excitation light of 
514 nm was used. The light penetration in skin was examined by placing an isotropic light 
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probe (Van Staveren ef al., 1995) at the surface or undcr the skin of a n-UVB and UVB 
animal on two different areas (no ALA). A homogeneous light field of 7 mm diameter and 
100 III \V cm"2 was projected on the skin. No differences in fluence rate between UVB and 11-
UVB on the surface of the skin and under the skin could be detected. In both cases the f1uence 
rate at the surface of the skin was approximately 150 mW cm", due to back scattered light. 
Under the skin the fluence rate was approximately 100 m\V cnf2, These measurements 
indicate that green light has sufficient penetration depth in mouse skin and that differences in 
results between UVB and n-UVB animals presented in this paper are not the result of 
differences in light penetration between these tissues. 
Light penetration in both UVB and n-UVB skin using 514 nm might alter due to 
vascular damage effects induced by PDT. This effect may have consequences for the PpIX 
fluorescence intensities in time. However, the strongest fluorescing layer of the mouse skin is 
the epidennis whereas hardly any fluorescence can be detected in the dennis (Vall def Veen et 
al; 1996). The vessels are located under the epidemlis. Therefore) alteration in light 
penetration due to vascular damage is not likely to be an important factor on the observed 
PpIX fluorescence intensities in time. 
Fluol'escence dutillg PDT 
The 50% fluorescence bleaching light dose (FBD50) of n-UVB skin was about two times 
smaller than that of UVB skin. The rate of bleaching with a constant fluence rate may depend 
on the concentration of oxygen and PpIX in the cells. This was investigated in aqueous 
solution, with either constant oxygen concentration and various PpIX concentrations or the 
reverse, by Robinson e/ al. (1995). They observed an increase in photobleaching rate after 
increasing the oxygen or the PpIX concentration in the solution. They also found that the 
oxygen concentration was rate limiting. Between UVB and nwUYB skin a clear difference 
could be observed in thickness of the epidennis, which is the strongest fluorescing layer. Due 
to the UYB irradiation the epidennis and dennis are thickened. The thickness of the epidennis 
of altered skin is 52 flm (s.e.m. ± 5), of tumour with the underlying epidermis 404 fUll (s.e.m. 
± 70) whereas the thickness of the epidennis of nomlal skin (n-UVB) 23 I'm (s.e.m. ± 1) is. 
The nonwvascularized epidemlis depends on oxygen by diffusion from the demlis. This may 
result in less oxygen during treatment in the epidennal layer of the thickened UYB skin 
compared to the epidennal layer of the thin nwUYB skin. The lower oxygen concentration in 
UVB skin may then result in the lower photobleaching rate compared to n-UVB skin. The 
faster bleaching rate in n-UVB skin compared to UVB skin may be beneficial for the 
therapeutic ratio between these tissues. Hnuma e/ al. (1994) suggested that some threshold of 
cellular PpIX concentration is required for PDT-induced cell killing. The fast bleaching of the 
sensitiser in nwUYB skin may reduce the concentration of sensitiser to a level below the 
threshold for producing photodynamic therapy which may enlarge the therapeutic ratio (Moan 
e/ al., 1996). 
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\Ve could not find a correlation between the initial fluorescence intensity and the 
photobleaching rate. There was a difference (a factor of approximately 1.5) in fluorescence 
intensities before treatment in both UVB or n-UVB bctween group Band C (see table II). 
However, similar values of the FBD50 were observed. A condition for finding a higher rate of 
photobleaching for higher fluorescence (Robinson e/ at., 1996) is that optimum oxygen 
concentration must be available during the treatment. This condition can be realized with in 
vitro studies. In vivo vascular constriction during PDT is a common phenomenon (van der 
Veen e/ at., 1994; Star e/ at., 1986). Also after topical ALA-PDT a rcduced circulation, which 
was temporary, was observed in this hairless mouse model (results will be presented in a 
forthcoming paper). Conshiction results in less optimal oxygenation of the cells which may 
explain why different initial fluorescence intensities were not accompanied by different 
photoblcaching ratcs. Also, in group B the location of PpIX in the cell may be different than 
in group C. This was indeed found by Malik & Lugaci (1987) who observed a gradual 
translocation of porphyrins from the mitochondria to less sensitive sites. The influence of this 
factor on the photobleaching rate has not yet been investigated. However, it seems that the 
initial fluorescence intensity is less relevant for the photobleaching rate than the oxygen 
concentration during treatment. 
The autofluorescence bleached to approximately 50% of its original values. Depending 
on the ALA-induced fluorescence intensity this is a factor which should be taken into account. 
Especially with low ALA-induced fluorescence intensities, which mostly occur in nonnal 
tissues, the contribution of the bleached autofluorescence to the total photobleached 
fluorescence may be significant. The nature of the spectrum before and after PDT is discussed 
in section 4.4. 
By correcting the results for the photobleaching of the autofluorescence the bleaching 
of ALA-induced fluorescence could be detennined. '-IVe then found that approximately 18% of 
the ALA-induced fluorescence intensity before treatment did not bleach. This was 
independent of the initial fluorescence levels, the different tissues or the different treatment 
intentals. This phenomenon was also not the result of a low light dose because after 20-30 J 
cm-' approximately 80% of the ALA-induced fluorescence had already bleached. Spectra of 
the remaining fluorescence of the treated areas were measured but no clear emission bands 
could be detected. An overall higher fluorescence intensity of the detected area between 620 
and 720 nIll was observed. This might indicate that the remaining fluorescence is not from 
photoproducts, not from PpIX which can not be bleached any [miher due to lack of oxygen 
nor from PpIX which is still continuously synthesised in time. \Ve are not aware of studies in 
which comparable results conceming residual fluorescence were absented. In vivo, especially 
in humans, it is almost jmpossible to detennine the non-bleached fluorescence by correcting 
the measured fluorescence for the bleaching of the autofluorescence. Because no clear 
emission bands were absented and the residual fluorescence could hardly be bleached further 
the relevance of this phenomenon for the PDT efficacy remains unclear. 
Ailer 30 J cm-2 in UYB skin and after 20 J cnf2 for n-UVB skin already 80% of the 
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fluorescence was bleached. As mentioned a PpIX threshold level for producing PDT damage 
was observed by Iinuma ef al. (1994). It would be interesting to perfonn a light dose-respons 
study to examine the PplX threshold level for producing PDT-damage with topical ALA. 
Experiments have been started looking at the correlation between photoblcaching rate and the 
damage for different fluorescence levels. If there is a correlation, monitoting the 
photobleaching dming PDT can then be a useful tool to detennine the required light dose. 
\Vith FSM we examined the fonnation of photo products during PDT. The decrease of 
fluorescence in the 3 spectral regions (640, 680 and 709 nlll) was not proportional. The 
fluorescence around 680 nm decreased at a lower rate than the other two bands. Several 
authors have reported (Konig ef al., 1993; Ahram ef al., 1994) PplX photoprociuct formation 
in vitro and in vivo during irradiation. A minor emission peak in the vicinity of 670 IUn or a 
slower decrease of this peak during PDT has been observed which presumably indicates the 
fonnation of hydroxy aldehyde chlorin-type of photo product. The occurrence of photo products 
and their possible role in the effectiveness of ALA-PDT is unclear. It appeared that the 
occurrence of photoproducts in vitro depends on the solvent used and on the oxygen 
concentration (Konig ef al., 1994). Konig ef al. (1994) investigated the role of photo products 
on the PDT efficacy in vivo by applying a combined treatment. They used 630 IUn for PplX 
activation during the first part of the treatment and subsequently 670 nm for activation of the 
photoproducts during the second part. This combination treatment compared to a single 
treatment with 630 nm did not enhance the therapeutic efficacy. However, the significance of 
photoproducts needs to be investigated in more detail before conclusions can be drawn. 
Fluorescence post PDT 
The fluorescence afier PDT was followed in animals treated at t~4 (group B) or t~lO (group 
C) to see whether new fluorescence was fonned which might be llsed for a second 
illumination, like after systemic ALA (van der Veen et al., 1995). 
Because bleaching of the autofluorescence was observed the fluorescence post PDT 
was also followed to examine a possible recovery of the autofluorescence. In the 
autofluorescence measurements no clear emission bands were observed before and after 
treatment. After treatment similar spectra but with lower fluorescence intensities were 
detected. Also, in the obsen'ation time after treatment no increase in fluorescence or changes 
in spectra could be observed indicating that the increase in fluorescence observed after ALA-
PDT is not the result of autofluorescence recovery. In 21% of the autofluorescence 
spectroscopy recordings a weak emission band in the vicinity of 679 rull could be detected 
before and/or after treatment. This peak did not always appear on both areas in the same 
mouse and no clear corTelation could be made between the appearance of this band and the 
location of the area on the mouse. \Veagle et al. (1988) examined the chromophore 
responsible for the 679 band in mouse skin. They observed the emission peak at all sites of the 
mice with the highest intensity at the abdominal side. This fluorescence peak was the result of 
a degradation product of one of the chlorophyll molecules. Because in our results no 
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correlation could be established between the sites of measurements and the appearance of the 
679 band it is not likely that this band is the result of chow components. It is more likely that 
the occasional band is the result of stray light from the experimental apparatus. 
With FIM, the fluorescence increase in the treated areas after PDT in group B was 
similar in time as in the control areas. In contrast, in group C an increase in fluorescence in 
the treated areas was observed whereas the fluorescence of the control areas did not increase 
in time. These results were similar in both UVB as in n-UVB animals. 
The spectra of the new fluorescence of the treated areas after PDT in group Band C 
were typically PpIX spectra. Other components like Uro and Coproporphyrin (Up and Cp) 
were expected based on experiments performed by Dietel ef al (1996). They observed an 
enhanced fonnation of Up and Cp under photolysis conditions which was due to 
mitochondrial damage after PDT. PpIX is synthesized in the mitochondrion (figure 1), a cell 
organelle initially damaged in PDT (Iinuma ef al., 1994; Malik ef al., 1987). This damage 
might lead to an accumulation of various water soluble Up and Cp derivatives. Although 
water soluble porphyrins are rapidly transported into the blood stream and cleared from the 
body an increase of these hydrophillic porphyrins in the mice could occur due to a shut down 
of the circulation caused by the treatment. However, no emission band around 610 run, 
indicating Up and Cp accumulation, was observed. 
Because ALA was applied to a relative large area of the body a possible explanation 
for the new fluorescence post PDT was PpIX leakage, from cells surrounding the PDT -treated 
area or from PpIX synthesised in other parts of the skin and transported through the 
circulation. However, looking at the images we did not see fluorescence from the edges 
slowly penetrating into the treated area which then would result in a decreased diameter of the 
non-fluorescent area in time. In contrast, as illustrated in Figure 3, we did observe a 
homogenous fluorescence increase in the entire bleached area in time, which makes PpIX 
leakage from cells surrounding the bleached area unlikely. To examine PpIX leakage from 
tissues outside the treated area an additional experiment was perfomled. In this experiment we 
measured the difference in increase of PpIX fluorescence between animals having ALA 
applied to a large area (the entire dorsal skin) and animals with ALA applied to an area of the 
same size as the PDT-treatment field. This experiment was perfonned at t=10 in UVB mice 
(n=4); an interval were maximal fluorescence in the skin was observed and where one would 
expect maximal PpIX leakage. In both the control and in the PDT -treated area no difference in 
fluorescence increase was observed between a large and a small ALA application area (data 
not shown). These results suggest that new fluorescence post PDT observed in group Band C 
probably results from locally fonned PpIX and is unlikely to result from PpIX leakage. 
The treated areas in both groups revealed a similar increase of fluorescence as the 
control areas in group B which might indicate that the increase in the treated areas is 
enzymatically regulated. Dan ef al. (1993) and Malik ef al. (1979) observed a decreased 
ferrochelatase activity in cells after PDT. Also, due to recovery reactions less Iron is available 
for incorporation in the PpIX molecule. This may result in an increase of PpIX due to a 
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decreased metabolization of PpIX to haem. As a consequence the fluorescence increase of 
treated areas in group B should be stronger than the control areas. As illustrated in figure 2a 
the areas treated in group B showed a slightly stronger increase between 2 and 5 hours after 
treatment compared to the control areas. In the control areas the fluorescence increase 
between 2 and 5 hours is not maximal indicating that ALA is no longer in excess available. 
Infonnation about the importance of this decreased PpiX metabolization to haem may only be 
gained by applying ALA again to the entire skin (treated and control area) immediately after 
treatment. In that situation again a large ALA depot is created in the skin and differences 
between maximal PpIX accumulation of the treated and the control areas can be investigated. 
Although no appropriate explanation can be given at this moment it is clear that new 
PpIX is fonned after treatment which can be used for a second treatment. The PDT-induced 
damage after single treatment delivered at t=4 or at t= 1 0 will be presented in a forthcoming 
paper. The effect of multiple light treatments, with topically applied ALA, on the therapeutic 
efficacy will also be presented in a forthcoming paper. The first experiments conceming 
multiple irradiations are completed and indeed we observed increased damage after multiple 
irradiations. 
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Abstract 
Several options were investigated to increase the efficacy of Photodynamic Therapy (PDT) 
using protoporphyrin IX (PpIX) induced by topically applied 5-aminolevulinic acid (ALA)_ 
Hairless mice with normal skin or UVB-light-induced skin changes were used as a model. In 
the first part of the study animals were illuminated immediately (t~4) or 6 hours (t~10, PpIX-
fluorescence maximum) after the end of a 4 hour ALA application. A total incident light 
fluence of 100 J/cm' (514.5 nm) was delivered at a fluence rate of 100 or 50 mW/cm'. The 
PDT-induced damage to nonnal skin was more severe after treatment at t=1O than at t=4. 
Illumination at 50 mW/cm' caused more visible damage than when the same total light 
fluence was given at 100 mW/cm2, For UVB-illuminated skin, different intervals or fluence 
rates made no significant difference in the severity of damage although some qualitative 
differences occurred. In situ fluence rate measurements during PDT indicated vasoconstric-
tion almost immediately after the start of the illumination. The second part of the study 
examined the effect of two illuminations. The first illumination bleaches the PpIX fluores-
cence. At the start of the second illumination, new PpIX had been formed. Light of 514.5 nm 
was delivered at 100 mW/cm' to a total incident light fluence of 200 J/cm' at t~4 (single 
illumination) or 100 J/cm' at t~4 plus 100 J/cm' at t~IO. There was no visual difference in 
skin damage between 100 and 200 Jlcm' single illumination. Two-fold illumination (100 + 
100 J/cm') caused significantly more skin damage, indicating a potentially successful option 
for increasing the efficacy of topical ALA-PDT. 
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Introduction 
Skin lesions associated with sunlight exposure like actinic keratoses (AK), basal cell 
carcinoma (BCC) and squamous cell carcinoma (SCC) are the most frequent (pre)-malignant 
skin lesions in Caucasians. At present, surgical and nonsurgical treatments like excisional 
surgery, cryosurgery, topical chemotherapy and radiotherapy are used. These methods can be 
costly, unsuitable for elderly people and the cosmetic outcome is not always satisfactory. 
Photodynamic therapy (PDT) using topically applied 5-aminolevulinic acid (ALA) appears a 
promising addition to the treatment modalities of superficial non-melanoma skin lesions such 
as AK, BCC and SCC. ALA is a prodmg and is converted in tissues in situ through the heam 
biosynthetic pathway into the photosensitizer protoporphyrin IX (PpIX). An excess of 
exogenous ALA can lead to diagnostic and therapeutic levels of intracellular PpIX in various 
malignant tissues. Several nonnal tissues, especially those originating from ecto- and 
endodenn may also become sensitized after ALA administration, in contrast to tissues from 
mesodenual origin (Divaris ef al., 1990; Loh ef al., 1993). 
Kennedy ef al. introduced topical ALA-PDT for skin lesions and reported 90% (1990) 
and 80% (1992) complete response rates of superficial BCC. The ALA-PDT protocol used by 
Kennedy is still the basis for clinical research to date. Briefly, a 20% ALA solution is applied 
to the target area for 4 to 6 hours. In normal skin, with an intact skin barrier, the penetration is 
limited. Because SCC, BCC and AK have abnomlal keratin layers, ALA may easily penetrate 
the epidennis to be converted into PpIX in the tumour cells. The difference in skin barrier 
between tumour and nonnal skin may result in a selective photosensitization of tumours. This 
can be observed after the application as red PpIX fluorescence in the tumour which is clearly 
demarcated from the normal skin. The tumour and a margin of nomlai skin are then 
illuminated with light of a suitable wavelength and dose which results in tumour necrosis. 
Because of the relative simplicity of the treatment and the promising results published 
by Kennedy, topical ALA-PDT drew widespread attention. In the past 5 years many 
investigators studied the efficacy of ALA-PDT for the treatment of superficial AK, BCC, 
see and Bowen's disease. The initial response rates were high. Long tenn histological 
complete responses were still 92% for AK, 87% for Bee, 81 % for sec and 85% for Bowen's 
disease (Caimduff ef al., 1994; Lui ef al., 1995; Meijnders ef al., 1996; Stables ef al., 1997; 
Svanberg ef al., 1994; Wolf ef al" 1993). However, Fiuk-Puches ef al. (1998) recently 
reported a projected disease free rate at 36 months after ALA-PDT of 50% for BCC and only 
8% for SCC. Nodular BCC and SCC were also treated with ALA-PDT but the results were 
disappointing in all studies (between 0 and 50% complete clinical response rate). 
Improvement of the PDT efficacy, especially for nodular lesions is necessary and researchers 
have examined several options like duration of ALA application (Szeimies ef al., 1993), 
multiple ALA-PDT treatments (Calzavara-Pinton ef al., 1995; WarIoe ef al., 1995; Fijan ef 
al., 1995 and Morton et al., 1995), the use of penetration enhancers and enhancement ofPpIX 
production using iron chelators (Orenstein ef al., 1994; Berg ef al., 1996). All these options 
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contribute to some extent to an enlarged PDT effect. In the present study, the effect of interval 
between ALA-application and illumination, fluence rate and multiple illuminations of nannal 
and altered skin were investigated using the UVB-iITadiated mouse skin as a model for (pre-) 
malignant changes. 
Materials and Methods 
Anima/model 
The protocol ofthe animal experiments was approved by the local ethical committee. Ontbred 
female albino hairless mice, Skh hrl, 18 weeks old, were obtained from the University of 
Utrecht. The dorsal skin of the mice had been exposed to UYB light for 80 days, with a daily 
UVB dose of l.5 kJ/m' from a Westinghouse FS40TLI 2 lamp according to a method 
previously described by de Gruijl el al. (1983). As a result, the entire dorsal skin showcd a 
histological thickening of the epidenllis with hyperkeratosis, increased basal mitotic activity 
and disorganization of the architecture (Fig. I). Also the demlis was thickened, showing an 
increased amount of dense collagen. Additionally, small intra-epidennal lesions of atypical 
spinous cells were seen in several animals. No infiltration into the dermis was seen, thus 
classifying these lesions as actinic keratosis (AK). Technically, it is not possible to shield part 
of the mouse skin for 110nnai tissue control. Therefore, a comparison was made between 
UVB-treated skin and the nonnal skin of nOIl-UVB mice and not between AK and the 
surrounding skin. 
The UVB-treated mice were chosen for the resemblance of their skin lesions to 
sunlight-induced skin lesions like AK and SCC observed in humans (Fears el al., 1976). In 
both humans and mice, thickening of the epidennis is seen after exposure to lTV itTadiation. 
In humans this reaction is only temporary and the thickness retums to Honnal values within 
weeks when the skin is no longer exposed to sunlight. In our model the daily UYB dose given 
to the mice was so high that an acute thickening of the cpidcnllis and dennis occurred which 
remained longer and was only partly reversible (Sterenborg ef al., 1986). 
Preparatioll alUl admillistratioll of ALA 
5-Aminole\~llinic acid hydrochloride was purchased from Finetech Ltd (Haifa, Israel). ALA 
was dissolved in 3% carboxymethylcellulose after which the solution was set at pH 5.5 by 
adding NaOH (2M) to prevent irritation of the skin. Under anaesthesia using Hypnoml 
(Janssen, Beerse, Belgium) and diazepam (Centrafaml, Etten-Leur, the Netherlands) a thin 
gauze soaked in a 20% ALA solution (max. 20*20 mm') was applied to the dorsal skin for 4 
hours. This is the most common topical ALA concentration used clinically. A piece of 
transparent film dressing (Molnlycke, \Varemme, Belgium) was placed over the gauze. 
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Table I: Summary of the PDT study on 7 groups of animals. One group scrved as a control. A solution without ALA was applied for 4 hours 
followed by illumination. On the animals of group A to F, ALA (20%) was applied for 4 hours after which they received an illumination at 
different time intervals after application with different light fluencc rate and fluence. The number of animals in the follow-up study (Visual Skin 
Damage) and the histological study are shown separately. 
00 
w 
Group 
Control 
A 
B 
C 
D 
E 
F 
Interval from start 
ALA-application 
to illumination 
(h) 
4 
4 
10 
4 
10 
4 
4+10 
Fluence rate 
mW/cm2 
100 
50 
50 
100 
100 
100 
100 
Light fluence Numbers of 
J/cm2 Animals 
NormaVUVB 
VSD Histology 
100 4/4 4/4 
100 4/4 2/2 
100 4/4 212 
100 6/6 3/4 
100 6/6 4/4 
200 4/4 -I-
100+100 4/4 -1-
Illuminatioll schemes alUl visual skill damage score 
In the first part of the study the effect of fluence rate and interval between ALA application 
and illumination on the damage to the skin was examined. Reducing the fluence rate may 
improve oxygenation and the interval affects the concentration and distribution of PpIX in the 
tissues. Four UVB-treated and 4 nonnal animals were used to examine the effect of Jight and 
carboxymethylcellulose (control group). Four groups (A-D) were treated with ALA and light, 
each group consisting of UVB and nom,"1 animals (Table I). Illumination at the end of a 4 h 
ALA-application is designated "t=4", illumination at maximum fluorescence. 6h later, is 
designated "t~IO". The difference between 50 mW/cm' (groups A, B) and 100 mW/cm' (all 
other groups) is relatively small, but chosen for practical reasons: with 50 mW/cm' it takes 33 
minutes to deliver 100 J/cm'. The effect of ALA-PDT at a very low fluence rate (5 mW/cm') 
has been studied before (Robinson ef al., 1998). All mice received a light fluence of 100 
J/cm', which causes complete photobleaching of PpIX-fluorescence (and also of the 
photoproduct (Robinson ef al., 1998 and 1999). Intervals for the illumination were based on 
the PpIX-fluorescence kinetics study or'van der Veen ef al (1996). Briefly, illumination at 
t=1O was chosen because of maximal PpIX-fluorescence in UYB skin (both in lesions and in 
sUlTounding thickened skin). Illumination at t=4 was chosen because clinical ALA-PDT 
treatment is often applied at this interval. At t~1O the PpIX-fluorescence in UVB skin and in 
nomlal skin was 1.3 times higher than at t~4. At both intervals the PpIX-fluorescence in UVB 
skin was 1.7 times higher than in nomml skin, as measured with a CCD-camera (van der 
Veen ef ai, 1996). 
Before illumination, the animals were anaesthetized with a combination of Ethrane/-
oxygeniN,O and placed on a temperature controlled stage. To restrict damage to the target 
area a black polythene mask was used. A 7 mOl diameter homogeneous light field with an 
incident power density of 50 or 100 mW/cm' and a wavelength of 514.5 nm (from a Spectra 
Physics model 2040E Argon ion laser) was projected on the back of the mouse. A black 
polythene mask was used to facilitate (re)positioning of the beam and to block scattered light 
from the micro lens. The 514.5 nm wavelength was chosen because it allows measurement of 
the full PpIX-fluorescence emission spectnllll during PDT (Robinson ef ai, 1998) and the 
light penetrates sufficiently deep into mouse skin (see below). Variations of the beam 
intensity profile (± 10%) were checked in the light field using an isotropic light probe (Van 
Staveren ef al., 1995). The skin response of between 4 and 6 UVB and between 4 and 6 
normal animals in each group were detemlined every day for the first week and every two to 
three days until 25 days post treatment according to the visual skin damage score (VSD), as 
shown in table II. Mean damage scores were calculated by summing partial scores weighted 
with the fraction of the total illuminated area. Accordingly, the mean scores of day 2 to 7 post 
treatment for each treatment site were used to calculate a mean VSD for each group. In UVB 
skin each area contained one or two small lesions which were histologically classified as AK. 
\Ve did not observe any macroscopical or histological differences in damage between the 
lesion and the sun'ounding hyperplastic skin. Therefore, no distinction between AK and the 
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surrounding skin was made in the observations. The hairless mouse model is unsuitable to 
study long teml response to PDT because new skin lesions develop in time in the entire DVB 
affected skin. Therefore, the VSD was determined until healing of the skin was complete 
with a maximum of25 days. 
The VSD was based on the prevalence of the visual skin damage with regard to the 
time of recovery was detenllined in group A to D. Visual skin reactions like oedema, 
discolouration and scab fonnation were observed in DVB and nonnal skin. Oedema was 
observed 5-10 hours after the illumination and had disappeared at day two. The degree of 
oedema did not correlate with the severity of the damage and was therefore not included in 
the VSD. Discolouration (redness) and scab fonnation ensued at day 2 after illumination. We 
could make a distinction between dry desquamation, thin scab and thick scab fomlatioll. Dry 
desquamation had disappeared at day 3 after PDT and healing was complete after an average 
of 6.1 days (n~21; sem ± 0.1). A thin scab fell off 5 to 7 days after PDT and healing of the 
skin was complete after an average of 10.3 days (n~7; sem ± 0.9). A thick scab fell of 6 to 8 
days after PDT, after which the underlying skin showed strong red discolouration. Complete 
healing was observed after an average of 17.6 days (n~8; sem ± 2.2). When more than 25% of 
the area was covered with a thick scab, a thinner and greyer skin was still observed 25 days 
after PDT. 
Table II: Visual skin damage (VSD) scoring system for UVB and nonnal skin 
His/ology 
Grade 
o 
2 
3 
4 
5 
Visual Skin Damage 
No change in colour 
Minimal redness 
Redness 
Dry desquamation 
Thin scab fanllatian 
Thick scab fomlation 
To detemline the extent of tissue damage after ALA-PDT with varying treatment parameters, 
limited numbers of animals were sacrificed for histology (Table I). Forty eight hours after 
PDT between 2 and 4 UVB and between 2 and 4 normal animals in each group were 
sacrificed. The illuminated area and an untreated (ALA, no light) area were excised, fixed in 
buffered formalin, processed far routine tissue sectioning, and then stained with haematoxylin 
and eosin (HE). Maximum depth and diameter of the lesion in relation to the thickness of 
epidermis and dermis were measured with an eyepiece graticule in 2 to 3 slides of each 
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excised area. Because of the rather large variation in these measured values, the difference in 
thickness of dennis and epidennis between UYB-treated and normal skin was related to the 
involved stmctures. The skin was divided into four layers. From the tissue surface they are: 
layer I the epidennis, layer II the papillary dennis, layer III the reticular dennis not including 
the demlal cysts (dilated hair follicles) and layer IV the deep dennis including dennal cysts 
down to muscle (Fig. I). Accordingly, the location (rim or centre) of the deepest extension of 
damage of the treated area was determined. A study of the histology following twofold 
illumination (see below) will be presented when this treatment scheme has been optimized. 
a b 
I 
II II 
IV 
M 
Figllre 1. Histology o/lIol'lIIal hairless 1II0llse skill (A) alld UVB-tl'eated skill (B). The layers 
are:! tlte epidermis; lL the papillm)1 dermis; IlL the reticular dermis not including lite 
del'llwl cysts (dilated hail' /ollicles); IV, the deep del'lIIis illcllldillg del'lIIal cysts dowlI to 
IIIl1scle. M~Mllscle. Totalthicklless a/layers I-IV as illdicated 0.37 111111 (A) alld 0.69 111111 (B), 
respectively (H&E, objective lOx). 
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Vascular effects 
Two additional experiments were perfomlCd to look for possible vascular effects of topical 
ALA-PDT. In the first experiment we examined the exclusion of fluorescein dye afler the 
illumination. This method has been used by several authors (Bellnier et al., 1995; Fingar et 
al., 1987) and is based on the exclusion of fluorescein dye from tissue vessels with impaired 
perfusion due to PDT induced vascular damage. Immediately after illumination (perfonned at 
1'=4 or t~lO, 100 mW/cm' or 50 mW!cm') 2 UVB and 2 nonnal animals of each treatment 
group (a total of 16 mice) were given an intraperitonal injection of 20 mglkg fluorescein dye 
(10 mg/ml of sodium fluorescein, ACROS, Geel, Belgium; diluted in phosphate-buffered 
saline). Fluorescein~fluorescence was excited with 460 ± 60 om with a maximum fluence rate 
of 0.1 mW/cm' and detected through a long-pass coloured glass filter (OG 530). Before and 5 
min after injection the fluorescein fluorescence (FF) of a treated (ALA and light) and an 
untreated (ALA, no light) area on the same mouse was recorded using a charge-coupled 
device camera according to a method previously described by van der Veen et al. (1996). 
Mean FF fluorescence intensities of the entire recorded images were calculated and the 
autofluorescence before fluorescein injection was subtracted. The data are expressed as 
percentage fluorescein fluorescence ofthe treated area as compared to the untreated area. 
A second experiment was performed to investigate acute vascular constriction durrilg 
t~e illumination. This was examined using the fact that green light (514 nm) is strongly 
absorbed by red blood cells. Vascular constriction reduces the tissue blood content and thus 
reduces absorption of green light. Changes in blood flow can then be detected by measuring 
the fluence rate under the skin. The fluence rate during illumination (t~4, 100 mW/cm' or 50 
mW/cm') was measured in2 nonnal (4 areas) and 2 UVB (4 areas) animals of each group (a 
total of 8 mice) using two isotropic light detectors (van Staveren et al., 1995), which were 
manufactured in our laboratory. One probe was placed on top of the skin in the centre of the 
illumination field. A small incision (approximately 1 mm) was made at least 1 cm from the 
illuminated area and a second probe was placed under the skin beside the first probe. The 
probes were connected to photodiodes (Photop UDT-455, Graseby Electronics, Orlando FL, 
USA), whose output was AID convelied and stored in the computer. The fluence rate during 
illumination of both probes was recorded every 5 seconds. To exclude the effect on light 
absorption of non-vascular changes in optical properties) as a control 2 areas on each of 2 
UVB mice were illuminated at t~4 with 630 nm light (from a Spectra Physics model 375B 
dye laser pumped by a model 2040E argon ion laser) and a fluence rate of 100 mW/cm'. 
Because the absorption coefficient (Il,) of partially oxygenated human blood for red light is 
10 times less than for green light (Cheong et al., 1990) no significant increase in fluence rate 
was expected during red light PDT. 
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Twofold il/llmillatiolls 
In the second part of the study the effect of twofold illuminations was examined. The basis 
for this experiment was a previous study by van der Veen el al (1997). In that study animals 
received a light treatment immediately after a 4 hour ALA application time (t~4). After the 
illumination the PpIX-fluoresceuce had bleached completely indicating that PpIX was no 
longer present. However, after the illumination an increase in PpIX~fluorescence was 
observed, at the same rate as in non~illuminated animals at the same time after AIA-
application, indicating new PpIX formation. This phenomenon led to the idea that two 
illuminations separated by a waiting interval, in which new PpIX was fonned, would be more 
effective than a single illumination. 
Two groups (E and F) were assessed, each group containing UVB and nomlal animals 
(Table I). Group F received illuminations at t~4 aud at t~ 10 both with a fluence rate of 100 
mW/cm' and a light fluence of 100 J/cm' (total light fluence 200 J/cm'). Group E served as a 
control group and received a single illumination at t~4 (immediately after the 4 hr ALA-
application) with a fluence rate of 100 mW/cm' and a total light fluence of 200 J/cm'. The 
damage scoring protocol (Table II) was the same as that used for the fluence rate and 
illumination intervals study. The results of group E and F were compared with those of group 
C. 
Statistics 
Stastistical tests were perfonned using the analysis of variance followed by a Student-
Newman-Keuls test, as necessary. \Vhenevcr the tenn "significant" is used in this paper we 
mean that the test yielded a p-value of less than 0.05. 
Results 
Fluellce rate aud iutervalto ilIuminatioll 
There was no visual damage in the control group of 4 UVB and 4 normal animals, to which 
solvent without ALA was applied for 4 hours followed by illumination (100 mW/cm', 100 
J/cm'). Figure 2 shows the mean VSD of the first part of the study. In nOtmal skin, 
illumination with a fluence rate of 100 m \V /cm2 caused very mild damage and no significant 
difference in VSD was observed between both illumination intervals. The damage in both 
groups (t~4 and t~ 10) increased when the fluence rate was lowered to 50 m W /cm'. In 
particular at t~IO the VSD clearly increased (3.5 times higher than with 100 mW/cm'), 
resulting in a significant difference in VSD between illumination at t~4 and t~1O using 50 
mW/cm'. In UVB animals lowering the fluence rate or postponing the illumination had no 
significant effect on the VSD (Fig 2). 
During the observation period a distinct pattern of skin changes was noted that 
depended on the fluence rate. In both nonnal skin and UVB-treated skin, maximum skin 
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change was observed at the rim (high fluence rate) or in the centre (low fluence rate) of the 
illuminated area. An illustration of rim damage is given in Figure 3. Figure 3A shows an area 
ofUVB mouse skin illuminated with 100 mW/cm' and Fig. 3B an area illuminated with 50 
m\V/cm2, Table III presents the number of mice showing rim reactions, including the animals 
sacrificed at day 2 for histology. Rim reaction occUlTed most frequently in DYB animals 
illuminated at 100 mW/cm' (significantly more than in UVB-treated animals illuminated at 
50 m\V/cm2) and least frequently in normal animals illuminated at 50 m\V/cm2, .To examine 
the OCCUlTences of rim reaction related to the VSD, the UVB-treated animals were pooled and 
two new groups were fonned showing rim or central reaction (mice used for histology were 
not included here, because no VSD was available). \Ve observed a significantly lower mean 
VSD in areas showing rim reaction than in areas showing a more central reaction. In eight 
areas with rim reaction a VSD of 1.76 (± 0.28) was found, while twelve areas with a more 
central reaction had a VSD of2.51 (± 0.21). 
Table III: Number ofUVB or nonnal animals (%, and the numbers in each group), two days 
post treatment, showing more damage at the rim than in the centre of the illuminated area. 
The animals used for the histology Shldy are also included. 
Interval from start Fluence rate Fluence rate 
of ALA-application to 50 mW/cm' 100 mW/cm' 
illumination 
t~4 NOlTIlal 16% (lout of6) 33% (3 out of9) 
UVB 33% (2 out of 6) 60% (6 out of 10) 
t~IO Nonnal 16% (lout of6) 44% (4 out of9) 
UVB 33% (2 out of 6) 80% (8 out of 10) 
Histology 
ALA-PDT caused acute skin changes that were similar in UVB and nomlal skin (Fig.4). In 
epidemlal lesions they ranged from hyperplasia, coagulation necrosis of the epidermis and 
crust formation to re-epithelization. In deeper (demml) lesions necrosis of adnexal structures 
and blood vessels, and polymorphonuciearinfiltration were seen. No damage was observed to 
muscles and large blood vessels below layer IV (hair follicles). 
The thickness of the epidermis and the diameter and depth of the damage were measured. In 
all groups we found large variations in diameter and depth. Two days after PDT the thickness 
of normal epidemlis in all groups had increased significantly compared to the untreated areas 
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(ALA, no light) on the same mouse. No significant increase occUlTed in UVB-treated skin. 
Additional significant differences after PDT were in diameter of damage between normal and 
DYB-treated skin (group C, 1.4 ± 0.4 mm and 7.1 ± 0.9 mm, respectively), as well as between 
nonnal skin of group A versus C (3.9 ± 1.4 mm and 1.4 ± 0.4 mm, respectively), and in 
thickness ofnon11al epidermis (group B versus D, 0.043 ± 0.01 mm versus 0.068 ± 0.008 mill 
respectively). Generally speaking, the depth and diameter of damage in nomlal skin increased 
when the fluence rate reduced from 100 mWlcm' to 50 mW/cm'. This was not clear in UYB-
treated skin. More fluorescence (t~ 10 versus t~4) did not lead to greater depth or diameter of 
damage. 
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Figure 2: Meall visllal skill dall/age (2-7 days; ± s.e.II/.) of grollp A. B. C. D (Table J) Irealed 
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Areas were illlllllillaled illlllledialely (1~4) 01' 6 hOllrs after Ihe elld of ALA applicalioll (t~10). 
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Figure 3: Illustration of PDT treated areas ill UV8 mouse skill showing a rim reaction (3A) 
and a central reactioll (28) at day 4 after illumination (fluence rate was 100 mW/cm1 in 3A 
and 50 mW/cm1 ill 38). The diameter of the damage is approximately 7111m, the diameter of 
the illuminated area. III Fig. 3B three small lesions are located outside the illuminated area. 
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Figure 4. Histology of hairless mouse skill, 48 h after PDT (H&E, objective 4.,). (AJ Normal 
skill treated at t= 1 0 and 100 III w/clll. III lite centre a crater is visible, covered with crust, The 
damage extends down to, but !lot into, layer IV. Thickness oj crust plus layers I-IV at centre 
0.6 mm. (B) UVB-Ireated skill illuminated at 1=4 alld 100 mWlcl1/ Damage extends into layer 
IV and over tlte/ull widtlz ojthe picture. Thickness layers I-IV at centre O.6mm. 
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I 
The histological examinations (48 h after PDT) showed similar patterns of skin damage as 
with the daily macroscopical examinations. Therefore, the location of maximum histological 
damage (rim or centre), the depth of the damage (mm) and the layer into which it extended (I, 
II, III, IV) were determined and are shown in Table IV. The results of all treated groups were 
pooled. In both nonnal and UVB treated skin when damage was located at the centre of the 
illuminated area, more animals showed extension of damage into the deeper layers III and IV 
than when damage was located at the rim of the illuminated area. In addition, more UVB 
animals than nomlai animals showed extension of damage into skin layers III and IV, 
irrespectively of the site (centre or rim). 
Table IV: Histological location of maximum damage (rim or centre) related to the depth of 
damage and to the skin layer which it extended, in nonnal and UVB skin (results of group A 
to D were pooled). The skin was divided into four layers. From outside to inside they consist 
of: Layer I the epidermis, layer II the papillary delmis, layer III the reticular dermis not 
including the dernlal cysts (dilated hair follicles) and layer IV the deep dermis including 
dermal cysts down to the muscle. For layers with more than two measurements, mean depths 
(± scm) are given, otherwise the measured values. 
Nannal skin UVB skin 
Location Skin depth of animals Skin Depth of animals 
of damage layer damage (mm) layer Damage (mm) 
Center 0 0 I 0 - -
II 0.17 I II - -
III 0.22 2 III 0.26 I 
0.21 
IV 0.39 2 IV 0.34 4 
0.50 (± 0.07) 
Rim 0 O· I 0 - -
II 0.09 2 II 0.18 I 
0.07 
III 0.15 I III 0.15 4 
(± 0.04) 
IV - - IV 0.21 2 
0.43 
.. 
* Only crust remammg at tllne of histology, 48 h after PDT. Any damage In underlymg 
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tissues had apparently healed at this time. 
Vascular dalllage effect 
Fluorescein dye exclusion: 
In the untreated areas (ALA, no light) we observed no differences in fluorescein fluorescence 
(FF) intensities between UVB and nonnal skin. In the areas of both normal and UVB skin 
after PDT no significant difference was observed FF between illumination at t~4 and t~IO 
(Fig 5.). Therefore these results were pooled. In UVB-treated skin, after PDT with a fluence 
rate of 100 m\V/cm2, the FF was less than in nonllal skin. A reduction of the fluence rate to 
50 m\V/cm2 resulted in an increase in FF in both UVB and 110nnal skin. This was significant 
(factor 1.6) innonnal skin. 
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Figure 5: Fluorescein fluorescence of PDT treated areas (incident jlllence rate FR= 50 01' 
100 m JVlcm1) relative /0 cOlltrol (ALA, 110 light) areas. Fluorescence recordings were made 5 
minutes after the end of the illumination for PDT. The results of illumination at (=4 alld (= 1 0 
were pooled fo}' both UVB and normal skill and each group consist of 3 to 4 animals (± 
s.e.m.). 
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Fluence rate measurements: 
In the ALA-PDT groups the fluence rate measured with a probe on the skin did not change 
signifieantly (± 5 %, interval 2 min) during the illumination. In areas treated by PDT a 
maximum increase in fluence rate under the skin was measured at approximately 2 minutes 
after the start of the illumination. Therefore, this inten'al was chosen to calculate the ratio 
between the fluence rate under the skin and the fluence rate on the skin. The results of the 
increase of fluence rate are shown in Figure 6. In nOl1nal (n=3) and UVB (n=3) control 
animals treated with light and solution (no ALA) the fluenee rate did not increase during 
illumination. UVB animals (n~4) illuminated with red light (630 nm) showed a small increase 
(3,3% ± 1,6). In nOlmal animals treated at 514.5 !lin with tOO mW/cm' (n~4) or 50 mW/cm' 
(n=4) there was no significant increase in flue nee rate, compared to the control group. In 
UVB animals illuminated with a fluenee rate of 100 m\V/cm2 a significant increase in fluence 
rate (34,3% ± 3,7) was measured 2 min after the start of illumination. With 50 mW/em' the 
increase was less (11% ± 3,4, n=4) but still significantly more than in the control animals. \Ve 
note that the fluence rate measurements indicate a significant reduction in perfusion just after 
the start of illumination only for UVB-treated skin, whereas the FF indicates the same only 
for nOl1nal skin after the end of the illumination. 
Tw%ld illuminations 
The VSD scores of group C, E and F (nonnal and UVB animals) are shown in Figure 7. In 
both nonnal and UVB skin there was no difference in damage between group C (l00 J/cm') 
and E (200 J/cm'). However, two illuminations of 100 J/cm' seperated by a 6 h interval 
caused a significant increase of damage as shown by group F. The VSD after the multiple 
illuminations in normal skin was 4.3 times and in UVB skin 2.5 times higher than after a 
single 200 J/cm' light dose delivery. In both nonnal and UVB skin the areas treated with 
multiple illuminations were still different from HOllnal skin 25 days post treatment. Nonnal 
skin showed dennal scars with diameters of 2.1 and 2.3 mm. In the UVB skin scars in the 
dennis ranged from 1.7 to 3.2 mm diameter. These areas were histologically examined and 
the long tenn effects consisted of fibrous scar tissue in the dermis (II, III, IV) with complete 
local loss of hair follicles. 
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Figure 6: Increase in fluellce rate measured ill situ under the skill (± s.e.m.J, 2 minutes after 
the start oj the illumination. Illumination of normal alld UVB skill occurred at (=4 with a 
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Figllre 7: Meall visual sldll dalllage (2· 7 days; ± selll) of gl'Oup C, E, F (Table 1) treated with 
a jluellce rate of 100 IIIW/clll' alld a light jluellce (FL) of 100 (1I~6), 200 (1I~4) cOlltilluous 
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(t~4). 
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Discussion 
Flue/ICe rate and illterl'ai to iIIumillatioll 
In the first part of the study the effect of interval between ALA-application and illumination 
as well as the effect of two different fluence rates on the PDT damage effect were 
investigated. The basis for these experiments were the fluorescence results described in a 
previous paper (van der Veen et al., 1996). Based on the fluorescence intensities, an increase 
in damage to UVB and nonnal skin was expected for illumination at maxil:nal fluorescence 
(t~IO) compared to an illumination immediately after ALA-application (t~4). At t~1O there is 
still a clear difference in PpIX-fluorescence between UVB and normal skin in contrast to 
human Bee and surrounding skin after 16 h ALA-application (Meijnders ef al., 1996). 
In nomlal skin a higher PpIX-fluorescence level indeed resulted in increased PDT 
damage (t~1O versus t~4), which was significant (Fig.2) when treating at 50 mW/cm'. With 
the lower flucllce rate the damage at both treatment intervals was significantly larger than 
with 100 mW/cm'. Further reduction of the fluence rate (to 5 mW/cm') leads to further 
increase of damage (Robinson et al., 1998 and 1999). In UVB skin there was no correlation 
between the fluorescence intensity and damage. Neither was there an increased effect after 
lowering the fluence rate from 100 to 50 mW/cm'. This might be due to the larger PpIX 
levels, causing oxygen depletion even at the lower fluence rate. Further reduction of the 
fluence rate should then eventually lead to increased PDT-induced damage in UVB-treated 
skin as well, which has indeed been observed, at 5 mW/cm' (Robinson et al., 1999). It would 
therefore seem that lowering the tluence rate would reduce the therapeutic selectivity in our 
model. This could not be confimled experimentally in the same animal, because the treated 
area of transformed skin was always surrounded by transfonned skin and not by normal skin. 
Fluence rate effects were also reported by Hua ef al. (1995) who observed an increase in 
tumour growth delay after systemic ALA-PDT treating with 25 mW/cm' compared to 100 
m W Icm'. In a different model De Bmijn ef al. (1999) could not confinn this effect. The 
difference may result from differences in tumour oxygenation and perfusion. 
Histology 
The pattem of damage (rim or centre), observed visually, were studied histologically. In both 
UYB and nomlal skin maximum damage which was located at the centre of the illuminated 
area extended deeper into the skin than maximum damage which was located at the rim of the 
illuminated field (Table IV). The rim pattem has also been observed in patients (personal 
communications W.M. Star and A.R. Osseroft) A possible explanation for this phenomenon 
is oxygen depletion by PDT and reduced oxygen supply to the centre by diffusion, combined 
with reduced perfusion during treatment, as demonstrated in Figs. 5 and 6. Oxygen is 
essential for PDT induced damage. During illumination the oxygen concentration in the cells 
rapidly decreases by consumption in the PDT reaction. Even with an intact circulation the 
need for oxygen may be greater than the oxygen supply by diffusion. The reduced perfusion 
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is limited to the illumination field. At the rim of this field the oxygen supply is larger than in 
the centre of the illumination field as a result of oxygen diffusion from the surrounding 
untreated tissues. The better availability of oxygen results in more damage at the rim than at 
the centre of the illuminated field. With a low fluence rate, the demand for oxygen is less so 
that diffusion might maintain the oxygen concentration at a higher level, resulting in a more 
central damage in both UVB and normal skin. 
Vascular effects 
So far, vascnlar effects were believed to be absent or much less for topical ALA-PDT than for 
PDT with systemically administered ALA (van del' Veen ef al., 1994). The fluence rate 
measurements as well as the fluorescein studies show a reduced vascular perfusion during 
illumination after topically applied ALA. Wang et al (1997) reported an increased vascular 
perfusion after topical ALA-PDT. These assays are complementary. The fluence rate 
measurements show a significant acute reduction in perfusion for UVB-treated skin, whereas 
the FF shows a significant reduction in perfusion after illumination for nonnal skin.\Vang et 
al. (1997) reported an increased vascular perfusion after topical ALA·PDT of human BCC. 
However this occurred predominaly in the surrounding nonnal skin. The perfusion in the 
centre of the lesion after PDT appeared almost unchanged. 
During and after PDT using i.v. ALA-administration we have directly observed 
vasoconstriction (1994), which recovered in time after a single illumination. In the present 
study, we have observed reduced perfusion, which may be the result of vasoconstriction. It is 
possible that increased interstitial pressure, due to histamine induced reaction, reduces the 
blood volume. However, edema was only obsen'cd after PDT in time, in contrast to the 
measurements of fluencc rate and fluorescein fluorescence. 
Concluding the discussion of the first part of the study, we note that in clinical 
treatments the incident fluence rate is usually made as large as possible, to limit the treatment 
time. The upper limit is detennined by the desire to avoid hyperthemlia and by pain felt by 
the patient. In our experience, reducing the fluence rate may relieve the pain during 
illumination. Therefore, reducing the fluence rate may serve a dual purpose: less pain and an 
increased effect. Using mouse data as a guide for clinical protocol requires caution. 
Nevertheless, it seems safe to conclude that not only the total light fluence , but also the 
fluence rate should be reported and kept constant in ALA·PDT treatments. The mouse data 
suggest an association between more central and deeper damage at lower fluence rate and 
between rim type and less damage at higher fluence rate. Since the rim type damage has also 
been observed clinically at fluence rates of 100 m \V/cm2 or more, it seems wise to keep the 
fluence rate as low as practically possible. ALA-PDT at very low fluence rates deserves 
further study. The long treatment times may seem impractical, but with low power, diode 
lasers and suitable light delivery devices low-fluence rate ALA· PDT may become an 
attractive option. 
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Tw%ld il/llminations 
In the second part of this study the effect of mUltiple illumination on the PDT damage effects 
was investigated. Two illuminations separated by a dark period of 6 hour may not be 
clinically practical. However, this study was designed to achieve maximal damage under the 
most optimum circumstances concerning PpIX-fluorescence intensities. \Vhen the mechanism 
for the enhanced effect is better understood it may be possible to design a more practical 
protocol. 
Twofold illuminations separated by an almost 6 hours interval resulted in a 2.5-4.3 
times higher VSD than after a single illumination. The enhanced damage effect with multiple 
illuminations was not the result of an increased light fluence, as shown by group E. A 200 
J/cm2 single illumination "control" was only performed at t=4 and not at t=lO. Since 100 
J/cm' at 100 mWlcm' completely photobleaches the fluorescence of PpIX as well as the 
photoproducts (Robinson ef al., 1998 and 1999), no increase of damage was expected upon 
increasing the fluence to 200 J/cm' and this was confirmed at t=4, for both nomlal and UVB-
treated skin. 
After the first illumination the PpIX-fluorescence of the treated areas increased at the 
same rate as the control (ALA, no light) areas on the same mice (van der Veen ef al., 1997). 
The similar rate of increase may suggest that all cells (damaged or not) still have the capacity 
to fonn PpIX. An altemative explanation is that some cells have an increased PpIX 
accumumlation and that severely damaged cells have lost the capacity to form PpIX. This 
effect was illustrated by He ef al. (1993) who observed a decreased ferrochelatase activity in 
cells after PDT, which may result in an increase of PpIX due to a decreased metabolization of 
PpIX to haem. Since ALA was applied to a relatively large area of hairless mouse skin, one 
may wonder if circulating PpIX is not partially responsible for the new fluorescence after 
photobleaching. We have checkes this by measuring the fluarescence before and after 
illumination of 7mm diameter spots on UVB-treated mouse skin when ALA was applied to 
different areas: in one group to a large part of the dorsal skin, in the other group to areas of 
about 7 mrn diameter. There was no significant difference in rate of increase of fluorescence 
(Van der Veen ef al., 1997). New fluorescence was also found to arise in human BCC after 
ALA-PDT (Orenstein ef al., 1997; AfKlinteberg ef al., 1999), although relatively less than in 
hairless mouse skin. Orenstein ef al. (1997) reported substantial new fluorescence afler PDT 
of nodular BCC. A second illumination was mentioned but not the clinical resultThe PpIX-
fluorescence level just before the second illumination in the treated areas given PDT was for 
UVB-treated skin 2.5 and for normal skin 2.4 times less than the control areas on the same 
mice at the same time after the ALA-application. This relatively low PpIX-fluorescence level 
of the treated areas suggests that the increased damage effect after the second illumination is 
unlikely to be ollly the resnlt of new PpIX. The as yet unknown phenomona responsible for 
the light fractionation effect reported by Cumow ef al (1999) may also play a role here. 
Increased sensitivity for PDT may result from recovery reactions of the 
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cells initiated by the first illumination. Reoxygenatioll between the two light fractionations 
may also play a role, by diffusion and by reperfusion of constricted blood vessels. 
Nevertheless, even though the mechanism of the observed phenomena remains unclear, ALA-
PDT using twofold illumination has been shown to be more effective than using single 
illumination in different tumour models and with topical (present paper) as well as systemic 
ALA-administration (de Bruijn et al.,1999; van der Veen et aI., 1994). 
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Chapter 7 
Kinetics of PpIX fluorescence after topical ALA 
application to normal and tape-stripped human skin. 
Authors: IN. van der Veen, IH.S. de Bruijn, IW.M. Star and 'H.E. Bodde 
IDr. Daniel den Hoed Cancer Centre; Department of Clinical Physics, PDT research Labora-
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Laboratories, University ofLeiden.(H.E. Bodde deceased September 8, 1996) 
101 
102 
Introduction 
Photodynamic therapy using topically applied 5-aminolevulinic acid (ALA) is a relatively 
new and successful treatment modality for superficial llotHlleianorna skin tumours. ALA~ 
application to skin leads to an accumulation of the endogenous photosensitizer protoporphyrin 
IX (PpIX) in epidernlal cells. The conversion of ALA to PpIX is accomplished in nonnal and 
neoplastic skin cells by enzymes in the haem synthesis pathway. An iIInmination with light 
causes a photochemical reaction that results in tissue destruction. In the past 8 years a large 
number of clinical studies has been perfonned treating actinic keratoses (AK), basal cell 
carcinoma (BCC) and squamous cell carcinoma (SCC) (Kennedy ef al., 1992; Lui ef al., 1995; 
Meijnders ef al., 1996; Stables ef al., 1997). Although the results are promising, considerable 
variation in results was obscnred within and between different studies. 
The stratum corneum (SC) is the limiting barrier to the penetration through the skin of 
topically applied drugs. The stratum comeurn consist of comeocytes embedded in a matrix of 
lipid bilayers and stacked in overlapping layers. The shape and surface features of the 
corneocytes are adapted to maintain the integrity of the SC but also to allow desquamation. In 
the SC layer there is hardly any metabolic activity and the SC acts as a passive diffusion 
medium. There are important chemical and stmctural disparities in the SC from one site to 
another. As a result, the skin barrier function may vary between different sites. As an 
illustration, the penetration of hydrocortisone in humans at various sites is shown in table 1 
(table adapted from Feldmann and Maibach, 1967). Also, with a wide variety of other 
chemical moieties examined, a general pattern of regional variations was observed (Maibach, 
1971). It was found that the penetration of the drug cOlTelated with the thickness ofthe SC. 
The thickness and the structure of the SC above skin lesions like AK, SCC and BCC is 
different from nomlal skin. The penetration of dmgs into superficial lesions is mostly 
enhanced due to a decreased skin barrier function. The penetration into non-superficial lesions 
is mostly insufficient. leffes et al. (1997) obsenTed an inverse correlation between 
fluorescence (ppIX production) after topical ALA and the grade of AK. The PDT damage 
decreased with increasing grade of AK which was also observed for SCC and BCC by 
Szeimies el al. (1996). Besides the grade of the skin lesion, the location of the lesion is also 
important for the response to PDT. Non-melanoma skin lesions occur most frequently 011 the 
head, neck and hands, parts of the body habitually exposed to sunlight. Jeffes ef al. (1997) 
examined the differences in damage effect after ALA-PDT between AK's located on the fhee 
and scalp and lesions located on the tnmk and extremities. They observed a higher 
fluorescence after ALA-application to lesions located on the scalp and face than to lesions 
located on the tnmk: and extremities. Also, in the nonnal-appearing skin adjacent to the 
lesions the fluorescence on the face and scalp was higher (but less than the lesions) than on 
the tnmk: and extremities. Subsequently, after light irradiation a significantly better response 
of AK's on the face and scalp (91% complete response) was observed than on the tnmk and 
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extremities (45% complete response). Szeimies ef ai. (1996) reported similar diffcrenees in 
effects aftcr ALA-PDT between AK's located on the head and on the hands. This difference in 
effect between lesions on the face and scalp and lesions on the tmnk and extremities has also 
been observed after topically applied chemotherapy and chemical peels (Lawrence ef ai., 
1995; Pearlman ef ai., 1991). An important factor in this difference in damage effect between 
various sites is the thickness and composition orthe SC. 
Table 1. Penetration of Hydrocortisone in Humans at Various Anatomic Sites. 
Table adapted from Feldmann and Maibach (1967). 
Anatomical site Penetration ratio 
Foreann (ventral) 1.0 
Foreann (dorsal) 1.1 
Foot (plantar) 0.14 
Ankle (lateral) 0.42 
Palm 0.83 
Back 1.7 
Scalp 3.5 
Axilla 3.6 
Forehead 6.0 
Jaw angle 13.0 
Scrotum 42.0 
For a successful ALA-PDT treatment of superficial lesions located on the tmnk and 
extremities and for non-superficial skin lesions better penetration of ALA through the SC is 
necessary. Several options have been considered to increase the concentration of ALA in the 
skin. The use of the penetration enhancer dimethylsulfoxide (DMSO) increased the 
fluorescence after ALA-application to nodular lesions (Peng ef ai., 1995). However, the 
response rate after ALA-PDT of nodular lesions was not clearly improved (\Varloe et al., 
1995; Peng ef at., 1995). Iontophoresis was shown to increase the penetration of ALA 
through the nonnal SC (Rhodes ef ai., 1997). This teclmique involves the active deliyery of 
small charged molecules into the skin by the application of an electrical current. An increased 
concentration of drug in the skin can also be accomplished by increasing the duration of ALA-
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application. \Vith a long application time the increased ALA-availability in combination with 
a long occlusion time resulted in an increased fluorescence in normal skin (Szeimies et al., 
1993; Meijnders et al., 1997). The penetration of the dmg can also be cnhanced by tape-
stripping the skin which reduces the thickness of the SC. Tape-stripping the skin resulted in a 
fourfold increase in penetration of hydrocortisone (Feldmann and Maibach, 1965). Similarly 
enhanced factors have been found with other chemical compound (Maibach et al., 1971). The 
effect of tape-stripping on the penetration of topically applied ALA in human skin is 
unknown. 
In this study wc examined the cffect of ALA-application timc, location and tape-
stripping on the fluoresccnce kinetics. In a first experiment the fluorcscence kinetics after 4 
and 16 hours ALA-application on nonnal human skin was examined. ALA was given on two 
locations: the flexor of the foreann and the lower pmi of the back. In a second experiment the 
ALA induced fluorescence kinetics in nonnal and tape-stripped skin on the flexor ann was 
examined after a 4 hour ALA-application time. The fluorescence kinetics of both Ilomlal and 
tape-stripped skin was examined by excitation with three wavelengths and therefore three 
different penetration depths in order to estimate the penetration of ALA induced PpIX in time 
through the skirt 
Materials and Methods, Experiment I: 
ALA-applicatioll 
The first experiment was perfonned on 7 healthy voluntcers, 2 females and 5 males. On each 
person the fluorescence kinetics was examined on the flexor of both forearms and on the 
lower part of the back. On each ann 2 areas and on the back 3 to 4 arcas of 1.5 cnl were 
marked. In some areas the thickness of the SC was reduced by stripping the skin 10 times with 
tape. The stripping was perfonncd by a trained person according to a method well described 
by Pinkus et al. (1951). 
An indication of the skin bamer function before and after tape-stripping was obtained 
by measuring the transepidennal epidermal water loss (TEWL). Water molecules diffuse 
across the skin, and this process accounts for approximately 35% of the total water loss from 
the body. TEWL has been related to the skin banier function and it was observed that a high 
TEWL rate has been detected in patients with stratum corneum (SC) disorders, like psoriasis 
(Frost et al., 1968). In this study the TEWL was measured with an Evaporimeter. The 
working principle is the measurement of the partial water vapour prcssure at 2 points at 
known distances above the skin surface. The partial pressure gradient is computed according 
to Fick's law of diffusion and the evaporation rate, i.e. the transdemlal water loss rate, is 
displayed (Nilsson et al., 1977). The actual method and the factors affecting reliable 
measurements are described by H. Tanojo in his PhD thesis (University of Leiden, 1996): 
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"Fatty acids as enhancers of dmg pemleation across human skin". One person who had the flu 
showed a TEWL 2 to 3 times higher compared to the other persons, due to fever. This person 
was excluded from the study. 
After the TE\VL measurements a solution with ALA or a solution without ALA was 
applied to all marked areas for 4 or 16 hours (Table 2). The solution with ALA (Fine tech; 
Haifa, Israel) was freshly made in a concentration of 20 % (w/w) and 0.2 ml was absorbed 
into a gauze of 1.5 cm2 which was placed on the skin. A piece of transparent film dressing 
(Moinlycke, \Varemme, Belgium) was placed over the gauze to prevent evaporation and 
movement of the solution. After the application period the solution was removed and the skin 
was carefully cleaned with water and dried with a towel. 
Table 2. Areas of skin studied in the first experiment (n~6) 
Application ALA Skin Number of areas 
Time (h) Ann Back 
4 + non11al 15 8 
4 + stripped 9 8 
4 - stripped 4 -
16 + nonnal 4 4 
16 - normal - 4 
Fluorescence recordings 
Recordings were made before, immediately after and every 2 hours after ALA-application 
until 28 hours after the first fluorescence recording. Light from a halogen lamp and a 
bandpass filter were used to excite fluorescence at a wavelength of 500 ± 40 JUn with a 
fluence rate of 0.2 m\V/cm2• The fluorescence was detected through a filter that passes light 
above 665 nm. Fluorescence images were recorded using a charge-coupled device (CeO) 
camera with a two-stage image intensifier. The experimental set-up is explained in more detail 
by van der Veen ef al. (1994). The fluorescence was quantified digitally by calculating the 
mean greyscale value within an area as large as possible (approximately 1.5 cm2) of the 
recorded fluorescence image. 
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Results, Experiment I: 
Autofluorescence. 
The intensity of the autofluorescence signal on the flexor part of the ann was nearly the same 
in 5 out of 6 volunteers. The autofluorescence 011 the lower part of the back showed a large 
variation between volunteers. In almost all volunteers the autofluorescence of the back was 
higher than on the mm by a factor between 1 and 2. Tape-stripping did not alter the 
autofluorescence signal. 
PpIX-jlllorescence a/tape-stripped versus normal skill. 
There was a marked variation in the results because of problems with the experimental set·up. 
Some parts of the experimental set-up were not fixed which resulted in irreproducible 
measurements. The effect of tape-stripping on the PpIX-fluorescence kinetics was examined 
again in the second experiment with an improved set-up. Therefore, the results of the first 
experiment will not be discussed. 
Duration of ALA-applicatioJl. 
In 4 volunteers ALA was applied for 16 hours on the back and the ann. The results after 16 
hours of ALA-application were compared with the results after 4 hours of ALA-application on 
the same volunteer. The PpIX-fluorescence immediately after 16 hours of ALA application 
was all the anll 2.3 (s.e.l11. ± 0.2 ) and all the back 1.9 (s.e.m. ± 0.2) times higher than all skin 
with ALA applied for 4 hours. On the ann maximum fluorescence at 16 hours was 2.3 (s.e.l11. 
± 0.5) times higher than maximum fluorescence after a 4 hour ALA-application time. On the 
back, maximum PpIX-fluorescence intensity after 16 hours ALA-application was 1.1 (s.e.lll. ± 
0.5) times higher than maximum fluorescence of skin applied with ALA for 4 hours. After the 
16 hours ALA-application maximal PpIX-fluorescence on the ann and on the back was 
achieved between 0 and 8 hours (t=16 and 24 hours) with an average of approximately 4 
hours (t~20) post ALA-application. 
Location. 
In 5 out of 6 volunteers the TEWL value before and after tape-stripping was lower on the ann 
than on the back. Also, in these volunteers maximal PpIX-fluorescence intensity following 4 
hours ALA application on nannal skin was higher on the back than on the ann. After 16 hours 
ALA application there was no difference in maximal PpIX-fluorescence intensity on either 
back or aml. 
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Materials and Methods, Experiment II: 
ALA-applicatiol/ 
The second experiment was perfomled on 8 healthy volunteers, 1 female and 7 males. In the 
first experiment we observed that the variations in the results on the ann and back were large. 
Especially the application of ALA to the back was not optimal due to movement of the gauze 
with solution resulting from movement of the volunteer. Therefore, in this experiment only 
the fluorescence kinetics of the flexor of one foreatm was examined. On one arm 3 areas were 
marked and the skin of one area was stripped. In the second experiment the skin was stripped 
15 times with tape instead of 10 times as in the first experiment. This was done with the hope 
of increasing the difference in PpIX-fluorescence intensity between tape-stripped and nonnal 
skin. The TEWL before and after tape-shipping and at the end of the experiment was 
measured. A 20% ALA solution (w/w) was freshly prepared and the solution was set at pH 
5.5 by adding sodium hydroxide (2M). On one nonnal and one tape-stripped area 0.2 ml 
solution with ALA was applied and covered with a thin gauze of 1.5 cm2, On a third area the 
solvent without ALA was applied to the skin. A piece of transparent film dressing 
(Molnlycke, \Varemme, Belgium) was placed over the gauze to prevent evaporation and 
movement of the solution. The solution was applied to the skin for 4 hours after which it was 
carefully removed. 
C 
Figure 1. Template for correct repositioning of the arm. The arm was placed in the template 
alld positioned lIsing marks Oil the skill. By pumping air ill the bag (a) the arm Was lifted and 
fixed. For each wavelength a piece of fluorescent plastic (b) was placed 011 the template so 
that small variations ill 01llput of the excitation light could be corrected. The areas were 
repositioned under the CCD-camera lIsillg a rail system (c) with stops (d) at certain 
distances. 
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Fluorescence recordings 
Experience obtained with the first experiment resulted in an improved second experiment. A 
template (Figure 1) was made to fix the ann during the measurements and for correct 
repositioning of the ann each time. Also, the CCD camera was fixed to ensure an optimal 
light field during the entire experiment. Fluorescence recordings were made before and every 
2 hours after the start of the ALA-application until 28 hours after the first recording. In the 
second experiment an extra recording was made during the application, 2 h after the start of 
the application period. At that time the transparent film dressing above a gauze was carefully 
removed with scissors without damaging the skin. The gauze containing the ALA was also 
removed and a fluorescence recording was made. The solution is clear and non~f1uorescent so 
that the recordings could be made without cleaning the skin. After the recording the removed 
film dressing with the gauze was re-placed on the skin and a new film dressing was placed 
over the first. Light fi'om a Halogen lamp and bandpass filters located in a filter wheel were 
used to excite fluorescence at three different wavelengths as shown in table 3. The applied 
fluence rate and detection filters are also shown in this table. The experimental set~up is 
explained in more detail by Robinson el at (1998). 
Table 3 Fluorescence excitation and emission wavelengths of the second experiment. 
Fluence rate Excitation Detection 
(mW/cm') wavelength wavelength 
Violet 0,03 400± 30 670± 50 
Green 0,13 500± 20 670 ± 50 
Red 1,30 625 ± 20 700±20 
Results, experiment II: 
TEIVL 
The TEWL before stripping was almost the same in all volunteers (6.9 glm'h ± 0.4 s.e.m.). 
After stripping a large variation in TE\VL values between persons was observed. In 3 out of 8 
volunteers the TEWL was between 15 and 21 glm'h. In 4 volunteers the TEWL aaer stripping 
was larger, between 40 and 84 g/m2h. One volunteer did not show an increase in TEWL after 
stripping and this person was excluded from the entire study. The TE\VL values were lIsed to 
compose two groups. Group A consisted of 3 volunteers in whom the TE\VL increased by 10 
to 15 glm2h after tape~stripping. Group B consisted of 4 volunteers in whom the TEWL 
increased by 30 to 75 g/m2h after tape-stripping. In this group the skin of2 volunteers with the 
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highest TEWL increase glistened after tape-stripping indicating moisture and one day after the 
experiment a superficial crust had been fonned on the stripped area. 
Excitation wavelength 
The fluorescence after a 4 hour ALA-application time of both uonnal and tape-stripped skin 
was excited with violet (400 ± 30), green (500 ± 20) and red (625 ± 20) light. The effect of the 
excitatioll wavelength on the fluorescence kinetics wiII be discussed only for nomlaL skin (not 
tapeMstripped). In figure 2 the nonnalised fluorescence kinetics (fluorescence maximum is 
100%) of all volunteers excited with violet, green and red light is shown. The rate of 
fluorescence iIicrease was similar for the 3 excitation wavelengths. There was no difference in 
the time after ALA-application to maximum PpIX-fluorescence between violet, green and red 
excitation light. After the PpIX-fluorescence maximum, the fluorescence excited with violet 
decreased faster than the fluorescence excited with green and red. The decrease of 
fluorescence excited with green and red was similar. 
Figul'e 2. Afeall fluorescence kinetics (normalised at tlte fluorescence maximum; 1l=7; ± 
s,e.m.) a/normal sldn to which ALA had been applied/or 4 hours, excited with violet (400 ± 
30), green (500 ± 20) and red (625 ± 20) light. The autofluorescence was subtracted. The 
timescale indicates time after the start 0/ the 4 hOllrs ALA application. 
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Tape-stripping 
The PpIX-fluorescence kinetics of tape-stripped and nonnal skin of group A and B at three 
different excitation wavelengths are shown in figure 3a to 3f. For this figure the 
autofluorescence value was subtracted from the PpIX fluorescence data. In group A the 
fluorescence increase of stripped skin was higher than normal skin with all three excitation 
wavelengths. In two volunteers the fluorescence of both stripped and nomlal skin increased 
until t~IO (6 hours after the 4 h ALA application). After t~IO the fluorescence decreased and 
at t=18 the fluorescence of nonnal skin had almost retumed to autofluorescence level. The 
fluorescence of tape-stripped skin decreased only slowly and especially with red excitation 
light the fluorescence at the end of the experiment was still high. In one volunteer a different 
fluorescence pattem was observed. The fluorescence of both norulal and tape-shipped skin 
increased until t= 18. This resulted in the large s.e.lll. after t= 1 0 as observed in figure 3a to 3c. 
In group B the fluorescence increased until t=10 for all three excitation wavelengths. 
\Vith violet light the increase of fluorescence in tape-stripped skin was less than of Honnal 
skin. After Illaximulll fluorescence a fast decrease was observed in normal skin whereas the 
fluorescence of tape-shipped skin hardly decreased. With green and red excitation light the 
fluorescence of tape-stripped skin at all times was higher than that of Boruml skin in two out 
of 4 volunteers. After maximum fluorescence a decrease was observed in nomlal skin whereas 
in tape-stripped skin the fluorescence hardly decreased. Even at t=28 the fluorescence 
intensity was almost similar to the fluorescence intensity observed at time of maximum 
fluorescence. 
The difference in maximum fluorescence intensities and time of maximum PpIX-
fluorescence between group A and B is shown in table 4a to 4c. There is no difference in time 
of maximum fluorescence between the groups and between the different excitation 
wavelengths. Maximum fluorescence intensity of nonnal skin was similar in volunteers from 
group A and B. Maximum fluorescence intensity in group B of tape-stripped skin was similar 
to nonnal skin. Only in group A did the tape-stripped skin show a higher maximum 
fluorescence intensity compared to the other groups. 
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Figure 3. Fluorescence kinetics ( ± s.e.m.) of group A (figure 3a-c; TEWL increase elween 10 
alld 15 glm' ft; 1I~3) alld B (jigllre 3d-/: TETVL illcrease betweell 30 alld 75 glm'ft; 11=4) of 
normal alld tape-stripped skill excited with 3 wavelengths, violet (400 ± 30), green (500 ± 20) 
and red (625 ± 20) light. The autofluorescence was subtracted ill these figures. 
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a 
Violet (400 ± 30 nm) 
Group A Group B 
Skin nomlal stripped nannal Stripped 
Flu=, (a.u.) 56 (± 16) 73 (± 5) 58 (± 9) 42 (± 5) 
tnul (hours) 13 (± 6) 12 (± 3) II (± I) II (± I) 
b 
Green (500 ± 20 Illn) 
Group A GroupB 
Skin normal stripped normal Stripped 
Flu=, (a.u.) 44(± 14) 70 (± 6) 44 (± 8) 41 (± 4) 
t=, (hours) 13 (± 6) 12 (± 4) 11 (± 2) 11 (± 1) 
C 
Red (625 ± 20 nm) 
Group A Group B 
Skin Hannal stripped nannal Stripped 
Flumn (a. H.) 59 (± 26) 102 (± 1) 69 (± 23) 71 (± 2) 
t=, (hours) 12 (± 6) 10 (± 2) 11 (± 1) 11 (± 1) 
Table 4. Maximum fluorescence and time interval between the start of ALA application and 
maximum fluorescence of group A (TEWL increase 10-15 glm'h; ± s.e.m.) and B (TEWL 
increase 30~75 glm2h; ± s.e.m.) on nomlal and tape-stripped skin excited with violet (a), green 
(b) and red (c) excitation light. The fluorescence units are arbitrary but comparable between 
groups. 
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Discussion 
Experiment I 
Location 
The difference in ALA-induced PpIX-f1uorescence between the flexor of the foreann and the 
lower part of the back was examined. Before ALA-application an autofluorescence recording 
was made. In 5 out of 6 volunteers the autofluorescence on the back was larger than on the 
ann. Autofluorescence arises from elastin and collagen, both major compounds of the human 
dennis. \Vith age and exposure to sunlight these molecules may be altered. This was 
examined by Leffell el al. (1988) who found that the autofluorescence of sun-exposed skin 
was lower than of sUIl-protected skin. Furthemlore, the degree of pigmentation, Of melanin 
content, which absorbs light, varies between the locations. The effect of pigmentation, and 
changes in collagen and elastin due to sunlight, is likely to cause the lower autofluorescence 
intensity on the arm compared to the intensity on the back. 
The increase of PpIX-fluorescence, during and after 4 hours ALA-application on 
normal skin, was higher on the back than on the am1. The interval between the start of ALA 
application and maximum fluorescence was comparable between the back and the aml. For 
other topically applied dmgs the penetration through the skin was higher on the back than on 
the skin (table I). The limiting tissue layer for the penetration of dmgs through the skin is the 
SC. The SC on the back is thi,lller than on the amI, resulting in a higher penetration of ALA 
throngh the SC. This resnlts in a higher PplX concentration in the skin of the back compared 
to the skin on the ann. 
Duration oJALA-application. 
\Vith a long application time of 16 hours, the fluorescence was approximately 2 times higher 
than immediately after a 4 hour application. Also, in clinical studies a longer application time 
was also successful in increasing the fluorescence intensity in skin lesions (Szeimies et at., 
1993; Meijnders el al., 1997). With a long ALA-application time the fluorescence of the skin 
surrounding the lesions was the same as the fluorescence intensity observed in skin lesions 
(Meijnders el al., 1997). It may be that with a longer application of ALA the PDT effect can 
be increased. However, there have been no comparative clinical studies done so far, to 
examine the difference in damage between a short and a long application time. 
Differences behveen first and second experimellt 
In addition to differences in the experimental set-up and in the number of tape-shippings the 
applied ALA-solution also differed. In the second experiment the pH of the solution was 
higher than the solution used in the first experiment. In the first experiment the pH of the 
ALA-solution was approximately 2.3 (no adjustment of pH). In the second experiment the pH 
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of the ALA-solution was adjusted with NaOH to pH 5.5. This was done to avoid visible skin 
reactions like redness. as seen in our laboratory with animal studies. In a pilot study with 3 
volunteers the difference in fluorescence kinetics between the solution used in experiment I 
and II was examined. The ALA solution was applied to the skin for 4 hours and after removal 
of ALA the PpIX-fluorescence was measured 12, 16 and 20 hours with violet, green and red 
excitation light using the same experimental set-up as in the second experiment. In all three 
volunteers we observed a higher PpIX-fluorescence intensity in the areas with the ALA-
solution used in the first experiment (pH 2.3). The PpIX-fluorescence intensity of the solution 
with the low pH (as used in the first experiment) compared to the solution with the higher pH 
(as used in the second experiment) was the highest 16 hours after removal of ALA (1.30 
s.e.m. ± 0.18) and the lowest 12 hours after removal of ALA (1.13 s.e.m. ± 0.01). With all 
three excitation wavelength the fluorescence intensity following application of the solution 
with the low pH was higher than the fluorescence kinetics following the solution with the high 
pH. An enhanced penetration after application of a solution with a low pH, is also seen with 
other topically applied dmgs. A solution with a low pH results in an alteration of the integrity 
of the SC layer and therefore in alteration of the skin barrier function. 
Experiment II 
TEWL 
Although the skin of each person was tape~stripped 15 times a large variation in TE\VL 
increase after tape-stripping was observed. Because the SC is not a unifornl layer there is no 
relationship between stripping and the increase of TEWL. The stmcture, composition and the 
function of the comeocytes change {O\vards the outer surface of the skin. Cells in the deeper 
layer of the SC (stratum compactum) are thicker and have more densely packed, organized 
parallel arrays of keratin filaments, a more fragile comified cell envelope and a greater variety 
of modified desmosomes, compared with cells of the outer SC. The deep SC layer has the 
least water-binding capacity, but the highest water content among other SC regions. Mid~SC 
has the highest concentration of amino acids and is able to bind water with greater efficiency 
than cell-layers of either deeper or outer SC regions. The outer SC (stratum disjunction) has 
the lowest water content. Depending on what part of the SC is stripped away the TEWL 
increase will be small as seen in group A, or large as seen in group B. 
Excitation wavelength 
The skin is a multilayered organ with one strongly fluorescing layer, the epidennis. The 
thickness of the different layers varies between different sites but the SC is approximately 8-
15 ~m thick, the epidermis is 50-100 ~m thick and the papillary dennis with the skin 
appendages is approximately 100-200 ~m thick. The approximate depth oflight penetration in 
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fair caucasian skin to a value of 37% of the incident energy density was determined by 
Anderson and Parrish (The Science of Photomedicine, Chapter 6, Edited by Regan and 
Parrish, New York, 1982). They found that the approximate penetration depth of 400, 500 and 
600 nm light was 90, 230 and 550 fun respectively. This means that in our study with violet 
(400 ± 30 nm) light, fluorescence could be detected almost in the entire epidennis. With green 
(500 ± 20) and red (625 ± 20) excitation light PplX in the epidennis and the papillary dennis 
could be excited. The fluorescence kinetics between red and green excitation light was 
similar. \Vith violet excitation light the fluorescence decrease was faster than with green and 
red excitation light. \Ve had expected to see a shift in time of maximum fluorescence. The 
maximum of fluorescence excited with 600 nm light was expected to appear at the latest time. 
However, for all three excitation wavelengths the time of maximum fluorescence was the 
same. Apparently, the light penetration in non11al skin of all three excitation wavelengths was 
sufficient to excite fluorescence in all PpIX present. 
Tape-stripping versus normal skin 
Tape-stripping is a well known method to increase the penetration of dmgs through the skin. 
For example the penetration ratio of Hydrocortisone after tape-stripping was approximately 4 
(Feldmann and Maibach, 1967). Also, tape-stripping in combination with occlusion increased 
the penetration ratio by a factor of20 (Feldmann and Maibach, 1967). A similar pattern was 
observed with other dmgs (Feldmann and Maibach, 1967). Therefore, it is realistic to assume 
that also with ALA-application the penetration in tape-stripped skin is enhanced. Because the 
skin barrier is the limiting factor in the penetration through the SC, a higher fluorescence in 
tape-stripped skin was expected. This occurred in group A, volunteers with a relatively small 
decrease ill SC thickness after tape-stripping, but not in group B, volunteers with a strongly 
decreased SC thickness after tape-stripping. Topically applied ALA penetrates through the SC 
and is subsequently converied to PpIX in the epidemlal cells. In our study the fluorescence is 
an indication of the concentration of PpIX in the tissue. However, tape-stripping has a strong 
effect on the epidermal cells This strong epidennal cell reaction to tape-stripping, already 
visible Y2 hour after stripping, might result in alterations in the haem synthesis of these cells. 
This effect of tape-stripping on the epidennis was examined by Pinkus (1952) who used tape-
stripping as a method to study the mechanism of epidennal regeneration. After removing the 
SC of the flexor foreann he took biopsies y" 12,24,36,47, and 72 hours after tape-stripping. 
He examined the changes which take place in the number and sizes of cells, and also, in the 
number of mitoses in relation to completeness of stripping and to time elapsed after stripping. 
Already Yz hour after stripping macroscopical changes in the epidennal layer could be 
observed. The basal cells were larger and more widely spaced than in normal state and the 
number of prickle cell layers was reduced. Also, there were numerous pyknotic nuclei. At 12 
hours the basal cells were more hypertrophic, and their nuclei were situated at varying 
distances from the base. In the prickle cell layer there were still quite a few pyknotic nuclei 
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while other nuclei became hypertrophic. The 24 hour stage showed that one third or more of 
the thickness of the epidennis was made up of the columnar basal celIs and that a multiple 
parakeratotic layer covered the surface. At 47 hours he saw numerous cells in all stages of 
mitosis. The epidennis had almost doubled its nonnal thickness. In a second experiment 
Pinkus varied the number of tapcMstrippings and biopsies were made 48 hours after stripping, 
He found that the nuclear diameters and mitotic activity increased with increasing denudation, 
He concluded that the loss of keratinized cells itself acts as the primary stimulus to induce 
hypertrophy and mitosis 48 hours after stripping. Furthennore, he concluded that the mitotic 
activity was delayed in celIs that were appreciably damaged. 
Two factors are changed in tape-stripped skin. The penetration of ALA through the 
SC is increased whereas the haem synthesis might be decreased as a result of cellular changes 
after stripping. Both factors are detemlined by the decrease of the SC thickness after tape-
stripping. This may explain the results observed in this study. Depending on the increase of 
ALA penetration through the skin in combination with a decrease of haem synthesis in the 
cells the fluorescence in stripped skin is higher (group A) or lower (group B) than ofnomlal 
skin. 
The slope of the tape-stripped graphs was different from that of nomlal skin. The 
fluorescence of tape-stripped skin hardly decreased after maximum fluorescence. This may be 
the result of the high ALA-concentration in the tape-stripped skin as a result of the decreased 
skin barrier. Even at t=28 the fluorescence was almost similar to maximum fluorescence. 
Whether these porphyrins can be used successfully for PDT is unclear. In one volunteer a 
fluorescence recording was made at t=28. Because some fluorescing dirt was located on the 
area, the skin was carefully cleaned with water and dtied with a towel. After cleaning a second 
recording was made. With the second recording the fluorescence was clearly less, indicating 
that the PpIX fluorescence was wiped off. 
This study suggests that tape-stripping is not a good and reliable method to increase 
the PpIX concentration in nornlal skin tissue. \Vhether strong cell reactions after tape-
stripping also occur in skin lesions is not clear. 
Concluding remarks 
Diffusion of ALA across the SC of the skin is the limiting factor for ALA penetration in 
nonnal skin. Important factors that are successful in increasing the fluorescence intensity 
were, a long application time and a solution with a low pH value. Tape-stripping the skin did 
not automatically result in an increased fluorescence. In tape-stripped skin the limiting factor 
is no longer the diffusion across the SC but the rate of the haem synthesis. 
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Chapter 8 
General Discussion 
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General Discussion 
Studies using systemically administered ALA 
There are a limited number of publications about systemic ALA-PDT in patients. Small 
numbers of patients with rectal adenomas following surgery (Warloe e/ al., 1995), 
gastrointestinal tumours and polyps (Regula e/ al., 1995; Mlkvy e/ al., 1995), cancer and 
dysplasia in Barrctfs oesophagus (Barr et aI., 1996), precancer and cancer of the oral cavity 
(Fan e/ al., 1996) have been treated and in all cases only partial necrosis could be obtained. 
Optimization of systemic ALA-PDT is difficult because to avoid toxic reactions ALA-doses 
can not be increased above a maximum bolus of 60 mglkg. FurthemlOre, the bioavailability 
after oral ALA is low due to a low uptake from the gut and a poor penetration through cellular 
membranes. Improvement of the bioavailability is crucial to ensure sufficient PpIX 
concentration in tissues. The use of fractionated ALA administration and a fannulation for 
intravenous ALA administration are promising options to improve the ALA~bioavailability. 
Even when sufficient PpIX concentration in the tissues after oral ALA can be 
achieved in patients, it will still be difficult to achieve effective tissue damage after PDT. This 
is illustrated by animal studies. In animal studies high ALA~doses (intravenous, 200~600 
mglkg) have been used and the PDT efficacy using a single illumination was still found to be 
insufficient. The PDT effect is limited by the available oxygen concentration and oxygen 
consumption in the tissues and by the rapid photobleaching of PpIX. Reoxygenation of the 
tissues is limited by vascular constriction during illumination. \Ve found in the observation 
chamber model that vascular constriction occurred almost immediately after the start of the 
illumination. The severity of vascular constriction depended on the interval bctween AI:A 
administration and illumination. A bettcr reoxygenation due to the applied fluence rate or to 
the use of short light fractionation schemes was found to be successful in increasing the PDT 
efficacy by Curnow ef al. (1999), Hua e/ al. (1995) and Messman e/ al. (1995). However, this 
effect could not be clearly reproduced in our studies. We found that the most promising way 
to increase PDT efficacy was to use of long tenn light fractionation schemes (two 
illuminations separated by 75 minutes). In both the observation chamber model as well as the 
solid tumour model long term light fractionation induced substantial tumour necrosis. Long 
tenll light fractionation will be discussed below in a separate section. 
Concluding remarks: \Vhether PDT using systemically administered ALA can make a 
significant contribution to the treatment of cancer is not yet clear. Relatively new alternative 
exogenous photosensitizers are currently under investigation. The dmg m-THPC (meta-Tetra-
Hydroxy-Phenyl-Chlorin) has found to be very effective in inducing tissue necrosis. 
However, this drug causes a relatively long period of skin-photosensitivity (several weeks) 
compared to PpIX (one or two days). The limited skin-photosensitivity makes PDT using 
systemically administered ALA still attractive. However, problems concerning ALA-
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bioavailability and the oxygen concentration during illumination must be solved before PDT 
using systemically administered ALA can be applied successfully in humans. 
Siudies using lopically applied ALA 
Since the first publication of Kennedy el al. in 1990 many papers have been published about 
topical ALA~PDT for the treatment of non-melanoma skin tumours in humans. The long tenn 
histological response after topical ALA-PDT of superficial AK, BCC, SCC and Bowen's 
disease was approximately 85%. The efficacy of ALA-PDT for nodular BCC and SCC was 
disappointing in all studies (between 0 and 50% complete clinical response rate). However, 
Fink-Puches el al. (1998) recently reported a projected disease free rate at 36 months after 
ALA-PDT of 50% for BCC and only 8% for SCC. In almost all studies the clinical responses 
were found to vary strongly within and between patients. Jeffes el al (1996) found that AK's 
on the face and scalp responded better to ALA-PDT treatment than AKs on the trunk and 
extremities. In our study with healthy volunteers (Ch.7) we found that the fluorescence of 
skin on the trunk after topical ALA application was higher than the fluorescence on the 
foreann. The difference in thickness and composition of the SC between different sites of the 
body detennines the penetration of ALA into the skin. Present research to increase the PDT 
efficacy after topical ALA is therefore mainly focused on increasing the ALA penetration into 
the skin. The use of iontophoresis, penetration enhancers and ALA application time, to 
increase the ALA penetration into the skin, are options which are currently under 
investigation. 
In the volunteer experiment (Ch.7) the effect of reducing the SC by tape-stripping the 
skin was investigated. We expected that removing the SC by tape-stripping would 
substantially increase the ALA-penetration into the skin and therefore increase the PpIX 
concentration in the cells. However, we observed that removing the SC by tape~stripping of 
healthy human skin did not automatically result in an increased fluorescence after topical 
ALA application. Tape-stripping of skin with a relatively thick SC followed by topical ALA 
application resulted in a higher fluorescence intensity compared with ALA~application to 
nonnal skin (no tape-stripping). On the other hand, tape-stripping of skin with a relatively 
thin SC followed by topical ALA application did not result in a higher fluorescence intensity 
compared with ALA-application to nonnal skin (no tape-stripping). Tape-stripping causes 
epidennal cell rcactions which already occur 30 min after tape-stripping (Pinkus, 1952). This 
reaction is dependent on the thickness of the SC, e.g., a relatively thin SC reacts more 
strongly to tape-stripping than a relatively thick SC. The epidennal cell reactions may result 
in alterations in the haem synthesis and therefore in alterations in the PpIX synthesis. 
The fluorescence kinetics after topical ALA was examined in nomlai human skin and 
in hairless mouse skin (UVB~treated and non-UVB-treated). The most common clinical ALA 
application time is between 4 and 6 hours. Some institutes use a long ALA application time of 
16 to 20 hours. With this long application time the difference in fluorescence between the 
tumour and the surrounding skin may be lost. In our study on healthy human skin we 
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observed that the fluorescence after an application time of 16 hours was 2 times higher than 
immediately after a 4 hour application time. In both the hairless mouse model and in the 
human skin we observed a continuing increase in fluorescence 6-8 hours after the end of a 4 
hour application time. At maximum fluorescence, the intensity was approximately 2 times 
higher than immediately after application. In the hairless mouse model we observed in time 
after application an increased difference in fluorescence between UVB-treated and non-UVB-
treated skin. It was not possible to examine prolonged ALA-application in the hairless mouse. 
Considering the results obtained with the hairless mouse and the human skin studies it may be 
more £1vourable to apply ALA for a limited time and illuminate the applied area a few hours 
later. 
In the hairless mouse model larger PpIX fluorescence in UVB-treated animals at the 
maximum (t~lO, chapter 6) compared to immediately after ALA·application (t~4) did not 
result in significantly more damage upon illumination. This may be due to a limited oxygen 
supply in the tissues during the illumination. \Ve observed vascular constriction in hairless 
mouse model almost immediately after the start of illumination which was maximal 2 minutes 
later. The limited oxygen concentration during illumination, partly due to the constriction, 
resulted in a distinct pattern of skin changes. \Ve often saw more damage at the rim than at 
the centre of the illuminated area. These reactions were more often observed in UVB-treated 
mice than in the non-UVB-treated mice. The incidence of rim reactions was less after a lower 
fluence rate. This damage pattern is also sometimes observed in patients treated with topical 
ALA·PDT (personal communication W.M. Star). The incidence of this effect is not known 
because the damage reaction after a clinical treatment is not always followed in detail. The 
incidence of this effect needs to be investigated further to determine the occurrences .of 
vascular constriction during a clinical ALA-PDT treatment. 
In the hairless mouse studies using topically applied ALA, the effect ou UVB and 
nOIl-UVB skin after a single illumination was not severe. The effect after two illuminations 
(long telm light fractionation) separated by a dark period induced a strong damage effect to 
both UVB· and non·UVB·treated skin. The damage was so severe that after the observation 
time of 25 days the treated skin showed scar tissue and local loss of hair follicles. Long term 
light fractionation will be further discussed below. 
Concluding remarks: After topical ALA-PDT to hairless mouse skin, vascular constriction 
occurs which may limit the oxygen supply and therefore limit the PDT efficacy. The extent of 
these vascular effects in clinical ALA-PDT needs to be investigated. 
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LOl/g temllightjractiol/atiol/ (Twofold illllmil/litiol/s). 
Long teml light fractionation was the most successful way to improve the PDT effectiveness 
after systemically and topically applied ALA, compared to a single illumination. In all three 
models, observation chamber model, solid tumour model and hairless mouse model, two 
illuminations separated by a dark period induced clearly more tissue damage than a 
continuous illumination with the same light fluence. The damage to nonnal skin also 
increased clearly, so that the therapeutic selectivity did not increase. The precise reason for 
this strongly increased damage effect using long tenn light fractionation is not clear. Features 
that may account for this enlarged effect are: 
A) Recovery of vascular constriction during the dark period and as a result reoxygenation 
of the tissues. 
B) New PpIX synthetised during the dark period. In the observation chamber model and in 
the hairless mouse model the fluorescence after the first illumination was monitored. 
Immediately after the illumination the PpIX fluorescence was bleached and in time new 
fluorescence was observed. After topical ALA-PDT the iucrease of fluorescence iu the PDT 
treated areas was similar or faster (depending on the interval between ALA-application and 
the first ilIumiuation) than in the areas on the same hairless mouse which had received ALA 
but no illumination. \Ve have shown in the hairless mouse model that the new fluorescence 
was the result of locally fonned PpIX and was unlikely to result from PpIX leakage from the 
surrounding tissue. After systemic ALA~PDT we also found an increase in fluorescence after 
illumination in the observation chamber model. The increase was less than the increase in 
chambers which had received no illumination. The new PpIX synthetised after illumination 
may arise from cells that still have the capacity to synthetise haem. FurthemlOre, biochemical 
changes in the cells as a result of the first treatment may also cause an increased PpIX 
concentration. Cells can respond to photodynamic treatment by regulation of specific 
proteins, so called stress proteins (Fisher et aI., 1993; Curry and Levy, 1993). Qne of the three 
groups of stress proteins is haem oxygenase (Schlesinger, 1990), an enzyme which plays a 
key role in the regulation of haem hmlover. Induction of haem oxygenase due to ALA-PDT 
may then result in an increased PpIX concentration in the cell. 
The new PpIX synthetised in the dark period after the first illumination can be used in 
the second treatment to increase the PDT efficacy. The new fluorescence is unlikely to be the 
only detemlining factor in the increased PDT effect using long tenn light fractionation. After 
ALA-application the hairless mice received an illumination 6 hours after the end of the 
application (t~ I 0) or both immediately after application at t~4 and at t~ IO (long tenn light 
fractionation). The fluorescence intensity in the skin of the animals illuminated only at t= 10 
was approximately the same as the sum of the fluorescence in the second group (long tenn 
light fractionation) at t~4 (before the first illumination) and at t~IO (the new fluorescence 
synthetised during the dark period). The PDT damage between both groups however was 
clearly different. 
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C) An increased sensitivity to PDT due to recovery reactions after the first illumination. 
ALA-PDT may cause cell damage to membranes of Iysosomes, mitochondria and cytoplasm. 
The cells response to the treatment with a variety of damage protection/repair systems. Cells 
in this process may become more sensitive to PDT treatment. Also, after illumination the cell 
cycle phase may change. Cells in the S-phase or G2 are more sensitive to ALA-induced PDT 
than cells in the GI phase (Wyld el aI, 1998). This increased sensitivity in combination with 
the new PpIX synthetised in the dark period may result in the strong tissue response after the 
second illumination. This process needs to be investigated to understand the mechanism of 
the markedly increased tissne damage after long tenl1 light fractionation. 
Whether ALA-PDT treatment using long term light fractionation will be successful in humans 
is as yet unclear. There is only one study by Fan el al. (1996) who used long tenl1 light 
fractionation after orally administered ALA for the treatment of precancer and cancer of the 
oral cavity. They observed in all cases only partial necrosis after long and ShOl1 tenn light 
fractionation. However, in this study the systemically administered ALA doses were low 
compared to the doses used in animal studies and the synthetised PplX levels were around 
threshold level for producing tissue damage. 
In the DDHK the first patients with superficial skin lesions have been treated with 
topical ALA-PDT using twofold illuminations. The fluorescence prior to and after the first 
illumination was monitored and new fluorescence was observed in time after the illumination 
(Meijnders el aI, 1996). However, it is too early to tell whether topical ALA-PDT using 
twofold illumination is more successful than a treatment using a single illumination. 
Concluding remarks: Topical and systemical ALA-PDT using long tern] light fractionation 
induced the strongest PDT damage effect in tissues in our animal models. In the dark period 
between the illuminations processes like reoxygenation, the fomlation of new PpIX and 
probably an increase of sensitivity to PDT due to recovery reactions, take place that may 
account for this. Although it is tempting to apply ALA-PDT using long tenn light 
fractionation in patients, more information about the mechanism of the strongly induced 
damage after long term light fractionation is needed. 
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Summary of the studies 
Studies lIsing systemically administered ALA 
In chapter 2 PpIX-fluorescence kinetics in the observation chamber model arc described after 
two different doses of intravenously administered ALA. We found a higher fluorescence 
intensity in tumour tissue (IT) than in the surrounding subcutaneous tissue (ST), The initial 
maximum rate of fluorescence increase was similar between the two different ALA-doses in 
both TT and ST. This resulted in a later time of maximum fluorescence after the high ALA-
dose. Based on the PpIX-fluorescence kinetics, the IT and ST were illuminated at the time 
where the difference between IT fluorescence and ST fluorescence was maximal. 
Immediately after the start of the illumination, vascular constriction was observed and the 
damage effects on both IT and ST were disappointing. Treatment early after ALA 
administration resulted in less vascular constriction during the illumination and in a greater 
tumour tissue damage. After an early illumination ncw fluorescence, showing new PpIX, 
was observed which could be used for a second illumination. \Vith two illuminations 
separated by 75 minutes (long term light fractionation), complete TT necrosis could bc 
obtained while pemmnently damaging only a relatively small area of ST. 
In chapter 3 we show the results of different treatment schemes on the effectiveness of PDT 
using systemically administered ALA. Solid tumours, subcutaneously transplanted on the 
thigh of rats, were used as a model. The effects of four parameters on the PDT induced 
damage were determined by examining the difference in tumour growth delay. These 
parameters were: interval bctween ALA administration and illumination, fluence rate, short 
term light fractionation schemes (30 sec on/3D sec off or 5 J/cm2 then 2.5 minutes dark and 
95 J/cm2) and a long term light fractionation scheme (100 J/cm2 then 75 minutes dark and 100 
J/cm2). All of the investigated PDT schemes demonstrated a significantly longer tumour 
volume doubling time compared to control tumours. No significant difference in tumour 
volume doubling time was observed between the different schemes except the scheme using 
long tcrm light fractionation. This scheme increased the tumour volume doubling time by a 
factor of 2.6 over all thc other illumination schemes. 
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Study of the difference in fluorescence of hairless mouse skill after systemically and topically 
administered ALA 
The difference in fluorescence kinetics and localisation between topically and systemically 
administered ALA in the hairless mouse model is presented in chapter 4. The most apparent 
differences between both administration routes were the maximal fluorescence intensity and 
the time post administration to reach maximal fluorescence in UVB-treated skin. Maximal 
fluorescence after systemically administered ALA was reached early (2 h post injection) in 
UVB treated skin but was 3 times lower than maximal fluorescence after topically applied 
ALA, which occurred at 6 h after the end of the ALA application. The results obtained with 
the fluorescence cryo-microscopy study showed no important differences in localisation of 
PpIX fluorescence in the skin between both ALA administration routes. The fluorescence 
after both administration routes in both UVB treated and non-UVB skin was mainly located in 
the epidermal layer and in the hair follicles. 
Studies using topically applied ALA 
In chapters 5 and 6 we present the PpIX-fluorescence during and after PDT and the damage 
effects after topically applied ALA-PDT of UVB treated and non-UVB hairless mice are 
presented. Based on the fluorescence kinetics presented in chapter 4 two times for 
illumination were chosen, immediately after ALA-application (t=4) and at maximum 
fluorescence (t= 10). The animals received an iHumination with a fluence rate of 100 mW/cm2 
and a total light fluence of 100 J/cm2• In chapter 5 the results of fluorescence measurements 
during PDT (photobleaching) and after PDT are shown. We observed that the fluorescence 
during illumination of normal skin decreased at a faster rate than the fluorescence of UVB 
treated skin. No difference in bleaching rate was observed between an illumination at t=4 or 
at t= 10. The fluorescence after illumination of areas treated immediately after application 
(t=4) or at maximum fluorescence (t=lO) and of non-treated areas (ALA, no light) on the 
same mouse were examined. The arcas treated at t=4 showed a similar increase in time as 
non-treated areas. Areas treated at t=1O also showed a fluorescence increase after PDT 
whereas the fluorescence of non-treated areas on the same mouse did not increase (PpIX-
fluorescence maximum). \Vith both treatment times the new fluorescence showed a 
characteristic PpIX spectrum. \Ve demonstrated that the new fluorescence after PDT resulted 
from locally formed PpIX and was unlikely to result from PplX leakage out of the 
surrounding tissue. In chapter 6 the damage effects after PDT at t=4 or t= I 0 are presented. 
Although the fluorescence at t=1O of UVB treated skin was higher than at t=4 the 
macroscopical damage effects were similar. In non-UVB skin the fluorescence at t=4 and 
1=10 was almost the same but the damage to the skin which was treated at t=1O was higher. In 
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UVB skin the majority of the illuminated areas showed more damage at the rim than at the 
centre of the illuminated field. This damage pattern might indicate a limited oxygen supply, 
especially in the centre of the illumination. \Vith ill situ fluence rate measurements during 
illumination we observed vasoconstriction almost inunediately after the start of the 
illumination. Vasoconstriction was also demonstrated using the fluorescein exclusion assay. 
The vascular perfusion in UVB skin was more sensitive to PDT than the perfusion in non-
UVB skin. By lowering the fluence rate (from 100 to 50 mW/cm') an attempt was made to 
decrease the oxygen depletion and vasoconstriction during the illumination. This resulted in 
less constriction and reduced rim reactions but no clearly increased damage effect was 
observed in UYB skin. In non-UYB skin the damage was clearly greater compared to an 
illumination with a higher fluence rate. 
With long term light fractionation (illumination at t=4 and t=lO; 100 mW/cm'), using 
new PpIX-fluorescence arising after a single illumination, a significantly increased damage in 
both UYB and non-UYB skin was observed compared to a single illumination to the same 
total fluence (100 J/cm'). The damage to UVB and non-UVB skin was so severe that after the 
observation time of 25 days scar tissue and complete local loss of hair follicles was observed. 
Chapter 7 describes the effect of location, time of ALA application and tape-stripping on the 
PpIX-fluorescence kinetics of normal human skin. In this study ALA was applied during 4 
hours at two locations, the flexor of the forearm and the lower part of the back. We observed 
during and after ALA-application a larger PplX-fluorescence increase on the back than on the 
arm. The interval between ALA-application and maximum fluorescence on the arm and back 
was similar. With a prolonged ALA-application time (16 hours compared to 4 hours) the 
fluorescence at the end of application was approximately 2 times higher than immediately 
after a 4 hour application time. To examine the ALA penetration into the skin in time the 
fluorescence was excited with three wavelength bands, each with different penetration depth. 
However, this method did not yield clear differences in kinetics. A strong variation was 
observed between volunteers in PpIX-fluorescence kinetics after ALA application on tape-
stripped skill. An indication for the permeability of the skin after tape-stripping was given by 
the transepidermal water loss (TEWL). Based on the TEWL measurements volunteers were 
divided in two groups. The first group showed a slight increase in TE\VL after tape-stripping. 
In this group, the PpIX-fluorescence increase after ALA-application in tape-stripped skin was 
higher than of normal skin. The second group showed a strong increase in TE\VL after tape-
stripping. In this group the increase of fluorescence after ALA-application of tape-stripped 
skin was similar or less compared to normal skin. The time of PpIX-rnaximum fluorescence, 
approximately 8 hours after the end of the application period, was similar in tape-stripped and 
normal skin. 
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Samenvatting van de studies 
Studies met s),slemisc/z toegediende ALA 
In hoofdstuk 2 wordt de PpIX-fluorescentie kinetiek fla twee verschillende doses systemisch 
toegediende ALA in het observatie kamertjes model onderzocht. De fluorescentie intensiteit 
was hager in tumor weefsel (IT) dan in het omliggende subeutane weefsel (ST). De 
maximale fluorescentie toename in zowel IT en ST na twee verschillende ALA-doses was 
hetzelfde. Dit resulteerde bij cen hogere ALA-dosis in cen latcr tijdstip van maximale 
fluorescentie. Na het bepalcn van de PpIX-fluorescentie kinetiek werden de weefsels belicht 
op het tijdstip met maximaal verschil in PpIX-fluorescentie tussell IT en ST. Direct fla de 
start van de belichting werd vasoconstrictie geconstatecrd en de door PDT teweeggebrachte 
schade in zowel IT en ST was teleursteHcnd. Ecn belichting kort na ALA toediening 
resulteerde in minder sterke vasoconstrictie en in een hogcre tumor schade. Na eell vroege 
belichting werd in de tijd nieuwe fluorescentie waargenomen; cen aanwijzing voor nicuw 
gevormd PpIX. Deze nieuwe PpIX kan gebmikt worden voor een tweede belichting. Met 
twee belichtingen (lang licht fractioneringsschema), en daartllssen een wachttijd van 75 
minuten, werd complete IT necrose verkregen met slechts geringe permanente beschadiging 
van het ST. 
In hoofdstuk 3 werden verschillende behandeHngsschema's toegepast am de effectiviteit van 
PDT na systemisch toegediend ALA te verhogen. De invloed van 4 parameters op de 
cffectiviteit van PDT werd bepaald door vcrschillen in groeiuitstel te meten van solide 
tllmoren die sllbcutaan op de dijen van ratten groeien. De onderzochte parameters waren: 
interval tussen ALA toediening en belichting, flllentie tempo, korte licht fractionerings 
schema's (30 sec aan/30 sec nit of 5 J/cm' en 2.5 minuten danker gevolgd door 95 J/em' ) en 
een lang fractionerings schema (100 J/em' en 75 minuten danker gevolgd door 100 J/em'). In 
vergelijking met de contrale tumoren resulteerden aIle onderzochte schema's in cen 
significant langere tumor volume verdubbelingstijd. Met uitzondering van het lange 
fractionerings schema zagen we geen significant verschil in tumor volume verdubbelingstijd 
tussen de andere schema's. Met het lange Iicht fractionerings schema werd een 2.6 keer 
hogcre tumor volume verdubbclingstijd behaald in vergelijking met de andere schema's. 
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Studie over het l'ersc/lil ill jlllorescentie van de ham"loze l11uizen Iwid lUI systemisch ell 
topicaal toegediende ALA. 
In hoofdstuk 4 wordt het verschil in PpIX-fluorescentie kinetiek en lokalisatie tussen topicaal 
en systemisch toegediende ALA in het haarloze muizen model onderzocht. In 11lIid behandeld 
met DVB werd het maximale fluorescentie niveau na systemisch ALA vroeg (2 h na 
toediening) waargenomen. Het fluorescentie niveau was 3 keer lager dan het fluorescentie 
niveau na topicaal toegediende ALA. Hier werd het fluorescentie-maximum waargenomen 6 
uur na het einde van de ALA applicatie. Met fluorescentie cryo-microscopy studies werden 
tussen beide toedienings manieren geen duidelijke verschillen in lokalisatie van PpIX 
fluorescentie waargenomen. De fluorescentie was voomamelijk geiokaliseerd in de epidermis 
en in de haarfoIlikels van zowel huid behandeld met UVB als onbehandeld Imid. 
Studies mellopicaal toegediend ALA. 
In de hoofdstukken 5 en 6 worden de schade effecten na topicale ALA-PDT en de PpIX-
fluorescentie lijdells en lIa de belichting van Imid behandeld met DYB en onbehandelde huid 
gepresenteerd. Aan de hand van de fluorescentie kinetiek (hoofdstuk 4) werden twee 
tijdstippen voar belichtingen gekozen; direct fia ALA applicatie (t=4) en op maximale 
fluorescentie (t=IO). In hoofdstuk 5 worden de resuHaten van de PpIX-fluorescentie 
waamemingen tijdens (bleking) en na de PDT behandeling op t=4 en t=1O besproken. We 
vonden dat de PpIX-fluorescentie lijdens de belichting van de onbehandelde huid sneller 
afnam dan de fluorescentie van huid behande1d met UYB. Het tijdstip van belichten (t=4 of 
t=lO) had geen effect op de blekingssnelheid. Direct na de belichting werd geen PpIX-
fluorescentie meer gemeten. De fluorescentie na de belichting op t=4 en t= to werd gevolgd 
van zowel huid behandeld met UVB als onbehandelde Imid. Verder werd van dezelfde dieren 
de PpIX-fluorescentie gevolgd van een gebied behandeld met ALA maar niet belicht. Op t=4 
nam de PpIX-fluorescentie van de belichte gebieden even snei toe als de onbelichte gebieden. 
Op t= I 0 nam de fluorescentie van de belichte gebieden sneller toe dan de onbelichte gebieden 
op dezelfde muis. De nieuwe fluorescentie had het karakteristieke PpIX spectrum. De nieuwe 
PpIX-fluorescentie in de gebleekte gebieden werd niet veroorzaakt door lekkage uit de nog 
fluorescerende omliggende gebieden. De schade effecten na belichting op t=4 en t=6 worden 
gepresenteerd in hoofdstuk 6. In huid behandeld met UVB vonden we ondanks een hogere 
fluarescentie op t=lO geen verschil in schade tussen beide tijdstippen. In huid onbehandeld 
met UVB daarentegen was de PpIX-fluorescentie op beide tijdstippen bijna gelijk terwijl de 
schade van de Imid belicht op t=1O hoger was dan op t=4. Tijdens de dagelijkse metingen 
zagen we dat in de huid behandeld met UYB op zowel t=4 als t= 10 het merendeel van de 
dieren meer schade aan de rand dan in het midden van het belichte gebied hadden. Dit 
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schadepatraan kan het gevolg zijn van een zuurstofdepletie en een beperkte zuurstof-
voorziening in het midden van het belichte gebied. Dit werd bevestigd door de ill situ fluentie 
tempo metingen tijdens de belichting. Direct na de start van de belichting werd 
vasoconstrictie waargenomen welke maximaal was 2 minuten na de start van de beIiehting. 
Ook met fluorescelne fluorescentie metingen na de belichting werd vasoconstrietie 
aangetoond. We von den dat de vaten van llUid behandeld met UVB gevoeliger voor PDT 
waren dan de vaten van onbehandelde IlUid. Een nieuwe groep dieren werd behandeld met een 
verlaagd fluentietempo ( 50 m\V/cm2 versus IOO m\V/cm2) met als doel de vasoconstrictie en 
zuurstofconsumptie te vermindercn. In huid behandeld met UVB resulteerdc dit in minder 
vasoconstrictie en minder rand effecten maar niet in een versterkt schade effect. In de 
onbehandelde IlUid resulteerde een verlaging van het fluentie tempo in een vermindering van 
vasoconstrictie en in een grotere schade. 
In vergelijking met een continue belichting werd met lange licht fractionering 
(belichting op t=4 en t= 10) in zowel llUid behandeld als onbehandeld met UVB een sterk 
verhoogde schade waargenomen. De schade was zo sterk dat na de observatie tijd van 25 
dagen de huid nag niet volledig was hersteld. De haarfoilikeis waren verdwenen en er was 
littekenweefsel aanwezig. 
Het effect van plaats op het lichaam, ALA applicatie tijd en tape-stripping op de PpIX-
fluorescentie kinetiek van normale huid na topicale ALA applicatie wordt gepresenteerd in 
hoofdstuk 7. ALA werd geappliceerd op twee locaties, de binnenkant van de onderarm en de 
ondcITug. \Ve vanden dat de toename van PpIX-fluorescentie op de rug hager was dan op de 
arm terwijl het tijdstip van maxirnale fluorescentie hetzclfde was. De fluorescentie na een 
lange ALA-applicatie tijd (16 uur) was 2 keer hoger dan net na eell 4 uur durende applicatie. 
Het exciteren van de fluorescentie met drie golflengtes, am zo inzicht te krijgen in de 
penetratie diepte van ALA in de tijd, bleek niet het gehoopte resultaat op te leveren. De 
fluorescentie kinetiek voor al1e drie de golflengten was identiek. De fluorescentie kinetiek na 
het strippcn van de huid varieerde sterk tussen aile personen. De permeabiliteit van de huid 
voar en na strippen was gemeten en aan de hand van deze metingen werden de proef personen 
in 2 greepen verdeeld. In de eerste groep was er een kleine toename in permeabiliteit na het 
strippen en na ALA-appHcatie vonden we een hogere PpIX-fluorescentie toename in de 
gestripte huid dan in de niet-gestripte huid. In de tweede greep was er een sterke toename in 
permeabiliteit na het strippeu en ua ALA-applicatie vanden we een gelijke of mindere PpIX-
fluorescentie toename in de gestripte huid dan in de niet-gestripte huid. In beide groepen was 
het tijdstip van maximale tluorescentie (8 uur na applicatie) bij zowel gestripte als niet-
gestripte IlUid gelijk. 
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AK 
ALA 
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BCC 
Copro 
FF 
FIM 
FSM 
Lp. 
i. v. 
NS 
PBG 
PDT 
p.i. 
PpIX 
RH 
RJ\1A 
SC 
SCC 
S.C.Ill. 
T(TT) 
TEWL 
Uro 
UYB 
UYB-animals 
n-UVB-animals 
Actinic keratosis 
5-Aminolaevulinic acid 
A Itercd skin 
Basal cell carcinoma 
Coproporphyrin 
Fluorescein fluorescence 
Fluorescence imaging measurements 
Fluorescence spectroscopy measurements 
Intraperitoniai 
Intravenous 
Nomlal skin 
POI]lhobilinogen 
Photodynamic therapy 
Post injection 
Protoporphyrin IX 
Rhabdomyosarcoma 
Mammary carcinoma 
Stratum corneum 
Squamolls cell carcinoma 
Standard error of mean 
Tumour (Tumour Tissue) 
Trans epidennal water loss 
Uroporphyrin 
Ultra violet B 
Animals which received UVB irradiation 
Animals which received no UVB irradiation 
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Dankwoord 
Zo, het proefschrift is eindelijk af. Het dankwoord wil ik schrijven mbv een schematische 
weergave hoe dit proefschrift tot stand is gekomen en welke mensen daarbij belangrijk waren. 
Dit schema wordt in bedrijven gebruikt om allerlei organisatorische processen te beschrijven. 
Het leek mij wei een leuke manier om de invloeden en samenhang tussen de verschillende 
processen weer te geven. 
OMGEYING 
Familie 
Hans, Heleen 
llill.!I 
NKB-project 
Materialen 
Nynke, Riette 
r················ .. ··· 
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! 
t.. . ..................... , ... " ............................. " ............... J 
\Jitleg bii bovenstaand schema: 
OUTPlJT 
Artikelen 
Proefschrift 
Ret primaire praces bestaat uit tal van activiteiten, zoals experimenten, voordrachten, 
schrijven, vergaderen etc., die nodig waren vaor het tot stand komen van de artikelen en het 
proefschrift (de Output). Voor dit proces was input nodig welke in dit geval het NKB project, 
materialen en menselijke inspanning waren. Het geheJe primaire proces speelde zich afbinnen 
de afdeling photodynamische therapie en stond onder invloed van de omgeving. Voor het 
goed verlopen van het praces waren instandhoudings processen en bestuurlijke processen 
nodig. 
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INPUT/OUTPUT 
Het onderzoek was gebaseerd op cen project geschreven door Willem Star en gehonoreerd 
door de Nederlandse Kanker Bestrijding. De duur van het project was totaal4,5 jaar en in die 
tijd is er veel veranderd aan de hoeveelheid apparatuuf dankzij de inspalmingen van Willem. 
In het begin vau het project waren de middelen beperkter dan aan het einde van het project. 
Dit is ook terug te vinden in de artikelen, vooral in de artikelen gepresenteerd in hoofdstuk 4 
en 5 zijn modemere apparaten gebmikt dan in het artikel van hoofdstuk 2. Ondauks modeme 
middelen bleef het gelukkig noodzakelijk om je creativiteit te gebruiken tijdens de 
experimenten. De kleurenwaaier als referentiemateriaal is daar cen goed voorbeeld van. 
Het onderzoek was opgezet en uitgevoerd door mij en Riette. RieHe ik wil je hierbij bedanken 
voor de goede samenwerking gedurende het project. Behalve kwaliteiten die nodig zijn als 
analiste zoals, nauwkeurigheid, zelfstandigheid, kunnen meedenken, flexibiliteit, heb je oak 
nog veel andere kwaliteiten die zeker net zo belangrijk waren voor dit project. Ik wit er even 
enkele noemen: 
- Koken. Je zelfgemaakte hartige taarten smaakten altijd prima, zelfs al werden ze gegeten op 
gesmolten plastic bordjes. 
- Kletsen . We hebben er wat af gekletst in die Iaatste 4 jaar. Onze gesprekken achter het 
donkere gordijn vond ik erg gezellig en zo waren de wachttijden tussen de fluorescentie 
opnamen snet voorbij. Ik hoop dat je bij je nieuwe collega's weer een ktetspartner hebt 
gevonden. 
- VerdeI' benje oprecht en spontaan. 
Bedankt voor alles en ik hoop dat we nog lang contact met elkaar houden. 
AFDELING PDT 
In de 8,5 jaar die ik op de afdeling PDT heb rondgelopen zijn er verschillende collega's 
geweest, Jeanne, Eric, Hans, Otto, Hugo en Lars. Naast deze collega's hebben er ook vele 
studenten op de afdeling rondgelopen. Ik wil jullie allen bedanken voor de goede en gezellige 
werksfeer op de afdeling. Jullie waren altijd bereid mij te helpen met woorden en daden. Er 
zijn legio anekdotes te vertellen maar gelukkig zijn het er leveel om op te no em en. Mede 
dankzij jullie kijk ik met een goed gevoel temg naar die tijd op de afdeling PDT. 
INSTANDHOUDINGSPROCESSN 
Deze processen zorgen dat het primaire proces goed verloopt. De medewerkers van de 
afdelingen Medische Fotografie, Instmmentmakerij, Klinische Fysica, Bibliotheek, Magazijn 
en "Kantine" waren voor mij belangdjk voor het optimaal verlopen van het proces. lk wiI 
jullie bedanken voor onder andere de praatjes op de gang, het even kunnen bimlenlopen voor 
advies, het even snel tussendoor kUtlllen doen, de lekkere koeken en de vriendelijkheid. 
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BESTUURLIJKE PROCESSEN 
Mijn promotor Prof. Paul Wilson wil ik bedanken voor de begeleiding bij het tot stand komen 
van dit proefschrift. Mijn co-promotor Willem Star wil ik bedanken dat hij mij de 
mogelijkheid heeft geboden dit promotie onderzoek te doen. WiIlem, de hulp en ruimte die jc 
mij gaf maakte het mogelijk me optimaal te ontplooien. Ik bewonder je nimmer aflatende 
optimisme en gedrevenheid die hebben gezorgd dat het PDT-lab in 11 jaar tijd is gegrocid tot 
cen goed uitgcmst lab waaf menscn met verschillende disciplines succesvol samenwerken. 
OMGEVING 
De omgeving rond het primaire proces was solide en heeft gezorgd dat het proces zander veel 
problemen verliep. Mijn auders, broers, zus en hun partners hehhen mij gestimuleerd en 
waren de basis waarop ik altijd kon temgvallen. En ondanks dat mijn moeder niet meer leeft: 
weet ik dat ze nu haag in de wolken trots tegen de andere menscn verteld wat ik heb 
geprcsteerd. 
In de loop def jafen is er veel veranderd. Toen ik began op de Daniel was ik net van school af 
en 11U ben ik weer aan de studie, woon sarnen, ben maeder, heb cen huis, cen konijn en cen 
parkiet. Twec personen zijn de afgelopen jaren erg belangrijk veor mij geweest, mijn vriend 
Hans en mijn dochter Heleen. Hans, bedankt voar het maken van de omslag van dit 
proefschrift maar veeral bedankt veor je steun in de afgelopen jaren. Heleen, ik geloof niet 
dat je veel hcbt gemerkt van dit proefschrift. Ik hoop dat je later dit proefschrift onder ogen 
krijgt en weet dan dat the sky the limit is. 
Nynke van der Veen 
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Curriculum vitae 
Nynke van der Veen werd op 3 mei 1966 geboren te Deil. Na het behalen van haar 
HAVO diploma in 1984 volgde ze de studierichting zoologie aan de hogere laboratorium 
opleiding te Utrecht. Na het behalen van Imar diploma in 1988 ging ze werken als analiste op 
de afdeling photodynamische therapie van de Dr Daniel den Hoed Kliniek. Van 1993 tot juni 
1997 was ze werkzaam als aankomend wetenschappelijk onderzoeker op dezelfde afdeling. 
Deze werkzaamheden zijn de basis geweest voor dit proefschrift. 
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